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2DGE - 2-Dimensional Gel Electrophoresis 
3D - 3-Dimensional 
ABO - ABO blood system
ADULT - Acro-Dermato-Ungual-Lacrimal-
Tooth (syndrome)
AIDS - Acquired Immune Deﬁciency 
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arrayCGH - array-based Comparative 
Genomic Hybridization
ASP - Affected Sib Pair
BBS - Bardet-Biedl Syndrome
BIND - Biomolecular Interaction Network 
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BLAST - Basic Local Alignment Search 
Tool
BLOSUM - BLOcks SUbstitution Matrix
bp - base pair(s)
BRENDA - BRaunschweiger ENzyme 
DAtabase
CAP - College of American Pathologists
CCM - Chemical Cleavage Mismatches
cDNA - copy DNA
ChIP - Chromatin Immuno-Precipitation
cM - centiMorgan
CMBI - Centre for Molecular and 
Biomolecular Informatics
COG - Clusters of Orthologous Groups
CS - OMIM Clinical Synopsis ﬁeld
CT - SNOMED Clinical Terms
DB - DataBase
dbSNP - Single Nucleotide Polymorphism 
database
DDBJ - DNA DataBank of Japan
DGGE - Denaturing Gradient Gel 
Electrophoresis
DHMHD - Dysmorphic Human and Mouse 
Homology Database
DHPLC - Denaturing High Performance 
Liquid Chromatography
DIP - Database of Interacting Proteins
DNA - Deoxyribose Nucleic Acid
DSSP - Deﬁnition of Secondary Structure of 
Proteins
ECM - Enzymatic Cleavage Mismatches
EEC - Ectrodactyly-Ectodermal dysplasia-
Clefting
EMBL - European Molecular Biology 
Laboratory (institute/nucleic acid database)
eq. - equation
EST - Expressed Sequence Tag
FA - Fanconi Anaemia
FASTA - Fast Alignment
Search Tools All/Anything
FISH - Fluorescence In Situ Hybridization
GDB - Genome DataBase
GO - Gene Ontology
GOA - Gene Ontology Annotation
GXD - Gene eXpression Database
HGMD - Human Gene Mutation Database
HGP - Human Genome Project 
HMM - Hidden Markov Model
HPP - Human Phenome Project
HPRD - Human Protein Reference 
Database
HTML - HyperText Markup Language
HT - High-Throughput
IBD - Identity-By-Descent
ICD - International Classiﬁcation of 
Disease
ICD-9-CM/ICD-10-CM - International 
Classiﬁcation of Disease version 9/10 with 
Clinical Modiﬁcation
IR - Information Retrieval
KEGG - Kyoto Encyclopedia of Genes and 
Genomes
KOG - (euKaryotes) clusters of Orthologous 
Groups 
LDDB - London Dysmorphology Database
MALDI-TOF MS - Matrix-Assisted Laser 
Desorption/Ionization Time-Of-Flight Mass 
Spectrometry
MAPH - Multiplex Ampliﬁable Probe 
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Hybridization
Mb - Megabase(s)
MCA - Multiple Congenital Anomalies
MDS - Multi-Dimensional Scaling
MEBD - Muscle–Eye–Brain Disease
MeSH - Medical Subject Headings
MGD - Mouse Genome Database
MIM - Mendelian Inheritance in Man (see 
also OMIM)
MIMMAP - Mendelian Inheritance in Man 
MAP
MIPS - Munich Information center for 
Protein Sequences
MLC - Mouse Locus Catalog
MLPA - Multiplex Ligation-dependent 
Probe Ampliﬁcation
MPSS - Massively Parallel Signature 
Sequencing 
mRNA - messenger RNA
MS - Mass Spectrometry
NCBI - National Center for Biotechnology 
Information
NCHGR - National Center for Human 
Genome Research
NLM - National Library of Medicine
NMR - Nuclear Magnetic Resonance
OMIM - Online Mendelian Inheritance in 
Man
OPD - Oto-Palato-Digital (syndrome)
OSMED - Oto-Spondylo-MegaEpiphyseal 
Dysplasia
PAM - Point Accepted Mutations
PCR - Polymerase Chain Reaction
PDB - Protein Data Bank
PFAM - Protein FAMilies (database)
PH - Pallister–Hall
PIR - Protein Information Resource
PIV - Polydactyly, Imperforate anus, and 
Vertebral anomalies
POSSUM - Pictures of Standard Syndromes 
and Undiagnosed Malformations
QTL - Quantitative Trait Locus 
RefSeq - Reference Sequence (database)
REMTREMBL - Remaining TrEMBL
RNA - Ribonucleic Acid
RNAi - RNA interference
RT-PCR - Reverse Transcription-
Polymerase Chain Reaction
SAGE - Serial Analysis of Gene Expression
SLO - Smith–Lemli–Opitz
SMD - Stanford Microarray Database
SNOMED - Systematized NOmenclature of 
MEDicine
SNP - Single Nucleotide Polymorphism
SPTREMBL - SwissProt TrEMBL
SRS - Sequence Retrieval System
SSCP - Single Strand Conformation 
Polymorphism
STS - Sequence Tagged Site
SWISSNEW - SWISSprot NEW (updates)
SwissProt - Protein knowledgebase
TBASE - Transgenic/Targeted mutation 
dataBASE
TBC - TuBerCulosis
TDT - Transmission Disequilibrium Test 
TPC - Trismus-PseudoCamptodactyly 
(syndrome)
TrEMBL - Translated EMBL
TREMBLNEW - TrEMBL NEW (updates)
TTD - TrichoThioDystrophy
TX - OMIM full-TeXt ﬁeld
UCSC - University of California Santa Cruz
UMLS - Uniﬁed Medical Language System
UniProt - United Protein (databases)
UPGMA - Unweighted Pair Group Method 
with Arithmetic Mean
URL - Uniform Resource Locator
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WWW - World Wide Web
XP - Xeroderma Pigmentosum
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1 See also the list of abbreviations section.
1.1 Genetic disease
Genetic disorders are caused by abnormalities in the genetic material (or DNA1). These 
abnormalities can be located in a speciﬁc piece of DNA, or gene, which encodes instructions 
on how to make proteins. Essential life functions are performed by these proteins and they 
make up the majority of cellular structures in all cells. Changes in a gene are referred to 
as mutations. Genetic diseases can be caused by a mutation in a gene, but also by other 
abnormalities in the DNA. In general, four different types of genetic disorders can be 
distinguished:
1. Monogenetic
Monogenetic (also called Mendelian or single gene) disorders are caused by a mutation in 
a single gene. A mutated gene usually results in a mutated protein, which can no longer 
carry out its normal function. Single-gene disorders are manifest in about 1 out of every 400 
newborns (in Northern-Netherlands, www.eurocatnederland.nl). However, as life progresses 
these numbers may increase considerably due to mutations that have effects at a later age.
2. Multifactorial
This type of disorders is due to mutations in multiple genes in combination with external 
factors, such as lifestyle and environment. Some of the most common chronic disorders are 
multifactorial disorders, among which are cardiovascular disease, diabetes and Alzheimer’s 
disease. Complex patterns of inheritance and the involvement of (often unknown) 
environmental factors makes it more difﬁcult than in monogenetic disorders to identify the 
genes, and to ascertain the risk of carrying or passing on the disorder.
3. Chromosomal
The complete DNA of an individual is known as the genome and can be found in almost 
every human cell in distinct structures called chromosomes. The chromosomes are located in 
a special compartment of the cell called the nucleus. A nucleus holds 23 chromosome pairs, 
of which 22 have one identical chromosome inherited from each parent. Two chromosomes 
determine the sex of the individual; the sex chromosomes X and Y. Females have two of the 
same kind of sex chromosome (XX), while males have two distinct sex chromosomes (XY). 
Abnormalities in the chromosomal number or structure e.g. (partial) deletion, extra copies, 
breakage and (partial) rearrangements, can result in disease.
4. Mitochondrial
Apart from the chromosomes, a tiny portion of the human DNA is present in small 
compartments in the cell known as mitochondria that functions as the power plant of the cell. 
Genetic disorders due to mutations in the mitochondrial DNA are rare. Mitochondrial DNA 
mutations can affect both male and female, but are transmitted only via the mother.
Bioinformatics strategies for disease gene identiﬁcation
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Overall, genetic disorders (monogenetic and multifactorial) affect two to three infants in every 
100 births (www.eurocatnederland.nl). Although congenital abnormalities are less common 
than diseases like AIDS and tuberculosis (TBC), they are important. Genetic conditions are 
a major cause of neonatal and childhood diseases and of infant death in the western world[1]. 
Furthermore, studies of congenital developmental disorders have made major contributions 
to our understanding of the developmental process and the function of the genes and proteins 
involved[2].
1.2 Phenotype classiﬁcations
An adequate description of the clinical phenotype is essential for diagnosis and research. It can 
help to group and classify patients with the same disorder. Congenital anomalies can be divided 
in abnormalities and minor variants[3]. Embryonic development consists of several (more or 
less virtual) phases. Aberrations in these phases have a speciﬁc clinical outcome. A commonly 
used classiﬁcation system of congenital anomalies distinguishes between malformations, 
deformations, disruptions, syndromes, sequences, and associations. An intrinsically abnormal 
development process resulting in morphological defects of an organ is called a malformation. 
Malformations are caused by genetic and/or environmental factors. Congenital anomalies 
account for approximately 2-3% of the (live births) newborns (www.eurocatnederland.nl). 
For multiple malformations this is 1%[4]. The complexity of a malformation depends on the 
time of onset, early defects lead to more serious consequences. 
Deformations are anomalies caused by non-disruptive mechanical forces that distort normal 
developing structures. They usually originate in fetal life and can be the result of both maternal 
or fetal factors. The forces that lead to deformations can be extrinsic for example by an 
amniotic tear or by crowding in the case of twin foetuses. Intrinsic defects can also generate 
a deformation, for example when malformation of the urinary tract leads to insufﬁcient 
amniotic ﬂuid. Foetuses that grow in a uterine environment where not enough amniotic ﬂuid 
is present (oligohydramnios) have a ﬂattened face due to compression of the face against the 
uterine wall. 
Disruptions are structural defects, which are caused by interference with a genetically normal 
development. They can result from events like infection or amniotic bands.
Minor anomalies are deviations of the process of developmental ﬁne-tuning, called 
phenogenesis. Minor anomalies are structural variations that do not cause signiﬁcant 
functional impairment. They divide into rare variations and common variants based on their 
prevalence and implication. Rare variants have a prevalence lower than 4%, whereas common 
variants are above 4%[3].
The clinical outcome of any of these events may result in multiple congenital anomalies 
(MCA). Relations between anomalies can be classiﬁed with the terms syndrome, sequence, 
and association. A sequence occurs when a single developmental defect results in a chain 
of secondary (tertiary) defects. The group of defects can be traced back to the original 
C
ha
pt
er
 1
General introduction
13
event. Syndromes are anomalies that contain multiple malformations due to a single known 
underlying cause. The expression of defects in syndromes is variable and diagnosis of a 
syndrome depends on recognizing the overall pattern of the anomalies. An association is not 
a sequence or syndrome, but a statistically deﬁned non-random group of anomalies.
Various medical classiﬁcation systems are in use and are being developed. Each system 
emphasizes different aspects and has a different purpose. The International Classiﬁcation 
of Disease (ICD) is the oldest classiﬁcation system and is maintained by the World Health 
Organization (WHO; http://www.who.int/classiﬁcations/icd/en/). This system was designed 
to promote international comparability in the collection, processing, classiﬁcation, and 
presentation of mortality statistics. The 10th version of ICD (ICD-10) is adopted worldwide 
to describe causes of death. A clinical modiﬁcation of ICD (ICD-9-CM/ICD-10-CM) has 
become a diagnostic classiﬁcation framework for all general epidemiological and many health 
management purposes. Systematized Nomenclature of Medicine (SNOMED) Clinical Terms 
(CT) is a reference terminology that is maintained by SNOMED International, a division 
of the College of American Pathologists (CAP) (http://www.snomed.org/). SNOMED-CT 
is designed to consistently describe medical ﬁles that contain diagnoses and treatment. 
Both ICD and SNOMED-CT are general systems for clinical coding of disease features of 
conditions. The London Dysmorphology Database (LDDB) provides a more speciﬁc overview 
of genetic diseases and their deﬁnitions/nomenclature[5]. Unfortunately, to date there are no 
internationally accepted terms for deﬁning congenital abnormalities. Several attempts have 
been made to come to a universally accepted deﬁnition of global terms like malformation, 
deformation, and syndrome, but no consensus has been established. This also applies to 
deﬁnitions of individual defects.
In the absence of standardized nomenclature, clinical information is mainly available in a 
free text format in the literature (PubMed)[6]. Utilizing this information for e.g. extracting, 
comparing, or indexing, requires thesauri or medical language systems. The Medical Subject 
Headings (MeSH) Thesaurus was designed by the National Library of Medicine (NLM), 
and is a controlled vocabulary used for indexing articles for PubMed[7]. MeSH provides a 
standardized way to retrieve information that uses the same concepts, but different terminology. 
In 1986, NLM launched the Uniﬁed Medical Language System (UMLS)[8]. The purpose of 
UMLS is to aid in the development of computer systems, which ‘comprehend’ the meaning 
of the medical texts. Currently, UMLS contains around a million concepts, which map to 
MeSH, ICD-9-CM, SNOMED and other coding systems using the UMLS Metathesaurus. 
This Metathesaurus is a multi-purpose and multi-lingual vocabulary that contains medical 
concepts, their various aliases, and the relationships among them. 
1.3 Gene identiﬁcation/ﬁnding of inherited disease
For every gene there is a task in the cell. Therefore the identiﬁcation of disease genes is not 
very different from ﬁnding the genes that are responsible for normal functions or normal 
Bioinformatics strategies for disease gene identiﬁcation
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attributes such as eye or hair colour. The variation or mutation may be within a gene/protein, 
or within a regulatory part of the genome that for example affects the amount of protein being 
produced. A mutation in a gene changes the protein, which alters the way the task is usually 
performed, and this results in a disease.
The identiﬁcation of disease genes was tremendously accelerated by the invention of the 
Polymerase Chain Reaction (PCR) technique by Kary Mullis in 1983[9]. Mullis was awarded 
the Nobel Prize in Chemistry in 1993 for his invention. With PCR unlimited numbers of 
copies of a strand of DNA could be made. PCR offers the opportunity to speciﬁcally multiply 
a single DNA fragment out of a DNA haystack. Linkage studies and mutation screening 
became easier with PCR and the number of identiﬁed (disease) genes increased rapidly.
In 1989, the National Center for Human Genome Research (NCHGR) was created, ﬁrst 
directed by James D. Watson, known as co-discoverer with Francis Crick of the double-helical 
structure of DNA. By October 1990 the Human Genome Project (HGP) ofﬁcially started to 
map and sequence all human DNA. The main focus for the ﬁrst ﬁve years was on creating a 
detailed genetic map of the human genome. Sequencing of the DNA started in April 1996, the 
same year the DNA sequence of the ﬁrst eukaryotic genome (brewer’s yeast, Saccharomyces 
cerevisiae) was completed[10]. In a parallel effort, the private company Celera Genomics 
founded by the Applera Corporation and J. Craig Venter started to sequence the human genome 
in 1998. Their aim to ﬁnish the sequencing effort within two years was met. The competition 
between the two efforts accelerated the process, and by early 2001, both the International 
Human Genome Sequencing Consortium and Celera Genomics published a draft version of 
the sequence[11, 12]. A ﬁrst analysis of the human genome sequence remarkably showed that 
there are only 30.000 to 40.000 human genes, and not 100.000 as previously thought[13]. 
By 2003, the human genome sequence was completed and the number of genes was further 
adjusted to 20.000-25.000[14, 15]. Note, however, that although a so-called complete DNA 
sequence of the human species has been published, the sequence is still frequently updated 
with new and/or rearranged sequences, and some parts are still missing. 
With all the genetics technology in place, identiﬁcation of disease related mutations in 
Mendelian single gene disorders now mainly depends on having the right patients and 
families. However, the genetic analysis of complex diseases still remains a difﬁcult task, and 
most genes for multifactorial disease remain to be discovered.
1.4 Candidate deﬁnition
A candidate gene is a gene that is suspected to be involved in a genetic disease. The reason for 
a gene to be a candidate can be based on its functional characteristics or on the chromosomal 
position. Various methods are employed to ﬁnd a list of candidate genes (see paragraph 1.5). 
Once a list of candidates has been generated it is important to prioritise the candidates such 
that the lab work is minimized.
Now that a large portion of the human genes has been identiﬁed and the sequence is known, 
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it has become easier to identify candidate genes. However, the number of candidate genes 
identiﬁed based on chromosomal position can still be more than one hundred. Therefore, 
disease gene identiﬁcation from a list of candidate genes often remains laborious.
1.5 Candidate strategies
The strategies to identify disease genes evolved together with the technical possibilities in 
molecular biology. The two major strategies that were developed are position dependent 
cloning and position independent or functional cloning.
1.5.1 Position dependent
As opposed to position independent cloning, in position dependent cloning the gene can be 
found by genetic methods without knowledge of the disease pathology, even if the biochemical 
basis is unknown. 
1.5.1.1 Positional cloning
Chromosomal allocation of the ﬁrst human gene was accomplished in 1911 by Wilson. He was 
able assign the gene for colour blindness to the X-chromosome using phenotypic criteria[16]. 
In 1986, Nathans et al. were the ﬁrst to characterise and isolate the red, green, and blue visual 
pigment genes involved in colour blindness[17]. The ﬁrst autosomal gene mapped was in 
1968 by Donahue et al. This was the gene for the Duffy blood group system whose function 
can be compared to other blood systems like ABO and Rhesus[18].
Classical positional cloning is based on pure (cyto)-genetic data to pinpoint the defective 
gene to a particular chromosome or sub-chromosomal location. Various steps are involved in 
the process: a) Assignment of a genetic disease gene to a small sub-chromosomal candidate 
region by linkage analysis. b) Generation of a physical map of this region based on clones. 
c) Identiﬁcation of coding sequences within the region. d) Prioritise genes as candidates for 
mutation screening. e) Testing the candidate genes for mutations. In 1986, the ﬁrst gene was 
identiﬁed with this approach[19]. By 1995, about ﬁfty disease genes were identiﬁed using 
positional cloning. The positional cloning approach was expediting gene identiﬁcation and 
was increasingly favoured over other functional strategies[20]. 
With the start of the human genome project in 1990, more detailed mapping information 
was released. This combination of positional cloning and the mapping information release 
resulted in a slow but sure shift from genes identiﬁed with classical positional cloning towards 
positional candidate gene identiﬁcation. In 1997, the majority of the genes were identiﬁed with 
this positional candidate gene strategy[21]. Completion of the human genome draft sequence 
in 2001 allowed identiﬁcation of genes in silico, speeding up the positional cloning process 
(see also 1.6.5).
Bioinformatics strategies for disease gene identiﬁcation
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1.5.1.2 Chromosomal aberrations
In rare, but important patients, a chromosomal aberration can point directly to the gene or 
genes involved in the genetic disease. Various aberrations can occur, such as translocations 
or inversions. In balanced chromosomal changes genetic material is evenly exchanged with 
no extra or missing information. Such aberrations are particularly useful in disease gene 
identiﬁcation. Breakpoints are often located within the causative gene itself or in the gene’s 
vicinity. Rarely, these functional segments can be located as far as 1 Mb from the gene[22, 
23]. This is known as a position effect. Fortunately for geneticists, such long-distance effects 
are rare. Unbalanced chromosomal aberrations are also useful for gene identiﬁcation, as 
they can indicate a chromosomal region of interest. They do not, however, point directly 
to the causative gene. Because a varying amount of genetic material is lost in unbalanced 
abnormalities, the causative gene is not the only one affected but frequently other genes in 
the neighbourhood as well. When large chromosomal sections are lost this commonly results 
in (severe) mental retardation[24]. Mental retardation is a frequent feature of syndromes and 
especially in X-linked disorders. Over 140 X-linked syndromic forms have been described 
so far[25].
Sometimes, patients suffer from different genetic disorders at the same time. This can be 
the result of a chromosomal deletion of a contiguous gene set[26-29]. Small chromosomal 
deletions can be easily missed using classic microscopy analysis. These microdeletions can 
be detected by techniques like array-based comparative genomic hybridization (arrayCGH) 
or FISH[30, 31]. 
1.5.2 Position independent
In some occasions there is some knowledge of the disease pathology, which can be used to 
identify the disease gene without positional information.
1.5.2.1 Functional cloning
This strategy relies on the presumed biological function of a disease gene, as predicted 
from the disease phenotype. For this strategy it is necessary to understand the biochemical 
and/or pathogenetic background of the disease. Efforts using this approach may start with 
a (partially) puriﬁed protein, which can be used to deduce a partial amino acid sequence. 
These sequences can then be translated back to possible DNA sequences that in turn can 
be used to raise antibodies or to design primers for cDNA library screening. Before 1980, 
the majority of the disease genes found, were identiﬁed by this approach, because none or 
very limited genetic mapping information was available. Diseases with a clear (biochemical) 
change, such as phenylketonuria and haemophilia, were elucidated ﬁrst[32, 33]. Later on, 
newly developed techniques of positional cloning quickly became the preferred strategy (see 
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paragraph 1.5.1.1). Still today, functional cloning is used and providing clues for the genes 
involved in disease[34, 35].
1.5.2.2 Homologous phenotypes in animal models.
Knowledge from animal models like mouse (Mus musculus) and the fruit ﬂy (Drosophila 
melanogaster) has aided substantially in ﬁnding disease genes[36]. Information from model 
organisms to identify disease genes can be utilized in various ways. In some instances genes 
for a speciﬁc phenotype were localized in the mouse and then mapped back on the human 
genome via a so-called Oxford-grid (see ﬁgure 1). This grid shows what regions of human 
chromosomes correspond to mouse chromosomal regions. If natural or induced mutations 
in the mouse gene show phenotypic similarity with the human disorder under investigation, 
then these orthologous genes can become candidates because they map into the disease 
locus[37]. 
1.5.2.3 Gene expression. 
Methods that utilize a presupposed speciﬁc characteristic of the disease genes have proven to 
be successful. One approach for example tries to enrich for genes that have a speciﬁc function 
in the tissue(s) affected in the disease[38, 39]. Sequence characteristics can sometimes be 
predicted, for instance in the case of expanded tri-nucleotide repeats in several neurological 
diseases[40].
Aberrant levels of gene transcription can point to a disease gene. When a candidate gene 
encodes an mRNA which is quantitatively or qualitatively different in patients with the disease 
compared to a control group, one might identify this gene by a genome-wide expression 
screen. Various methods to screen for these gene expression differences were developed 
during the last decades (see also paragraph 1.7).
The microarray methods are increasingly used to measure the levels of expression. A 
microarray is a small two dimensional array of deposited or synthesized genes or gene 
fragments. The array carrier is typically glass, silicon wafer, or ﬁlter. Since the order of the 
samples is known it is possible to screen the array with an applied DNA or RNA sample, in 
a high-throughput and parallel manner. Initially, in microarray experiments only DNA/RNA 
samples were proﬁled, but today also antibodies or proteins can be tested. 
1.5.3 Disease gene conﬁrmation
To prove that the candidate is in fact the gene, demonstration of a genetic mutation is needed. 
Mutation analysis in small patients groups can be done by direct sequencing. For screening 
larger groups other methods are usually more cost efﬁcient: Single Strand Conﬁrmation 
Polymorphism (SSCP)[41], Denaturing Gradient Gel Electrophoresis (DGGE)[42], 
Bioinformatics strategies for disease gene identiﬁcation
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Figure 1 An Oxford-grid. The grid shows the relationship between human and mouse chromosomes. 
Chromosome location of either of the species often predicts the chromosome location in the other 
species. The colours indicate the number of orthologies: Grey (1), Blue (2-10), Green (11-25), Orange 
(26-50), Yellow (>50). From the Mouse Genome Database (MGD), Mouse Genome Informatics, The 
Jackson Laboratory, Bar Harbor, Maine. (http://www.informatics.jax.org, April, 2005). (Colour version: 
see appendix 2)
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Denaturing High Performance Liquid Chromatography (DHPLC)[43], Chemical Cleavage 
Mismatches (CCM)[44, 45], Enzymatic Cleavage Mismatches (ECM)[46]. Comparative 
sequencing strategy based on Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight 
Mass Spectrometry (MALDI-TOF MS) analyses can be used for high-throughput discovery 
of genomic sequence polymorphisms[47]. Copy number changes in genomic DNA can be 
detected using e.g. Multiplex Ampliﬁable Probe Hybridization (MAPH) and Multiplex 
Ligation-dependent Probe Ampliﬁcation (MLPA). Both techniques are suited to quantify up 
to ﬁfty loci in a single reaction[48-50].
Changes in the splicing process of the gene may be missed when screening protein-coding 
DNA sequences only, but are detectable at the RNA level using RT-PCR. With RT-PCR and 
related methods it is possible to evaluate whether the spatio-temporal gene expression pattern 
is compatible with the phenotype of interest. Ultimately, ﬁnal proof may require a functional 
test, i.e. examination of the effect of induced mutation in model organisms or the restoration 
of a normal phenotype by adding the normal gene. 
1.5.4 Complex disorders
The focus of disease identiﬁcation is shifting from Mendelian traits to complex disorders. 
Usually complex disorders are multifactorial and many such diseases, like heart and 
vascular disease are quite common. Variation in the phenotype among individuals is part 
of the evolutionary adaptation through (natural) selection, and determines (partially) the 
vulnerability of an individual to disease[51, 52].
In general the following steps are applicable to research of a complex disease. a) Establishing 
that the disease is indeed (partially) caused by genetic factors. Some traits can be inﬂuenced 
by e.g. the family environment (like behaviour or diet). b) Perform segregation analysis 
to determine the type of inheritance. Inheritance can vary from Mendelian to polygenic, 
depending on penetrance and environment. The mode of inheritance determines the linkage 
analysis methods that are applicable. c) Linkage analysis to map the susceptibility loci. In 
Mendelian diseases a parametric linkage model can be used, because the precise genetic 
model is known. In complex diseases this model is usually not clear and a non-parametric 
method will be preferred. These methods trace shared chromosomal regions among affected 
individuals. Examples are ‘Identity-By-Descent’ (IBD) or ‘Affected Sib Pair’ analysis (ASP). 
d) Population-association studies to ﬁne map the susceptibility gene. Association methods, 
like the transmission disequilibrium test (TDT), create associations between unrelated 
individuals, whereas linkage analysis works only within families. e) Elucidate the DNA 
sequences/genes; conﬁrm their molecular and biochemical action and involvement. All of 
this is not as straightforward as it is in Mendelian disorders, because a single change is not 
sufﬁcient to cause the complex disease. Susceptibility is often modelled as a quantitative trait 
locus (QTL), rather than a single DNA change[53].
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1.6 Bioinformatics approach to disease gene identiﬁcation
The human genome project and the release of the genomic sequences of a continuously 
increasing number of other species provide the opportunity to analyse the organization of 
the human genome. Genomic sequences, as well as full-length cDNA sequences, expressed 
sequence tags (ESTs) and large-scale expression micro-array data of model organisms like 
Saccharomyces cerevisiae, Drosophila melanogaster, Caenorhabditis elegans, and Mus 
musculus[54-57] offer invaluable resources for studying (human) genes. These encompass 
gene transcription and translation, which are referred to as the transcriptome and proteome 
when studied for the whole organism. In addition, understanding gene evolution offers 
prospects for functional assessments. Addressing these different aspects is far from trivial in 
view of the fact that very large amounts of data are stored in numerous different databases (see 
appendix 1), yet much of the data suffers from chronic incompleteness and errors. This makes 
the use of (high-performance) computing an essential tool for decoding the information that 
is contained in these databases.
1.6.1 Sequence databases
Primary sequence databases are the major repositories for nucleic acid sequences, and together 
form the International Nucleotide Sequence Database Collaboration, which comprises the 
DNA DataBank of Japan (DDBJ)[58], the European Molecular Biology Laboratory database 
(EMBL)[59], and GenBank[60] at National Center for Biotechnology Information (NCBI, 
Bethesda, MD, USA). These three organizations exchange data on a daily basis. Similarly, 
protein sequences are stored in SwissProt and PIR[61, 62]. Connections between the nucleic 
acid and protein databases based on translations from annotated coding regions in GenBank 
and EMBL, are stored in UniProt[61] and RefSeq[63]. Other sequence directed data encompass 
protein family, domain and motif organization or classiﬁcation as deposited in e.g. PFAM[64] 
or integrated in the InterPro database[65]. Structural information at different levels of detail 
can be found in e.g. the PDB and DSSP[66, 67].
1.6.2 Sequence related databases
Functional data linked to genes and proteins cover several molecular and cellular aspects. 
Annotation and/or experimentally derived data is deposited in the form of metabolic pathways 
(KEGG, Reactome)[68, 69], spatio and/or temporal expression patterns (Unigene, SMD)[6, 
70], and protein-protein interactions (BIND, HPRD)[71, 72]. 
Human genetics traits and phenotypes are described in the literature (PubMed)[6], but the 
main resource is the Online Mendelian Inheritance in Man (OMIM) database[73], developed 
by Dr. Victor A. McKusick and his colleagues at Johns Hopkins University (Baltimore, 
Maryland, USA). This catalogue contains over 15.000 entries, describing both human genetic 
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traits (~5.000) and human genes/proteins (>10.000). OMIM also holds genetic variation data 
linked to diseases, but in this respect its scope is limited. Mutation data is also deposited in 
specialist databases like the Human Gene Mutation Database (HGMD)[74] and in the Single 
Nucleotide Polymorphism database (dbSNP)[6].
1.6.3 Retrieval systems and browsers
In addition to the resources described in the previous paragraphs there are gene (group) 
speciﬁc, disease speciﬁc, species speciﬁc, and computational result databases. Although 
most databases have a web interface to access them, retrieval systems like NCBIs Entrez[75], 
the widely used Sequence Retrieval System[76], or the more recently developed MRS[77] 
provide easy and fast access to a collection of different databases. The main focus of these 
retrieval systems is fetching a set of database entries that meet the user query. Three genome 
browsers, NCBIs map viewer, ENSEMBL, and the UCSC browser now provide multi-species 
interfaces and integrate the major data repositories[6, 78, 79]. Furthermore, they continually 
analyse the genomes and keep track of annotations (ﬁgure 2).
1.6.4 Sequence analysis
1.6.4.1 Homology
The identiﬁcation of a disease gene is not always straightforward. Sophisticated algorithms 
and tools are required to understand the data. One way to understand more about the 
sequence of interest is to compare it with other known sequences, using sequence analysis 
tools. The French molecular biologist François Jacob described Nature as a tinkerer and 
not an inventor[80]. New functions require new proteins, which require new genes. Rather 
than designing sequences de novo, new genes are adapted during evolution from existing 
sequences. These adaptations are a gradual process and often we can recognize similarity 
between new and already known sequences. Sequences that show signiﬁcant sequence 
similarity are thus considered to be related and we can transfer information from the known 
to the new sequence. Two or more sequences are said to be homologous if they are alike 
because of shared ancestry.
1.6.4.2 Pairwise alignment
A most basic task in sequence analysis is the comparison of two sequences. But, evaluating 
the two sequences like two character strings is only possible if the sequences are very much 
alike. Crucial is the concept of alignment, because sequences can have insertions, deletions, 
duplications, inversions, substitutions, etc. Insertions and deletions are considered gaps and 
must be dealt with, usually by a penalty score for starting and extension of a gap. Furthermore, 
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some amino acids in protein sequences can be replaced without signiﬁcantly disrupting the 
protein structure and thereby its function while other changes are severe. Almost all sequence 
alignment algorithms use a scheme to score in such a way that the resulting alignment is 
optimally biologically relevant. Other aspects such as three dimensional protein structure 
and evolutionary relationship of the sequences are also addressed. A number of schemes 
with different characteristics and applicability have been published: Dayhoff/PAM and 
BLOSUM[81-83].
Finding the optimal alignment by making all possible alignments including gaps and scoring 
them is computationally very intensive, even for only a moderate number of sequences. 
Algorithms that ﬁnd optimal alignment while reducing computation time were initially 
based on so-called dynamic programming. Dynamic programming is a general algorithm 
for solving certain optimization problems. “Programming” does not refer to a computer 
program, but is mathematical jargon for using a ﬁxed set of rules to arrive at a solution. 
Dynamic programming was ﬁrst applied for sequence alignments in 1970 by Needleman and 
Wunsch[84].
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Figure 2 Partial screenshot of the UCSC genome browser[79]. The (horizontal) annotation tracks of a 
subchromosomal region are shown (Chr. 1: 94.033.925-94.399.032 Bp; Human May 2004 assembly). 
The vertical lines indicate the position on the chromosome. Many items are clickable, giving detailed 
information. More information on the tracks can be found at http://genome.ucsc.edu (April, 2005).
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The Needleman-Wunsch algorithm is designed to align two sequences head-to-tail, a so-
called global alignment, allowing gaps. Because the two sequences are treated as potentially 
equivalent, the main application for this algorithm is to identify conserved regions and 
differences, e.g. two genes with similar function but of different species.
Another application is to use alignments to identify conserved motifs/domains or for ﬁnding 
a smaller sequence in a genomic sequence. In this situation, two sequences are not necessarily 
related, and the best scoring alignment is called the local alignment. Smith and Waterman 
developed such a local alignment algorithm using dynamic programming[85].
1.6.4.3 Heuristic homology searches
To identify all sequences in a database that are broadly similar to the gene of interest using the 
Smith and Waterman algorithm requires a lot of computational resources and time. The Basic 
Local Alignment Search Tool (BLAST)[56] uses a different method to ﬁnd candidates for 
alignment without making the actual full alignment during the search through the database. 
BLAST is a heuristic alignment algorithm, which is faster than Smith-Waterman but is not 
guaranteed to ﬁnd the optimal alignment according to the speciﬁed scoring scheme. Heuristic 
alignment algorithms search for small identical sequences in the database to identify possible 
high scoring alignment matches. Another heuristic sequence search tool is FASTA[86] that 
can search a sequence against nucleotide and protein databases. FASTA can be very speciﬁc 
when identifying long regions of low similarity particularly for highly diverged sequences. 
BLAST is faster than FASTA and performs equally for highly similar sequences, but less well 
for very diverged sequences. Various adaptations to the BLAST algorithm have been made to 
increase the sensitivity for speciﬁc problems without losing too much speed[87, 88].
1.6.4.4 Probabilistic models
Computational sequence analysis may have difﬁculty determining the alignment signiﬁcance 
and is often plagued by low signal-to-noise ratios. To circumvent this, probabilistic models 
like hidden Markov models (HMMs) are currently used. They provide a general approach to 
the types of statistical problems that often occur in sequence analysis[89]. HMMs are used to 
model a single sequence or a family of sequences like protein domains. Proteins may contain 
structural domains that are independent from the rest of the protein in terms of folding and 
stability. Such domains are found in multiple proteins, and are named according to their 
biological function. The PFAM database contains multiple protein sequence alignments (ﬁgure 
3), functional annotation, and proﬁle hidden Markov models for protein domain families[64, 
90]. A proﬁle HMM is a mathematical description of a domain, which can be used to search 
for that domain in new sequences or to identify those sequences in a database.
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1.6.5 In silico positional cloning
Once the critical region for a genetic disease has been determined by linkage analysis or other 
positioning methods, the human genome sequence can be used to identify positional candidate 
disease genes. Genome browsers, biological databases, and other bioinformatics tools all 
contribute to the gene ﬁnding strategy. The ﬁrst step is to search for all genes between two 
genetic markers on the chromosome under study. Numerous genes were positionally cloned 
in projects that depended on the genome sequence, even using only the draft version[13]. 
Essential for in silico positional cloning is a proper description of the location of the genes 
and of other annotations like regulatory elements. Computational algorithms and tools have 
been developed to identify all genes on the human genome sequence[91, 92]. None of these is 
perfect and genes may be missed, or false genes have been found and annotated. In practice, 
this means that for a predicted gene different sources have to be evaluated manually. Criteria 
are whether the gene overlaps with ESTs, whether homologous sequences from other species 
exist, and whether the intron-exon structure is correct for proper RNA to protein translation. 
Sequence analysis tools like BLAST help with this manual survey. The three major genome 
browsers perform multiple sequence analyses and prediction programs and present the 
integrated results to the user (ﬁgure 4).
1.6.6 In silico functional cloning and candidate gene selection
In theory, every gene within the disease critical region can cause the disease. When the critical 
region is large or the gene density is high, positional candidates are many. Screening all these 
genes in the wet-lab is very labor intensive and thus expensive. Therefore it is more favourable 
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Figure 4 Partial screenshot of the Ensembl genome browser[78]. Shown is a part of chromosome 1: 
1:66.002.117-66.130.409 bp. The view is similar to the UCSC browser (ﬁgure 2). Different transcripts 
are predicted by GenScan, SLAM, and TwinScan[91-93]. The exons (vertical blocks) predicted by 
SLAM can be conﬁrmed by other sources (e.g. cDNA). From http://www.ensembl.org/ (April, 2005).
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to perform an in silico selection, combining positional information and function prediction. 
There may already be a suspicion on the biochemical and/or pathogenic background of the 
disease. This can be taken as a starting point for the selection of candidate genes. 
The expression pattern of the gene is likely to overlap the main affected tissues in the disease. 
If a genetic eye disorder affecting the retina is studied, the gene should be expressed in retina. 
It is possible to search the database for (all) genes expressed in retina e.g. when no linkage 
data is available[94, 95]. This in silico strategy can be used to generate candidate disease 
genes[96, 97].
Domain, motif, and proﬁle databases and tools permit a scan for other expected biochemical 
and cellular function characteristics. Possible examples are transporter, trans-membrane, 
enzyme, structural, or DNA binding function. Local genome organization and known 
regulatory elements can be useful in disease gene identiﬁcation[98-101]. 
For known genes, the knowledge in literature (e.g. PubMed) and the OMIM database can be 
used to select the candidate genes. If there is already a gene causing a related disease in the 
critical region, it is possible that the disorders are allelic, that is they are caused by different 
mutations in the same gene. Further, genes located within the critical disease region that have 
a functional similarity and/or relation with genes causing related diseases, can be considered 
good candidates.
Knowledge of model organisms makes comparative candidate gene selection possible. This 
situation applies when a gene is known, which causes a similar phenotype in another species. 
This is a powerful indicator for selecting a candidate gene. Yet, a direct comparison between 
the phenotypes in human and the model organism can be complicated because of the different 
anatomy. Transfer of knowledge by phenotype is most straightforward in other mammalian 
species like Mus musculus that are evolutionarily close to humans. An example is the disease 
gene identiﬁcation in Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome (EEC)[37].
1.6.7 Candidate gene prediction
Some genes are more likely to be involved in a speciﬁc disease than others based on the 
knowledge of that gene. This information is not always available, and various methods can be 
used to predict candidate genes for diseases.
1.6.7.1 Sequence based prediction
Which gene underlies a disease may not be immediately obvious from the list of candidates. 
When none of the known genes has mutations, one may try to ﬁnd new genes in the critical 
region. Methods for the identiﬁcation of new genes rely on sequence signatures that distinguish 
coding from non-coding sequences. Among the most frequently used discriminating 
characteristics are splice site motifs, which are found in the majority of the human genes. 
At the 5’ end of an intron a GT is found, whilst AG is found at the 3’ end. Algorithms to 
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ﬁnd exons also evaluate other characteristics. A single genome predictor algorithm like 
GENSCAN uses a general probabilistic model of the gene structure including transcriptional, 
translational and splicing signals, length distributions, and compositional features of exons, 
introns and intergenic regions[91]. The algorithm used in the TWINSCAN program similarly 
predicts exons but improves the accuracy by taking advantage of genome comparisons, and 
is called a dual genome prediction algorithm[92]. Multiple genome prediction methods have 
only recently been developed and though not used to their full potential yet, they promise to 
be more accurate than single and dual models[102].
1.6.7.2 Comparative prediction
Genes, whether newly identiﬁed or not, without a clear annotation, can be involved in human 
genetic disorders. Comparative genome analysis of more distantly related species presents us 
with a wealth of opportunities for studying evolution and gene/protein function. Although 
still under intense development, comparative genome analysis is already offering gene/protein 
function prediction methods at various biological levels.
Homology-based function prediction transfers information from known genes/proteins to 
unknown sequences and remains the primary method to determine the function of a new gene. 
However, in most genomes about 30-40% of the genes lack a clear functional annotation[103]. 
This limits the predictive value of homology-based methods like BLAST, FASTA, and Smith-
Waterman. Orthology-based protein function prediction uses information from multiple 
genomes, which renders it more speciﬁc. As orthologs are due to a speciation rather than to a 
duplication event in evolution, they are more likely to perform the same function in different 
species. Furthermore, comparison is gene-based instead of sequence based. Orthologs can be 
determined via various methods and have been stored in databases like Protein World[104], 
COG/KOG[105, 106], or OrthoDisease[107].
Functionally related genes may have protein-protein interactions that are subject to evolutionary 
pressure to stay and act together, because a change in one of the proteins impinges on the 
function of the second (or others). This concept has been used to predict protein function 
and hence transfer knowledge by functional relation. The tendency to evolve similarly (or 
complementarily) becomes apparent from the phylogenetic distribution of genes. This strategy 
has been applied successfully in the elucidation of the function of the frataxin gene involved 
in Friedreich’s ataxia (MIM 229300), which is a neurodegenerative disorder[108, 109].
Prokaryotes use a regulatory structure that controls a number of related genes within a 
region of the genome, the so-called operon. In prokaryotes genomic organization, order, 
and proximity of genes are commonly used for function prediction[110]. Eukaryotes lack 
these operon structures, but genomic-context based prediction may still be possible to some 
extent[111, 112]. Other methods for function prediction use correlated gain or loss of genes, 
co-evolution, and conservation of co-expression are reviewed in [113].
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1.7 Functional genomics
The completion of the human genome sequence is undoubtedly an important milestone in 
biology. Completion is a relative term, since an unknown number of genes remain to be 
identiﬁed. Small non-coding RNAs called microRNAs have been shown to play important 
roles in gene regulation. Only a limited number of microRNAs have been identiﬁed, but there 
are various indications that their current number is much higher[114]. Even, a complete list of 
all human genes using the methods described will not allow us to comprehend the function 
of all the genes or their interactions in the cell(s). This means that attention is shifting from 
identiﬁcation to functional annotation. In addition, there is a shift from single gene/system 
to whole genome/cell analyses. In other words there is a shift from a reductionist to a holistic 
approach. This global analysis of the function of genes is the foundation of functional genomics. 
Core concepts of functional genomics are the genomic expression or transcriptome, and the 
resulting proteins or proteomics. Ultimately, functional genomics deﬁned as the functional 
annotation of the genes, will lead to systems biology or a complete and integrated picture of 
cellular physiology at the molecular level.
Transcriptomics deals with gene expression in terms of RNA levels, regulation, processing, 
and turn-over/degradation. Observing expression changes in disease can reveal the role of the 
gene or its relations with other genes involved. Formerly, RNA expression was determined 
by transferring the RNA sample to a carrier membrane followed by screening with a 
radioactively labelled fragment of the gene of interest: Northern blotting[115]. This screening 
was generally on a gene-by-gene basis. RT-PCR then allowed the reverse transcription of 
RNAs from typically a speciﬁc tissue/cell type into copy DNA (cDNA) and the creation of 
cDNA libraries. This permitted global expression analysis as well as the identiﬁcation of 
genes, which were tissue speciﬁc or at least highly expressed genes. Such genes might be 
involved in diseases affecting that tissue. A range of (differential) expression analysis methods 
comparing disease and control gene expression have been developed. These include databases 
analyses for ESTs, differential display PCR, micro array, serial analysis of gene expression 
(SAGE), and massively parallel signature sequencing (MPSS) [116-119]. Data obtained from 
such experiments using micro arrays; can reveal the links between the individual genes. 
Analysis involves clustering techniques and requires special or newly developed software. 
Transcriptomics has been useful in the identiﬁcation of disease genes and potential drug 
targets[120-123].
Proteins are the products of genes and the study of their abundance and molecular function 
is the subject of proteomics. Often proteins are post-translationally modiﬁed by for example 
partial cleavage or phosphorylation. Furthermore, not every gene transcript results in a 
protein product[114]. Some genes encode functional RNAs. Both protein modiﬁcations result 
in differences with the transcriptome and this argues for a separate analysis of the proteome. 
Similar to genes, an analysis of protein expression can reveal interactions and may highlight 
changes that result in disease. Methods like 2-dimensional gel electrophoresis (2DGE) and 
mass spectrometry (MS) are used to study protein expression patterns of speciﬁc tissue or 
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cellular samples[124, 125].
The 3-dimensional (3D) structure of proteins gives direct insight into their molecular 
mechanisms, which can be explored for designing drugs or developing antibodies. Structural 
genomics aims to solve the 3D structures of proteins. X-ray crystallography and nuclear 
magnetic resonance spectroscopy (NMR) are two major experimental methods by which 
protein structures are resolved[66]. Unfortunately, both methods are very labor intensive 
and consequently the number of structures solved and stored in the Protein Databank (PDB) 
is vastly outnumbered by the number of known proteins [126, 127] (ﬁgure 5). Fortunately, 
the number of distinct structures seems to be relatively small, less than 10.000 by most 
estimates[128]. Ab initio prediction of the 3D protein structure, also known as the protein 
folding problem, is very complicated. Numerous attempts have been undertaken, but so far 
none has succeeded. Developing faster method for resolving protein structures is now the 
main focus[129].
The function of a protein may not be (fully) clariﬁed when analyses of its sequence, expression, 
and even its 3D structure have been done. Obviously, the molecular partners of the protein 
may provide essential clues. Among other experimental methods afﬁnity chromatography, 
yeast-two-hybrid analysis, and co-immunoprecipitation might allow isolation of the associated 
protein(s). 
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Figure 5 The growth in the number of structures in the PDB and the number of proteins in UniProt/
Swissprot[61, 66]. Note that structure models are included in the PDB. (From http://www.rcsb.org/pdb/ 
and http://www.uniprot.org/. April, 2005).
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1.8 Biological networks
Over the last decade, high-throughput interaction screening methods have been developed 
and used to map different biological interactions. These maps provide a ﬁrst glimpse of the 
overall organization of the molecular networks in biological systems. Biological networks are 
expected to change the general perception on biological systems such as the relation between 
genotype and phenotype. The networks model physical or functional relationships ranging 
from atomic to organism or even population level. For example, protein interaction data can 
be found in databases like BIND, HPRD, MIPS, DIP[71, 130-132]. Networks consist of nodes 
and edges, describing e.g. proteins and their interactions respectively (ﬁgure 6).
Networks are being generated from data generated by (functional) genomics studies. Such 
networks are still incomplete and contain multiple errors[133]. Large-scale experiments 
are conducted to establish the networks. A ﬁrst glance into the protein-protein interaction/
functional networks for e.g. Saccharomyces cerevisiae is available from yeast-two-hybrid 
and MS studies[134-137]. Another technique, chromatin immunoprecipitation (ChIP), was 
used to identify binding sites for transcriptional regulators in yeast[138].
The networks indicate that there are general characteristics of biological networks such as 
the topology that are similar to other complex networks. Similar non-random patterns were 
identiﬁed in networks from the World Wide Web as were present in biological networks[139-
141]. In a random network the distribution of the connectivity is even. Metabolic networks are 
not random. However, they are modular and scale-free, showing a very uneven distribution of 
connectivity between the nodes with a few very well connected nodes called hubs. Scale-free 
networks follow a Power law distribution (ﬁgure 7). Modularity in biological systems is not 
a new concept and was previously recognized in e.g. operons, embryonic development, and 
even proposed by the founders of cell-theory, the German botanist Matthias Schleiden and 
physiologist Theodor Schwann[142, 143].
A
B
E
D
C
F
Figure 6 Protein interaction network example. The proteins A-F are called nodes. The interaction 
relations between the proteins(/nodes) are represented by the lines between them, the edges.
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1.9 Phenotype networks/phenome
A major goal in genetic research is the identiﬁcation of genotypes that are associated with 
human phenotypes. That overlapping (syndrome) phenotypes might reﬂect biological 
relationships has been recognized for many years[144]. Phenotypes that share major clinical 
features are called ‘phenotype communities’ or ‘syndrome families’, and can be considered 
like disease phenotype networks. These phenotypic relations have shown to be helpful to 
identify new genes or mutations[145]. 
For complex diseases, much effort is put in elucidating networks that describe genes, proteins, 
interactions, or function. Although these projects are complex and crucial to understand 
complex diseases, phenotypes are essential. Phenotypes are the ultimate representation of 
the genotypes. However, current approaches to deﬁne phenotypes are probably inadequate to 
fully explore the genotypic data. A global network of phenotypes would describe the physical 
properties of an organism, its physiology, morphology and behaviour. The physical totality 
of all traits of an organism or of one of its subsystems is called the phenome. Studying the 
variation of the phenotype among individuals is the subject of phenomics.
Freimer and Sabatti proposed the Human Phenome Project (HPP), an international effort 
to create phenotypic databases and new methods to analyse such phenotypic data[146]. 
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Figure 7 a) Random network: most nodes have approximately the same number of links. The connectivity 
follows a Gaussian distribution (not shown). b) Scale-free network: some nodes are highly connected 
(hubs, C and G), whilst other nodes have only a few links. c) Connectivity of a scale-free network 
follows a power-law distribution.
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The human phenome would be beneﬁcial for the understanding of both Mendelian and 
complex diseases and (the identiﬁcation of) their causes. Recognition of the importance 
and the potential of the phenotype also translated into phenome initiatives in a number of 
other species[147-151]. A primary task for the HPP is to deﬁne what constitutes a phenotype. 
A broad spectrum of deﬁnitions in the biological literature for the term phenotype shows 
that this is not trivial, because it can refer to morphologic, biochemical, physiological or 
behavioural features[152]. Since covering all aspects of the phenome is too broad, the HPP 
and similar projects are mainly focusing on (human) disease phenotypes. As highlighted 
in paragraph 1.2, standardization in terminology and classiﬁcation is a slow process. New 
methodology for storage and analysis of phenotypic data awaits development, including (non-
parametric) statistical tools for association studies, clustering, data mining, machine- and 
statistical learning.
1.10 Bioinformatics approach to bio-networks
(Functional) genomics data is the main source for the (re-)construction of bionetworks (see 
also paragraph 1.8). Analysis of these networks using bioinformatics includes determining the 
architecture of networks, function prediction, simulation analysis, and other computational 
approaches.
The several types of networks that emerge are not independent. Rather they form a network 
consisting of networks, which determine the cell characteristics. Unravelling networks requires 
bioinformatics. Essential is to model and understand the topological and dynamic properties 
of the networks. Networks consist of nodes and edges and are called graphs in mathematical 
jargon. Each network has measures, which allow comparison and characterization. The 
connectivity of the nodes (number of edges), connectivity distribution, shortest and average 
path length, and cluster coefﬁcient (if there is a link between A and B, and B and C, how often 
is A linked to C) are basic network measures[153]. Important to the understanding of the 
cellular network was the discovery that most cellular networks follow a scale-free topology, 
including for example metabolic[153] and protein-protein interactions[154] networks. The 
network’s ability to respond to changes like e.g. gene deletion is called the network robustness. 
Scale-free networks when compared to random networks are more robust, because of the 
many nodes with a few connections and the small number of hubs. However, the tolerance to 
failure comes with a high vulnerability to attacks on the few crucial nodes (hubs)[140]. This 
has been found in gene knock-out experiments[154].
Cellular functional organization is likely to have a modular structure[155]. Modularity refers 
to groups of nodes that have a rather distinct function. Various methods were developed 
to identify modules in networks either by topology[141, 156] or by integrated functional 
data[157]. Network approaches are used to enhance function prediction for example in protein 
interaction[158, 159]. 
Topology alone is not capable of describing the function of cellular networks. Important 
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aspects for characterizing these networks are also the strength of the edges and the (spatio-
) temporal features[153]. Metabolic networks are studied with respect to the ﬂux of (the 
amount of) substrates and products. These analyses enable the formulation and veriﬁcation 
of hypotheses on the importance of various reactions[160, 161].
The release of ever more (genomics) data requires new computational approaches to analyse 
the networks. This ranges from new theories for topology characterization to identiﬁcation of 
modules, clusters and their dynamics in relation to biological function. 
1.11 Phenotype networks and bio-networks
All bio-networks whether interactome, metabolome, or phenome will continue to grow as 
knowledge accumulates. The purpose of the study of these networks is a better understanding 
of the biological systems. Large-scale mutagenesis projects are conducted and are an 
important resource for functional annotation. However, the number of mutations that need 
to be induced and screened to be comprehensive for both functional annotations as well as 
for the phenotypic consequences is unclear, and probably gigantic. To close the gap between 
genotype and phenotype (networks) it is also necessary to work on the phenotype side of the 
problem.
For many years, it has been recognized that biological relationship can be found in overlapping 
disease phenotypes[144]. Furthermore, functionally similar genes, when mutated, have a 
characteristic pattern of human disease[162]. Naturally occurring mutations and the related 
phenotypes are a fruitful source and may provide a bridge to start to close the gap.
Mutations are stored in databases like HGMD, and genetic variations in dbSNP. Phenotype 
descriptions are found in expert databases like OMIM, the London Dysmorphology Database 
(LDDB), Dysmorphic Human and Mouse Homology Database (DHMHD) and the Pictures 
of Standard Syndromes and Undiagnosed Malformations database (POSSUM)[5, 163, 164]. 
Besides the genome browsers, there are few initiatives to integrate speciﬁcally the (human) 
phenotype and genotype data[165, 166]. Also, the phenome is not determined by disease 
phenotypes alone. All phenotype variations are a potential source for a better understanding 
of biology. The international HapMap project aims to determine the common patterns of 
DNA sequence variation using samples from populations with ancestry from parts of Africa, 
Asia and Europe[167]. Projects like HapMap will also give insight in the genetic basis of 
phenotype characteristics e.g. racial differences.
Phenotype data from literature has been explored to ﬁnd biological relationships. But, the 
exploration of this information has only recently begun to be explored and all methods are 
aiming to identify genes for human genetic disorders[101, 168-170].
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1.12 Outline of thesis
These studies concern the relationships between diseases and genes, and the relationships 
among diseases as indicators of the underlying molecular mechanisms. Over 5.000 human 
genetic traits have been described. In this work we focus on human genetics disorders in 
general, rather than on a particular class of diseases. The present study aims to reveal some 
general principles of human disease and the bioinformatics strategies to explore them for the 
identiﬁcation of disease genes.
Chapter 2 describes a system called the GeneSeeker. The growing number of data collections 
is a direct consequence of the HGP. These databases make it possible to identify candidate 
genes for human genetic diseases, but all have speciﬁc target groups, contain particular 
information, and present this to the user in different formats. Furthermore, volume and 
complexity of these resources are a challenge to the researcher. The GeneSeeker aims to 
integrate various databases using a strategy that mimics the “normal” strategy used by the 
researcher. GeneSeeker is particularly well suited for syndromes in which the disease gene 
displays altered expression patterns in the affected tissue(s). 
Chapter 3 discusses the technical background of the GeneSeeker. Because of the bulk of 
data, the GeneSeeker uses a remote querying method, that obviates data warehousing and 
guarantees that the most recent data are queried. The analyses performed reduce the time-
consuming process of browsing manually to a few minutes. All options are presented to the 
user via a web-interface.
Chapter 4 discusses the use of phenotype information from syndrome families as a tool 
for functional genomics. Syndromes are constituted by a speciﬁc combination of clinical 
features. We discuss how this can be systematically explored and ask if this knowledge 
can be transferred to biological relationships. Furthermore, we discuss the possibilities of a 
phenotype map for the identiﬁcation of disease genes.
Chapter 5 describes a text mining method and analysis of the human phenome. The systematic 
exploration of human disease phenotypes and molecular relationships of the underlying genes 
has only been attempted in a few studies. We describe a fully automated method to generate 
such a phenotype map. Additionally, we analyse this phenomap for biologically meaningful 
information, and discuss the applications that could be derived from this approach.
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Abstract
To identify the gene underlying a human genetic disorder can be difﬁcult and time consuming. 
Typically, positional data delimit a chromosomal region that contains between 20 and 200 
genes. The choice then lies between sequencing large numbers of genes, or setting priorities 
by combining positional data with available expression and phenotype data, contained in 
different internet databases. This process of examining positional candidates for possible 
functional clues may be performed in many different ways, depending on the investigator’s 
knowledge and experience. Here, we report on a new tool called the GeneSeeker, which gathers 
and combines positional data and expression/phenotypic data in an automated way from nine 
different web-based databases. This results in a quick overview of interesting candidate genes 
in the region of interest. The GeneSeeker system is built in a modular fashion allowing for 
easy addition or removal of databases if required. Databases are searched directly through 
the web, which obviates the need for data warehousing. In order to evaluate the GeneSeeker 
tool, we analysed syndromes with known genesis. For each of 10 syndromes the GeneSeeker 
program generated a shortlist that contained a signiﬁcantly reduced number of candidate 
genes from the critical region, yet still contained the causative gene. On average, a list of 163 
genes based on position alone was reduced to a more manageable list of 22 genes based on 
position and expression or phenotype information. We are currently expanding the tool by 
adding other databases. The GeneSeeker is available via the web-interface (http://www.cmbi.
kun.nl/GeneSeeker/).
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Introduction
Positional cloning and candidate gene analysis are commonly used as complementary strategies 
for the identiﬁcation of genes involved in human genetic disorders. With the recent completion 
of the human genome draft sequence a comprehensive list of positional candidate genes can 
often be obtained. For many diseases the critical interval will be between 0.5 and 10 cM, 
with the number of genes anywhere between 5 and 300. Prioritising these genes for mutation 
analysis is the logical next step. This requires that the researcher collects information from 
various sources on expression patterns, biological function, animal models, related human 
diseases and other relevant data. Clearly, researchers differ widely in their ability to retrieve 
relevant information that is stored in a growing number of separate (and often unlinked) 
on-line databases. Moreover, this process tends to be very time-consuming, and many hours 
may go into collecting and sorting the relevant information. Integrating information from the 
databases in an automatic way would allow researchers to get a quick snapshot overview of 
their particular candidate region.
Here we report on a new bioinformatics tool, which gathers both positional as well as 
expression/phenotypic data in an automated way from nine different databases and then 
combines this information using Boolean operators. This results in a quick overview of 
candidate genes in the genetic region of interest. The GeneSeeker system is built in a modular 
fashion, making it easy to maintain and expand. A further advantage is that there is no need 
for data warehousing or updating because the databases are searched directly through the 
web.
In its present form, the GeneSeeker tool uses the Genome Database (GDB)[1] and the Online 
Mendelian Inheritance in Man (OMIM (URL: http://www.ncbi.nlm.nih.gov/omim/)) to 
obtain human mapping data. Genetic localisations speciﬁed by the user are also translated 
with the aid of an ‘Oxford-grid’, to search the appropriate mouse databases (e.g. the Mouse 
Genome Database (MGD)[2]. The key tissues affected by the genetic disorder are used to 
query phenotypic or expression related databases, including the OMIM phenotype ﬁelds, 
Swissprot[3], and Medline (National Library of Medicine, Bethesda, USA) for data on human 
phenotypes and the Gene Expression Database (GXD)[4], the Transgenic/Targeted Mutation 
Database (TBASE)[5], and the Mouse Locus Catalog (MLC)[2] for gene expression patterns 
and phenotypes in mice. A general overview of the data ﬂow within the program is given in 
ﬁgure 1.
Materials and methods
The GeneSeeker interface
The homepage of the GeneSeeker (http://www.cmbi.kun.nl/GeneSeeker/) allows the user to 
specify the genetic mapping information. This can be a chromosome, a chromosome arm, or 
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Figure 1 A general overview of the GeneSeeker program. The query entered by the user is pre-processed 
for Human and Mouse databases and subsequently reformulated into the format appropriate for each 
database. The database queries result in lists of genes, which are combined by Boolean operators 
according to the query as formulated by the user. The results are presented in the four boxes at the foot 
of the ﬁgure.
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a range (e.g. 7p15-7p14). If necessary, a combination of genetic localisations can be entered 
(e.g. 4p16-4p14 or 4q31-4q35). Gene expression or phenotypic information can be entered in a 
separate box, in which the user speciﬁes the tissue names where either direct RNA expression 
or phenotypic expression of the candidate gene is expected. For example, the phenotype of 
Hand-Foot-Uterus Syndrome[6] can be translated into the expression terms ‘limb or genital’. 
Advanced options include a thesaurus[7], which can be used to include alternatives and hence 
broaden the expression search term. In case of ‘limb or genital’ use of the thesaurus will 
result in ‘upper limb’ or arm or limb or joint or ‘lower limb’ or ‘hip joint’ or toes or digit or 
‘male genital’ or testes or testis or ‘Sertoli cells’ or ‘female genital’ or ovaries or ovary or 
uterus or vagina’.
A number of reﬁnement options have been implemented, such as the possibility to exclude 
databases, to exclude housekeeping or user-speciﬁed genes, to change the maximum distance 
for the Oxford-grid (used in Human-to-Mouse map translation, see below), and to put multiple 
searches in a batch list.
Databases used
The GeneSeeker searches three types of databases: genetic localisation, gene expression, 
and phenotypic databases. GDB and MIMMAP (a reformatted version of the OMIM gene 
mapping information) are searched for genes in a speciﬁed chromosome location in humans, 
while MGD is queried for mouse genes in the homologous regions. From the gene expression 
and phenotypic databases GXD, SWISSPROT, TrEMBL, MLC, OMIM, TBASE and Medline, 
all the genes are extracted which match the given expression terms. Database web addresses 
are given in table 1.
Gene naming
Different databases cause the data retrieved to be in different output formats. In contrast, 
communication between program processes, logical combination and analysis of the data 
obtained require a uniform nomenclature. To circumvent this problem a list of synonyms was 
created using the gene-name information stored in SWISSPROT in combination with GDB’s 
‘alias’ information. This synonym list is updated weekly, and its use should remove a number 
of potential naming problems. As an exception, the gene naming process in TBASE is highly 
variable and this could not always be neutralized by the use of these lists.
Extraction of genes from the databases
Human gene names are selected upon the fact that they must consist of one or more capital 
letters and/or numbers in the databases. Mouse genes begin with a capital letter, followed 
by one or more lowercase letters or numbers. The id-numbers of the genes in the databases 
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are taken as a unique identiﬁer. In cases where mouse databases are used (TBASE/MGD/
GXD), the mouse gene names are translated into human gene names, using a list obtained 
from GXD. The obtained gene names are compared with the synonym list, obtained from 
SWISSPROT. If a synonym exists, this then replaces the gene name. The gene names are 
reported to the GeneSeeker program together with an URL-encoded link (Uniform Resource 
Locator) to the entry.
Table 1 Database URL’s. The number of entries is based on the query formulation used by the 
GeneSeeker to extract human/mouse related information, and thus can differ from the total number of 
entries in the database.
Data bank No.entries URL
Localisation databases
OXFORD 5652 http://www.informatics.jax.org/a
MIMMAP 7171 http://www.ncbi.nlm.nih.gov/omim/
MGD 24925 http://www.informatics.jax.org/
GDB 51917 http://www.gdb.org/gdb/
Expression and phenotype databases
SWISSPROT 5908 http://www.ebi.ac.uk/ebi_docs/swissprot_db/swisshome.html 
SWISSNEW 5875 http://www.ebi.ac.uk/ebi_docs/swissprot_db/swisshome.html 
SPTREMBL 23567 http://www.ebi.ac.uk/ebi_docs/swissprot_db/swisshome.html 
REMTREMBL 19036 http://www.ebi.ac.uk/ebi_docs/swissprot_db/swisshome.html 
TREMBLNEW 10394 http://www.ebi.ac.uk/ebi_docs/swissprot_db/swisshome.html 
Medline 58978 http://www.ncbi.nlm.nih.gov/b 
TBASE 6768 http://tbase.jax.org/b 
GXD 24925 http://www.informatics.jax.org/ 
OMIM 13099 http://www3.ncbi.nlm.gov/omim/ 
MLC 24925 http://www.informatics.jax.org/ 
Other database(s)
GeneCards 20417 http://bioinformatics.weizmann.ac.il/cards/
aAccessed after processing from the local mirror site: http://www.cmbi.kun.nl/srs/. bAccessed directly 
using this address. Remaining sites were accessed using the local mirror site: http://www.cmbi.kun.
nl/.
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Databases containing locus information
The MIMMAP and GDB databases are searched for all genes between two human genetic 
locations, including any overlapping genes.
In order to be able to search mouse gene localisation databases, human genetic localisations 
are converted to mouse localisations by an ‘Oxford-grid’ as supplied by the MGD[2]. Mouse 
genes are searched positionally rather than on similarity, since the goal is to ﬁnd extra genes. 
The input for the ‘Oxford-grid’ is a human chromosome number with a band range (e.g. 7p15-
p21). This location is then translated into mouse chromosomes with a chromosomal range 
in cM. Two locations are taken as one range if they are closer to each other than speciﬁed 
in the maximum distance. If not, they are returned as two separate regions. Each region is 
returned with a standard extension of 5 cM, so as not to miss any genes located on the region 
boundaries. The output from the ‘Oxford-grid’ contains mouse chromosomes with their cM-
range and is reported back to the GeneSeeker main program. This range is subsequently used 
to query MGD for homologous mouse genes.
Databases containing gene expression or phenotype information
For all genes expressed in a certain tissue type or associated with a phenotypic feature 
involving a speciﬁed tissue or organ the description and comment lines, matching ‘human’ 
are extracted from the SWISSPROT, SWISSNEW, TrEMBL, and TrEMBLNEW databases. 
The gene names are selected from the gene-name ﬁeld.
The same procedure is followed for the Medline database, using an advanced Boolean search 
for all genes expressed in a certain tissue type or sharing a phenotypic feature of a syndrome 
in humans (query: ‘tissue and human[orgn] not mouse[orgn] not rat[orgn]’). The human gene 
names are selected by the fact that these begin with two capital letters, followed by one or 
more capital letters or numbers. Common abbreviations such as DNA, RNA, PCR, and others 
are ﬁltered out.
All genes expressed in a certain tissue type or with a phenotypic feature of a syndrome are 
extracted from the TBASE database using the ‘phenotype’ ﬁeld and selecting the mouse as 
the organism, from GXD and OMIM using the ‘abstract’ ﬁeld and ‘text’ ﬁeld respectively, 
and from the MLC database using the ‘phenotype’ ﬁeld. The obtained mouse gene names are 
translated into human gene names, using a list obtained from MLC itself. 
Test selection of human genetic disorders
To test the ability of the GeneSeeker program to identify candidate genes, eight syndromes 
with known genesis where used. We also evaluated two syndromes whose genesis at the time 
of the query had not yet been published: Acro-Dermato-Ungual-Lacrimal-Tooth (ADULT) 
syndrome[8] and Noonan syndrome[9, 10] (table 2). These two examples presented an 
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excellent opportunity to test the system without the noise from direct pointers to the gene in 
the databases used.
Querying the GeneSeeker 
The setup of the GeneSeeker makes it possible to submit queries in a number of ways. To 
benchmark the performance, accuracy, and the ﬂexibility of the system, the same query was 
formulated in different ways. Each syndrome mentioned in table 2 was queried using primary 
expression terms (table 2) combined with the Boolean operators and or or for all terms. For 
example Alagille syndrome was formulated once as ‘liver and eye and heart’, and also as 
‘liver or eye or heart’. In addition, in some queries the thesaurus/embryological terms were 
used. Thus, ‘eye’ became (eyes or eye or conjunctiva or cornea or lens or optic nerve or retina 
or vitreous or ‘conjunctival sac’).
Evaluation
Each result is saved as a HTML ﬁle in a separate directory, containing the output from the 
different databases analysed by the GeneSeeker. The output of the analysis is presented in 
four tables. (1) A list of human genes in the correct genetic region and matching the speciﬁed 
expression proﬁle, (2) a list of mouse genes matching the syntenic region(s) as well as the 
expression proﬁle, but with no matching human gene name, (3) a list of mouse genes found in 
the syntenic region in mouse, for which the homologous human gene is found to map outside 
the critical interval, and (4) a list of all the remaining human genes that are present in the 
Table 2 Selected disorders
Syndrome (OMIM#) Expression terms Genetic localisation
Acro-Dermato-Ungual-Lacrimal-Tooth Syndrome 
[103285] Limb/Hand/Teeth 3q27
Alagille Syndrome [118450] Liver/Eye/Heart 20p12
Hand-Foot-Uterus Syndrome [140000] Limb/Genital 7p15-7p14.2
Holt-Oram Syndrome [142900] Limb/Heart 12q24.1
Multiple Synostoses Syndrome 1 [186500] Ear/Joint 17q22
Noonan Syndrome [163950] Skeletal/Heart 12q24.1
Renal-Coloboma Syndrome [120330] Renal/Eye 10q24.3-10q25.1
Townes-Brocks Syndrome [107480] Limb/Ear 16q12.1
Tricho-Dento-Osseous Syndrome [190320] Ectoderm/Skeleton/Tooth 17q21.3-17q22
Ulnar-Mammary Syndrome [181450] Limb/Mammary 12q24.1
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genetic interval, but which do not match the expression proﬁle. The data in the HTML ﬁles 
was extracted and converted to a spreadsheet for further analysis.
Results
The evaluation queries were performed in batch in June and July 2001. The processing time 
of queries using both genetic localisation and expression/phenotypic information varied from 
2 min for simple queries to 10 min for complex queries. The number of hits per database for 
the genetic localisation, expression/phenotypic and the combined queries are presented in 
ﬁgure 2a, b, c respectively. For the genetic localisation query, no large differences were found 
between the GDB and MIMMAP. The number of MGD hits is relatively large for several 
regions. First, because this list includes both mouse genes whose human homologues are 
present in GDB as well as a smaller list of mouse genes for which a human homologue could 
not be identiﬁed, either directly or by applying the synonym list. In addition, the conversion 
through the Oxford grids caused more genes to be retrieved because of wider segment limits. 
Both ﬁgure 2b and c show a very small contribution from TBASE compared to the other 
queried databases. This likely reﬂects the relatively small number of genes in TBASE as well 
as inconsistent gene naming.
All the causative genes were found in the queries done with only the genetic localisation data 
(table 3). The average number of genes in a disease critical interval was 165. This number 
varied from 322 in the case of Tricho-Dento-Osseous syndrome in 17q21.3-17q22, to only 49 
in Townes-Brocks syndrome located at 16q12.1.
Combining genetic localisation with expression/phenotype data was most successful if a 
Boolean or was used to combine expression sites. In all 10 such cases, the causative gene was 
retrieved. Starting from an average number of 165 positional candidate genes (range 49 – 322), 
the number of candidate genes that matched both location and expression pattern was reduced 
to 22 (range 2 – 63). A match was also obtained for both syndromes for which the gene had not 
previously been identiﬁed as causing the disease. For ADULT syndrome, a candidate gene list 
of 12 genes was generated, reﬂecting a 10-fold reduction from 116 positional candidate genes. 
TP63, which was subsequently been proven to be the causative gene for ADULT syndrome, 
was present among these 12 selected genes[11].
A similar result was obtained for Noonan syndrome. Using ‘skeletal and heart’ as search 
terms, the number of genes from chromosome band 12q24.1 was 174. This was reduced to 
10 in the candidate gene shortlist. Among this ﬁnal selection was the PTPN11 gene, which 
indeed causes Noonan syndrome[10].
Discussion
Human disease genes can sometimes be rapidly identiﬁed by using information on RNA 
expression patterns or by studying knockout phenotypes in mice. For instance systematic 
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screens for genes expressed in retina or inner ear are currently being applied successfully 
in labs around the world in order to identify genes for deafness or blindness respectively[12-
14]. Similarly, direct comparison of human and mouse phenotypes allowed for the rapid 
a)
c)
b)
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Figure 2 The average number of hits per database in the candidate gene list of the GeneSeeker: (a) only 
the genetic localisation query; (b) only expression/ phenotypic query, combining the search terms with 
a Boolean or; (c) genetic localisation and expression/ phenotypic information combined with a Boolean. 
For the expression terms the thesaurus table is used. The ranges indicate the standard deviation of the 
mean.
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recognition of ROR2 as the Robinow syndrome gene[15, 16].
A systematic approach to this conservation of phenotypes has already been attempted and 
is presented in the Dysmorphic Human-Mouse Homology Database (DHMHD)[17]. Others 
have attempted to use cross-species conservation with invertebrates to identify genes that 
underlie human developmental syndromes and diseases[18].
All this argues for a systematic bioinformatics approach that includes all available information 
from public databases to prioritise among positional candidate genes. In a pilot experiment it 
was previously shown that it is possible to use a bioinformatics approach to identify plausible 
candidate genes for human multiple congenital anomaly syndromes by systematically using 
data on murine gene expression patterns[7].
We have since developed this data mining approach further to create a web-based tool that 
combines data on genetic localisation from OMIM, GDB, and MGD with data on gene 
expression from GXD and SWISSPROT/TrEMBL and data on phenotypes in humans 
Syndrome
Localisation 
selectivity
Expression 
selectivity
Candidate gene 
selectivity
Total or and or and
Acro-Dermato-Ungual-Lacrimal-
Tooth Syndrome
1/116 1/2664 0/109 1/12 0/2
Alagille Syndrome 1/102 1/6435 1/420 1/17 1/3
Hand-Foot-Uterus Syndrome 1/148 1/4550 1/78 1/29 1/2
Holt-Oram Syndrome 1/154 1/4523 1/136 1/18 1/2
Multiple Synostoses Syndrome 1 1/273 1/846 0/102 1/10 0/5
Noonan Syndrome1 1/174 1/1090 1/349 1/21 1/12
Renal-Coloboma Syndrome 1/154 1/3774 1/504 1/33 1/7
Townes-Brocks Syndrome 1/49 1/1874 0/74 1/2 0/1
Tricho-Dento-Osseous Syndrome 1/322 1/3046 1/189 1/63 1/4
Ulnar-Mammary Syndrome 1/154 1/4523 0/136 1/18 0/2
Table 3 Selectivity and reduction. All queries were performed using expanded thesaurus terms
The localisation selectivity represents the number of genes in the genetic region, whereas the expression 
selectivity reﬂects the number of genes that match the expression terms speciﬁed by the user; the 
candidate selectivity is the combination of the two. The Boolean operators indicate how the primary 
expression terms (table 2) are combined. 1: This analysis was performed in October 2001.
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(OMIM, Medline) and mice (MLC, TBASE). This approach mimics the steps currently 
undertaken in most human genetics labs around the world once a critical region for a genetic 
disease is identiﬁed. The biggest advantage of the current automated approach is that it 
provides combined data from nine databases in a matter of minutes, rather than hours or days 
if individual databases are queried one gene at a time. Genetic localisation and expression 
databases were used in almost equal proportion. The number of hits per database varied 
greatly, but all contributed to the ﬁnal selection of candidate genes. Of all databases, TBASE 
contributed the smallest number of genes. This is partly due to the fact that gene names in 
TBASE often do not conform to the nomenclature used in OMIM or GDB. Moreover, TBASE 
presently contains information on only a small number of genes.
The most successful search strategy with the GeneSeeker was by using the thesaurus in 
combination with or Boolean operators. More restrictive strategies failed in a signiﬁcant 
proportion of cases, suggesting that the data in the databases is still incomplete, and that 
inappropriate search terms may have been used that failed to detect the presence of the gene 
in one or more databases. Some of these failures are to be expected as no single system has 
been adopted for scoring expression patterns and phenotype across the various databases. 
This situation is likely to improve considerably over the next few years. First, the genomic 
databases presently contain only draft versions of the genome with many genes yet to be 
identiﬁed, and properly annotated[19, 20]. In addition, efforts are currently underway to 
set up more complete databases on gene expression and on knockout phenotypes. As one 
example, a comprehensive inventory of expressed mouse genes during development is in 
progress[21]. Adding such databases to combined data mining strategies as presented here 
for the GeneSeeker may further improve their performance. Given the simplicity of the 
approach that is incorporated in the GeneSeeker tool, one might have expected that other 
similar applications might already exist. To the best of our knowledge this is not the case. 
Speciﬁcally, no program appears to be available that evaluates gene expression or phenotype 
information to aid with selection of positional candidate genes.
It is encouraging that all 10 causative genes were found for the human malformation 
syndromes with known genesis, and that this was accompanied by an on average 10-fold 
reduction compared to using localisation data only. We acknowledge that only prospective 
studies of syndromes that have not yet been deﬁned molecularly can establish the true value 
of the bioinformatics tool described here. However, a considerable number of human disease 
genes have already been identiﬁed wholly or partly by virtue of comparing their mutant 
murine phenotypes and expression patterns. This by itself suggests that this approach can 
only become more effective as more information becomes available for each human gene. 
The modular setup employed in this ﬁrst version of the GeneSeeker should allow easy 
expansion by adding further databases to improve the detection rate of disease genes. We 
are currently adding the Unigene database[22] and other EST database sources in order to 
expand the available information on expression patterns. SAGE (Serial Analysis of Gene 
Expression) data can also be added in the future, thereby further improving the sensitivity 
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of the tool. Some text-based modules such as Medline may become more effective by using 
MeSH (Medical Subject Heading) terms and context sensitive searches.
Additional features like a comparison of old and new results, automatic selection of 
expression terms based on the OMIM clinical synopsis, and the ability to use STS marker 
data and physical coordinates rather than chromosome bands to specify genetic localisation 
are currently under development.
In its current form, the GeneSeeker is mainly suited for malformation syndromes in which 
the assumption can be made that the disease gene has an aberrant or absent gene expression 
in the affected tissues. For metabolic diseases other strategies can be applied, for example 
incorporating biochemical pathways such as the Kyoto Encyclopedia of Genes and Genomes 
(KEGG)[23]. This can also be added to future versions of the program.
In spite of the obvious limitations of the system, even in its present early stage of development 
the GeneSeeker (version 2.0) offers researchers a useful tool to generate a starting list of 
candidate genes involved in human genetic disorders. The GeneSeeker site will be continuously 
updated and curated by the Centre for Molecular and Biomolecular Informatics at Nijmegen 
University. The current setup of the GeneSeeker relies on external databases. This means that 
regular checks of web addresses and database structures will be necessary to avoid losing 
individual databases. We intend to provide such regular follow-up, and note that the setting 
within a centre that provides support for more than 70 databases already would seem to be 
ideal for this. (Average downtime for these databases over the past 3 years has been less than 
0.5%.) Also, the current GeneSeeker system has a number of advantages. Using external 
databases means that we avoid data warehousing. Therefore, all data are up to date and we 
would argue that in practice WWW front-ends are more stable than their underlying relational 
tables. In fact when changing the internals of the database, database developers often try to 
keep the WWW front-end unchanged. In conclusion, current developments in the availability 
of genomics data as well as improving bioinformatics strategies support the notion that data 
mining approaches as applied in the GeneSeeker may become a useful adjunct to wet lab 
experiments in human genetics.
Note added in proof
The program described here has previously been presented at scientiﬁc conferences and in 
abstracts as the ‘GeneMachine’[24]. In order to avoid confusion with a recently published 
program[25], we henceforth shall use the name GeneSeeker.
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Abstract
The identiﬁcation of genes underlying human genetic disorders requires the combination of 
data related to cytogenetic localisation, phenotypes and expression patterns, to generate a list 
of candidate genes. In the ﬁeld of human genetics, it is normal to perform this combination 
analysis by hand. We report on GeneSeeker (http://www.cmbi.ru.nl/GeneSeeker/), a web 
server that gathers and combines data from a series of databases. All database searches are 
performed via the web interfaces provided with the original databases, guaranteeing that 
the most recent data are queried, and obviating data warehousing. GeneSeeker makes the 
same selection of candidate genes as the human geneticist would have performed, and thus 
reducing the time-consuming process to a few minutes. GeneSeeker is particularly well suited 
for syndromes in which the disease gene displays altered expression patterns in the affected 
tissue(s).
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Introduction
Identiﬁcation of causative genes in human genetic disorders will be accelerated by the wealth 
of “omics” information being generated. Geneticists consult a number of databases to search 
for these genes. Each database concentrates on a different (molecular) aspect. In addition, 
databases have their own user interface, different formats to present the data, and sometimes 
even their own ontologies. Data such as gene localisation and expression patterns may be 
distributed over multiple databases.
Geneticists normally collect phenotypic and/or expression data and the genes in the 
chromosomal region(s) of interest, and combine these to get a list of candidate genes. The 
rationale for this is that the gene that causes a disease is likely to be expressed in the tissues 
affected by that disease[1-3]. Using model organisms, such as the mouse, it is often possible 
to obtain information on genes, proteins, protein interactions and other functional attributes 
that can be transferred to Homo sapiens by means of synteny and protein homology relations. 
The use of data from other species (such as mouse) often proves helpful in identifying the 
location or function of the equivalent human gene[4]. GeneSeeker mimics this multi-species 
identiﬁcation strategy[5].
Material and Methods
Databases used.
Table 1 list the databases that GeneSeeker queries. These are divided over database groups 
(DB-groups). All databases are accessed through their standard WWW interfaces except 
MIMMAP and OXFORD. MIMMAP is a reformatted version of the OMIM[7] gene mapping 
information. OXFORD is used to translate human to mouse chromosomal locations, and 
is described in more detail in the pre-processing section. We use SRS (Sequence Retrieval 
System, Lion Biosciences, Cambridge, UK) to access these two databases[16]. The SRS 
parser was modiﬁed to allow searches for chromosomal ranges.
Data processing
The layout of the GeneSeeker web server is shown in ﬁgure 1. The user query consists of a 
chromosomal band range using standard nomenclature (e.g. “7p15–p21”). This cytogenetic 
localisation is passed through DB-group 1. Syntenic regions in the mouse are sought in DB-
group 2 using an Oxford-grid. Tissues of interest or phenotypic features of a syndrome can 
be speciﬁed by the user as a Boolean expression that is split up and processed by DB-group 3. 
This modular set-up makes it easy to add extra DB-groups in the future. For every database, a 
plug-in was designed to perform all tasks from user-query pre-processing to query-result post-
processing. These plug-ins deal with a series of technical topics, such as query reformatting, 
generating the correct URL, ﬁlling in the form on that database’s web interface, requesting 
all hits rather than in chunks, parsing the database HTML output, and so on. 
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The name of a gene can vary from database to database. The gene for the multi-drug resistance-
associated protein 1, for example, is stored as ABCC1, MRP, or MRP1, depending on the 
database used. These gene nomenclature problems have to be solved because GeneSeeker 
depends on the gene names in the combination steps. For each DB-group the results are 
Table 1 Databases accessed by the GeneSeeker
Database URL
DB-group 1: localisation databases (human)
OXFORD[6] srs.bioasp.nl:4080
MIMMAP[7] srs.bioasp.nl:4080
GDB[8] www.gdb.org
DB group 2: localisation databases (Mouse)
MGD[6] www.informatics.jax.org
Datasets used in the interface
GXD thesaurus Van Steensel et al.[9]
Zuerich dataset Brewer et al.[10, 11]
DB group 3: Expression/Phenotype databases
PubMed (National Library of Medicine, 
Bethesda, Maryland, USA)
www.ncbi.nlm.nih.gov/pubmed
OMIM[7] srs.bioasp.nl:4080
UniProt[12](SwissProt, TrEMBL, etc) srs.bioasp.nl:4080
GXD[13] www.informatics.jax.org
MLC[6] www.informatics.jax.org
TBASE[14]
www.informatics.jax.org
(was tbase, merged January 2005)
“Link out” database
GeneCards[15] bioinfo.weizmann.ac.il/cards/
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integrated with a Boolean OR. The resulting gene lists of the three DB-groups are combined 
according to the Boolean logic speciﬁed in the user query. 
Implementation issues
Parallelisation.
The database plug-ins run in parallel to minimise the waiting time. A queuing system prevents 
excessive loads on remote servers. The plug-ins return the results of the queries to GeneSeeker 
as a list containing the gene names and corresponding database hyperlinks. 
Figure 1 Overview of GeneSeeker. The query, which consists of a cytogenetic localisation, a phenotypic 
description and expression data, is divided over the three DB-groups that use the database-speciﬁc 
plug-ins to deal with all topics ranging from user-query pre-processing to post-processing of the query 
output. Results from each DB-group are merged with a Boolean OR. The results of the three DB-
groups are combined as speciﬁed in the user query.
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Mouse-Human synteny.
An Oxford grid[17] is used to ﬁnd the homologous genes and gene regions in the mouse 
genome for all human chromosome locations entered by the user. A human chromosomal 
band range is translated into the corresponding mouse chromosome locations. Two mouse 
locations are combined if the genetic distance is shorter than a user-speciﬁed value (defaults 
to 10 cM). We regenerate this Oxford grid weekly to ensure that the latest synteny information 
is used in each query.
Gene Nomenclature. Inconsistent gene nomenclature is resolved using gene synonym 
information from UniProt database[12]. We use the MGD human homologues information 
to interconvert mouse and human gene names. We maintain local copies of these conversion 
tables because nearly all queries require that gene nomenclature problems be solved.
User interface
The GeneSeeker interface consists of the query form shown in ﬁgure 2 and an options form 
that usually requires no user input. A genetic localisation and the phenotypic/expression terms 
should be entered for a meaningful search. Databases that generate more noise than signal can 
be removed from the query. The user can also suppress the display of housekeeping genes or 
a speciﬁed list of genes. The options form contains a thesaurus[9] that can help the user to 
select the correct expression terms: for example, when the user is interested in a genetic trait 
that results in abnormalities in the brain, selection of the “brain” category returns the hints 
“brain or hindbrain or forebrain…”. Hints for the genetic localisation data can be found in 
a table containing frequently aberrant chromosomal bands in speciﬁc disorders taken from 
literature[10, 11]. The user can be notiﬁed on request about the completion of GeneSeeker 
searches by email. All parameters are linked to help screens. The results are presented in four 
tables (ﬁgure 3).
Figure 2 An example of a GeneSeeker query. Analyses of Trismus-Pseudocamptodactyly syndrome 
(TPC; MIM 158300) has been linked to 17p12-p13.1[18]. TPC is characterised by defects in muscle 
tissue mainly in limb and/or mouth. The options form is data not shown. 
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Results and Discussion
The GeneSeeker offers a user-friendly quick scan of several databases that are commonly 
used by geneticists to identify candidate genes for speciﬁc Mendelian diseases. As such, 
GeneSeeker uses those databases that are most appropriate for the questions asked. Several 
aspects are likely to change in the near future as genomics and genetics develop. For example, 
our usage of an Oxford grid can be improved or replaced as soon as consensus is reached about 
the localisation of genes on the mouse and human genomes among the various databases. 
Expression pattern information (e.g. microarray data) is growing rapidly, and is expected to 
become useful for GeneSeeker in the near future. At the moment, publicly available expression 
information is still sparse, scattered and not yet standardised.
In its present form, GeneSeeker is best suited for syndromes in which one can assume 
aberrant or absent gene expression in the affected tissues. GeneSeeker allows the user to query 
heterogeneous databases and obtain good candidate genes for the disease of interest based on 
positional, expression and model data[5]. With the present hardware set-up GeneSeeker can 
perform about 1000 searches per day. 
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There are more than 2.000 monogenic syndromes in man. Each syndrome has a speciﬁc 
combination of phenotypic features, and each differs from other syndromes by only one or 
a few of those features. Could the ordering of phenotypes into syndrome families tell us 
about the relationships of the underlying genes? If so, such phenotype relationships could 
be systematically exploited to ﬁnd new disease genes and provide clues to gene interactions, 
pathways and functions.
One way to deﬁne the function of the genes in a genome is to scrutinize mutant phenotypes 
in a systematic manner. Indeed, large-scale mutagenesis programmes that aim to do this 
have been completed for yeast and are underway for model systems such as Caenorhabditis 
elegans, the mouse and zebraﬁsh. It is not clear how many different mutants will be required 
for such screens to be comprehensive. What is clear, however, is that creating a single knockout 
in a mouse model will rarely be sufﬁcient to probe a gene’s functions in development and 
homeostasis. In fact, to obtain a comprehensive view of gene function, the number of random 
mutations that need to be examined in detail at the phenotype level will probably be very 
large. Starting from interesting phenotypic differences and then comparing the mutations that 
underlie them might well be more effective. Spontaneous mutations are frequent in nature, 
and the study of their associated phenotypes can contribute to our understanding of gene 
function. This underlines the necessity for a phenotype-driven approach that saturates the 
genome with mutations, either with induced mutations (in animal models) or, in the case of 
humans, in disease states.
The study of naturally occurring mutations in humans has several advantages. First, differences 
in phenotypes reﬂect an alteration in a functional module, whether it is developmental or 
homeostatic. Second, the number of known monogenic phenotypes in humans is large, 
and many have been described in considerable clinical detail. Medical systems worldwide 
effectively operate as an enormous mutation screen of unequalled power. Because we are 
more likely to notice a subtle change in a human being than in a worm, we can detect the 
effects in more detail and at many more loci in humans than we can in any other species[1].
The vast amount of phenotypic information that is stored in a few accessible databases, such as 
Online Mendelian Inheritance in Man (OMIM; http://www.ncbi.nlm.nih.gov/Omim; [2])[3], 
is another advantage of studying human disease phenotypes. Nonetheless, the systematic 
analysis of phenotype relationships has only recently begun to be explored[4-7].
Syndromes and syndrome families
To fully exploit the scientiﬁc potential of mutant phenotypes, we need to deﬁne them 
precisely[8]. The process of syndrome delineation starts at the clinical level, often from a few 
patients, and involves the continuous addition of new cases that help to establish and reﬁne 
the phenotype[9]. Initially, cases of the syndrome that are identical or nearly identical to the 
original description are reported, and this might create the false impression that a syndrome is 
clinically homogeneous[9]. One possible way to avoid this would be to only include affected 
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family members, and to exclude the index cases from the analyses[10]. Reports on patients with 
partly overlapping phenotypes frequently lead to debates between ‘splitters and lumpers’[11]. 
As syndrome deﬁnition is initially intuitive and analytic, clinical arguments alone rarely 
resolve such debates. Only a few reports describe mathematical approaches to syndrome 
deﬁnition[12, 13], and syndrome diagnosis remains largely a matter of comparison with the 
‘ideal’ aspect of the given syndrome. Once the gene for a syndrome has been found, a clearer 
picture emerges of what constitutes the core phenotype and its variants. However, having a 
molecular deﬁnition of a syndrome does not completely solve the problem of understanding 
its phenotypic variability: allelic mutations can be associated with considerable phenotypic 
diversity, and the action of modiﬁer genes further adds to this variability[14]. Furthermore, 
as mutations in different genes can cause the same or related phenotypes, a strictly molecular 
classiﬁcation would obscure the relationship between molecularly distinct syndromes at the 
phenotype level[15].
It has been recognized for many years that overlapping syndrome phenotypes might reﬂect 
biological relationships[16]. Designated ‘phenotype communities’ or ‘syndrome families’, 
these terms refer to groups of syndromes that share a large proportion of their key features. 
Because the process of syndrome delineation is iterative, syndrome phenotypes tend to evolve 
as more information becomes available. For this reason, and because of advances in molecular 
genetics, syndromes can merge or split over time, and can even disappear[17]. Consequently, 
syndrome families can only be arbitrarily deﬁned as groups of syndromes that are coded 
as independent entities in expert databases, such as OMIM, the London Dysmorphology 
Database (LDDB; http://www.lmdatabases.com) or the Pictures of Standardized Syndromes 
and Undiagnosed Malformations (POSSUM; http://www.possum.net.au) database[2, 3]. In 
spite of these limitations, the syndrome-family concept has been remarkably successful in 
predicting allelic mutations, as in several skeletal dysplasias (BOX 1).
Biology of syndrome families
It is not immediately obvious that phenotypic overlap should be a reliable indicator of shared 
function. Perhaps perceived phenotypic similarities between syndromes are simply the result 
of our inability to appreciate the relevance of various discriminating features. For instance, 
we can ask whether the assignment of what seems to be a single human genetic disease 
to different genes represents diagnostic failure or shared biological mechanisms. From the 
examples given below, the latter would seem to be much more common.
The fact that mutations at different loci could lead to apparently the same human genetic 
disease was ﬁrst recognized almost 50 years ago, when N. Morton showed that although 
some families with elliptocytosis were genetically linked to the Rhesus bloodgroup locus, 
other families were not[21]. It has since become clear that non-allelic genetic heterogeneity is 
frequent in Mendelian diseases, and that it can be extensive[22-26]. Genetic heterogeneity is 
commonly regarded as an obstacle to understanding human genetic disease, because it results 
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in more ambiguous linkage assignments and slows down the gene-ﬁnding process. However, 
genetic heterogeneity can also be viewed in a different light: it might reﬂect interactions at 
the protein level, such as ligand–receptor interactions, the different subunits of a multiprotein 
complex or proteins that function at different steps of a metabolic pathway.
Such interactions have two implications: not only could we ﬁnd the other genes more effectively 
once the ﬁrst gene is found, but we can also speculate that apparently unrelated genes that are 
involved in the same phenotype will ultimately be shown to have a functional relationship. In 
this way, clinical classiﬁcation could precede molecular veriﬁcation, and syndromology could 
become a functional genomics tool.
From genetic heterogeneity to molecular interactions and pathways.
Fanconi anaemia (FA) is an example of a heterogeneous syndrome that has provided important 
information on the pathways that underlie it. This syndrome is an autosomal recessive disorder 
that is associated with cardiac, renal and limb malformations, as well as dermal pigmentary 
changes. Progressive bone-marrow disease can lead to bone-marrow failure and leukaemia. 
Somatic-cell hybrid studies that deﬁned multiple complementation groups ﬁrst showed that 
FA was genetically heterogeneous[27]; since then, at least nine FA loci have been identiﬁed 
and seven genes have been cloned. The function of each of these genes was unknown at the 
time that they were identiﬁed, although given that at the cellular level, FA was characterized 
by chromosome breakage, it was probable that these genes were involved in DNA repair. 
Box 1 An example of the syndrome-family approach: skeletal dysplasias
The syndrome-family approach was ﬁrst systematically applied to the skeletal dysplasias. 
The number of these syndromes grew steadily from a single entity — achondroplasia — to 
more than 200 at the start of this century[18]. It was in 1985 that the German paediatrician 
J. Spranger proposed the syndrome-family system for grouping several clinically distinct 
skeletal dysplasias into a smaller number of categories, which he termed chondrodysplasia 
families[19], on the basis of key shared features. Almost 20 years on, molecular analysis 
has vindicated Spranger’s classiﬁcation. His concept of a Stickler–Kniest family has been 
shown to involve mutations in interacting collagen genes (see BOX 2), whereas the three 
members of the achondroplasia (weblink)1 family of bone dysplasias all have mutations in 
ﬁbroblast growth factor receptor 3 (FGFR3)[18]. Interestingly, recent data indicate that 
the Oto-Palato-Digital syndrome (OPD) and Larsen syndrome, which Spranger grouped 
together in a further bone-dysplasia family, arise through mutations in ﬁlamin A and B, 
respectively. Filamin A and B are two closely related members of a family of cytoplasmic 
proteins that regulate the structure and activity of the cytoskeleton by crosslinking actin 
into three-dimensional networks[20].
What is true for skeletal dysplasias is also true for other diseases. Human disease-phenotype 
groups might reﬂect the different functional domains of a single protein, the interaction 
between different proteins such as ligand and receptor, the interaction between proteins in 
a multiprotein complex and different steps in a cellular pathway.
1 Weblinks: These terms are linked online to databases that 
are listed at the end of this paper.
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Subsequently, it was shown that the proteins that the FA genes A, C, F, E and G encode indeed 
form a complex that functions in DNA repair. The FA D2 protein (FANCD2) functions as 
a downstream effector of this complex, and the latest FA gene to be identiﬁed (FANCL) 
encodes a putative ubiquitin ligase that might be responsible for the mono-ubiquitylation of 
FANCD2[22, 28]. So, the molecular genetics of a single syndrome can deﬁne a previously 
unknown multiprotein complex, which in this example has an important role in DNA repair.
The converse process is equally frequent in human molecular genetics. If a molecular pathway 
is already known, this knowledge can be used to accelerate the gene-ﬁnding process for 
a genetically heterogeneous disease. This candidate-gene approach was used to show that 
recessive mutations in each of the ﬁve subunits of translation initiation factor eIF2B cause 
the same recessively inherited leukoencephalopathic brain disease, which is characterized by 
vanishing white matter[29].
There are also several examples for which the same phenotype is caused by the mutation of 
either the receptor or the ligand gene for a signalling step. A striking example of this is the 
combined phenotype of pre-senile dementia and bone cysts. Mutations in a gene that encodes 
a membrane receptor on natural-killer and myeloid cells, and in the gene that encodes a ligand 
for this receptor, each resulted in this disease phenotype[30].
Syndrome families and pathways.
What is true for a single genetically heterogeneous disease might equally apply to distinct 
syndromes with phenotypic overlap. One such syndrome family comprises the Walker–
Warburg syndrome, Fukuyama Muscular Dystrophy and muscle–eye–brain disease (MEBD 
(weblink)). These diseases are characterized by abnormal neuronal migration, variable eye 
involvement and congenital muscular dystrophy. Although these syndromes can usually be 
distinguished on clinical grounds alone, there is also a clear overlap in the features that deﬁne 
them, and it has previously been suggested that they form a clinical spectrum of diseases[31]. 
Biochemical staining of muscle specimens has shown that all three conditions share a defect in 
the glycosylation of proteins such as α-Dystroglycan. The predicted biochemical function for 
the three genes that are involved in Walker–Warburg syndrome (weblink), Fukuyama muscular 
dystrophy (weblink) and MEBD is consistent with a shared role in O-Mannosylation[32]. So, 
these three independent but clinically similar syndromes represent the disruption of different 
steps in the same biochemical pathway. 
Similar interactions among gene products occur in Usher syndrome types 1B, 1C, 1D and 
1G[26] and among Waardenburg syndrome types 1, 2 and 4[33, 34]. The clinical distinction 
of Waardenburg syndrome types 1, 2 and 4 pre-dated the identiﬁcation of the causative genes 
by many years. As is common in these situations, both the clinical differences as well as the 
similarities turned out to be relevant for the various forms of Waardenburg syndrome. When 
the genes were found to be distinct, the clinical similarities immediately stimulated research 
to identify the functional module that links them together at the level of transcription.
Given that mutations that affect different steps in a pathway can cause the same monogenic 
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phenotype, in some instances, the combined effect of mutations in different genes might 
interact to produce digenic or polygenic inheritance of human-malformation syndromes. 
Indeed, several examples of digenic or triallelic inheritance in humans have been recorded[35]. 
The most striking is Bardet–Biedl Syndrome (BBS (weblink)). In this syndrome, there is 
genetic interaction between several of the loci. Although the functions of the BBS genes 
remain largely unknown, the additive effect of mutations at BBS1, BBS2, BBS4, BBS6 (weblink) 
(MKKS) and BBS7 (weblink) indicates that the products of the different BBS genes share at 
least part of their functions[24, 36]. Consistent with this prediction is the recent discovery that 
all known BBS genes for which there are homologues in C. elegans are expressed exclusively 
in ciliated neurons[37].
Exceptions to the rule
If different phenotypes result from mutations in a single gene, the probable explanation is that 
the mutations disrupt different functions that are encoded by that gene. Detailed genotype–
phenotype analysis might indicate the localisation of such functions within a gene and the 
protein that it encodes.
For example, mutations in the XPD (weblink) (ERCC2) gene can cause either Xeroderma 
Pigmentosum (XP) or TrichoThioDystrophy (TTD (weblink))[38]. Sensitivity to sunlight 
with the development of cancer at an early age is a leading feature of XP. By contrast, patients 
with TTD have brittle hair and nails, ichthyotic skin, and physical and mental retardation. 
Many, but not all, patients with TTD are sensitive to sunlight, but they do not have any 
unusual pigmentation changes, and there are no reports of cancer in TTD patients. The XPD 
gene encodes a subunit of the basal transcription factor TFIIH. The TFIIH complex has two 
principal independent functions, one in the initiation of basal transcription and the other in 
DNA repair. It has been proposed that if the defect in the XPD gene affects the DNA-repair 
function of TFIIH without affecting its transcriptional role, XP will result. On the other hand, 
if the transcriptional role of TFIIH is affected, the consequence will be the developmental 
defects that are found in TTD[38]. The hypothesis that XP is a repair syndrome and that 
TTD is a transcription syndrome predicts that the mutations that are associated with the two 
disorders could be located at different sites in the gene. Indeed, the mutation spectrum is 
consistent with the hypothesis that the site of the mutation in the XPD gene determines the 
clinical phenotype[39].
Considerable phenotypic heterogeneity has also been demonstrated for the p63 gene. At least 
six clinically different syndromes are caused by mutations in this gene. Here too, different 
classes of mutation cause different syndromes. The most parsimonious explanation for 
this pattern is that each phenotype reﬂects the disruption of a speciﬁc function or set of 
functions[40].
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Multifactorial disease
Phenotype clustering might equally be applied to multifactorial diseases. Although one or 
several distinct processes might be involved in disease causation for a multifactorial disease, 
we can predict that at least some of the individual genes will converge on a single biological 
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that are coded as independent entities in
expert databases, such as OMIM, the London
DYSMORPHOLOGY Database (LDDB) or the
Pictures of Standardized Syndromes and
Undiagnosed Malformations (POSSUM)
database2,3 (see online links box). In spite of
these limitations, the syndrome-family con-
cept has been remarkably successful in pre-
dicting allelic mutations, as in several SKELETAL
DYSPLASIAS (BOX 1).
Biology of syndrome families
It is not immediately obvious that phenotypic
overlap should be a reliable indicator of
shared function. Perhaps perceived pheno-
typic similarities between syndromes are sim-
ply the result of our inability to appreciate the
relevance of various discriminating features.
For instance, we can ask whether the assign-
ment of what seems to be a single human
genetic disease to different genes represents
diagnostic failure or shared biological mecha-
nisms. From the examples given below, the
latter would seem to be much more common.
The fact that mutations at different loci
could lead to apparently the same human
genetic disease was first recognized almost 50
years ago, when N. Morton showed that
although some families with ELLIPTOCYTOSIS
were genetically linked to the Rhesus blood-
group locus, other families were not18. It has
since become clear that non-allelic genetic
heterogeneity is frequent in Mendelian dis-
eases, and that it can be extensive19–23. Genetic
heterogeneity is commonly regarded as an
obstacle to understanding human genetic dis-
ease, because it results in more ambiguous
linkage assignments and slows down the
gene-finding process. However, genetic het-
erogeneity can also be viewed in a different
light: it might reflect interactions at the pro-
tein level, such as ligand–receptor interac-
tions, the different subunits of a multiprotein
complex or proteins that function at different
steps of a metabolic pathway.
Such interactions have two implications:
not only could we find the other genes more
effectively once the first gene is found, but
we can also speculate that apparently unre-
lated genes that are involved in the same
phenotype will ultimately be shown to have
a functional relationship. In this way, clinical
classification could precede molecular verifi-
cation, and SYNDROMOLOGY could become a
functional genomics tool.
From genetic heterogeneity to molecular inter-
actions and pathways. Fanconi anaemia (FA)
is an example of a heterogeneous syndrome
that has provided important information on
the pathways that underlie it. This syndrome
to this variability14. Furthermore, as muta-
tions in different genes can cause the same or
related phenotypes, a strictly molecular clas-
sification would obscure the relationship
between molecularly distinct syndromes at
the phenotype level15.
It has been recognized for many years that
overlapping syndrome phenotypes might
reflect biological relationships16. Designated
‘phenotype communities’ or ‘syndrome fami-
lies’, these terms refer to groups of syndromes
that share a large proportion of their key fea-
tures. Because the process of syndrome delin-
eation is iterative, syndrome phenotypes tend
to evolve as more information becomes avail-
able. For this reason, and because of advances
in molecular genetics, syndromes can merge
or split over time, and can even disappear17.
Consequently, syndrome families can only be
arbitrarily defined as groups of syndromes
members, and to exclude the INDEX CASES from
the analyses10. Reports on patients with partly
overlapping phenotypes frequently lead to
debates between ‘splitters and lumpers’11. As
syndrome definition is initially intuitive and
analytic, clinical arguments alone rarely res-
olve such debates. Only a few reports describe
mathematical approaches to syndrome defi-
nition12,13, and syndrome diagnosis remains
largely a matter of comparison with the
‘ideal’ aspect of the given syndrome. Once
the gene for a syndrome has been found, a
clearer picture emerges of what constitutes
the core phenotype and its variants. How-
ever, having a molecular definition of a
syndrome does not completely solve the
problem of understanding its phenotypic
variability: allelic mutations can be associ-
ated with considerable phenotypic diversity,
and the action of modifier genes further adds
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Figure 1 | Integrating functional relationships and linkage analysis. Three separate genome scans
for a hypothetical multifactorial disease result in multiple peaks of possible linkage (red traces) on 3
different human chromosomes (1, 6 and 12). Integrating linkage results with data from other sources,
such as gene/protein networks (A … Z), points to a set of functionally related candidate genes (H, G and
K) that together might explain the linkage patterns. Numbers along the highlighted chromososmes
indicate the corresponding chromosome bands.
Figure 1 Integrating functional relationships and linkage analysis. Three separate genome scans for 
a hypothetical multifactorial disease result in multiple peaks of possible linkage (red traces) on 3 
different human chromosomes (1, 6 and 12). Integrating linkage results with data from other sources, 
such as gene/protein networks (A … Z), points to a set of functionally related candidate genes (H, G 
a  K) that together might explain the linkage patterns. Numbers along the highlighted chromosomes 
indicate the corresponding chromosome bands. (Colour version: see appendix 2)
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process. A pertinent example might be Alzheimer disease (weblink), for which four genes 
are known. These Alzheimer genes are all involved in the proteolytic cleavage of amyloid 
precursor protein[41].
Current studies of multifactorial diseases do not take pathway information into account when 
analysing linkage data. We propose that bioinformatics analysis of the various interaction 
and pathway data sets (see, for example, refs [42, 43]) can be used to ﬁnd the mechanism that 
links different genetic loci for a multifactorial disease. In this way, if a pattern emerges, it will 
immediately indicate the involvement of speciﬁc candidate genes (ﬁgure 1). These candidate 
genes can then be tested in more detail by examining SNPs that cover each of this set of genes 
at the different loci.
Pathway information can also be used to construct testable hypotheses about the additive 
or interactive effects of these loci. This strategy might aid the interpretation of linkage 
data that show that different loci are involved in a single disease. It would not be surprising 
to ﬁnd that although the relative importance of a locus might differ between populations 
because of differences in the frequencies of mutant alleles, the loci themselves still form a 
recognizable pattern from a biological point of view. Whereas this combined linkage and 
data-mining approach remains to be tested for multifactorial diseases, a conceptually similar 
bioinformatics strategy showed promising results for several oligogenic diseases[44].
Bioinformatics and syndrome families
If we cease to view phenotypes as independent entities and apply the syndrome-family 
approach, we might discover new relationships between genes, proteins or cellular 
pathways. By clustering the known human phenotypes into groups, we can examine whether 
relationships at the phenotype level reﬂect shared functions at other biological levels, such 
as the proteome, genome or interactome. In principle, the biological order that underlies 
phenotype classiﬁcation can now easily be explored in a systematic fashion. So far, only 
a few attempts at using phenotype clustering for the prediction of disease genes have been 
undertaken[7, 44].
OMIM contains 15.000 full-text records[2]. Of these, 5.000 describe a human phenotype, 
including some 2.000 syndromes. For approximately 1.200 human phenotypes, the 
corresponding genes are known. OMIM therefore holds data that can be used to validate ideas 
about phenotype-to-genotype relationships. However, although OMIM provides a wealth of 
information, its full-text character makes it difﬁcult to analyse systematically. OMIM also 
lacks a standardized vocabulary and knows few rules for the organization and representation 
of its data. Other more specialized syndrome databases are not yet accessible through the 
Internet, and also lack a clear system for assigning the relative importance of the various 
syndrome features[3]. Finding similar phenotypic descriptions in such databases therefore 
requires text-analysis techniques.
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Freudenberg and Propping manually extracted and analysed nearly 1.000 OMIM phenotype 
entries of diseases with known genetic origin using episodic occurrence, primary aetiology, 
primary tissue, mode of inheritance and age of onset as classiﬁcation indices[7]. They 
collected approximately 10.000 Gene Ontology (GO)-annotated genes, and showed a good 
correlation between phenotypic clusters and GO-annotation clusters. Indeed, with stringent 
cut-offs, the correct gene was among the top 1.5% of the list in one-third of all cases.
We have used fully automated text mining to analyse all OMIM disease records. We used 
the medical subject headings (MeSH) as a repository of keywords. The MeSH system is 
organized as a hierarchical tree, in which ‘nail’ is part of ‘ﬁnger’, ﬁnger is part of ‘hand’ and 
hand is part of ‘extremity’. In this way, it is possible to correct for differences in the level 
of detail of a description. To allow this process to be automated, the keyword frequencies 
were represented as vectors, with one vector per OMIM record (ﬁgure 2). Similar phenotypic 
descriptions have similar keyword frequencies, and therefore similar keyword vectors. We 
corrected for the length of the record, and applied the inverse-document-frequency technique 
to compensate, at least partly, for keyword frequency differences[45]. We then determined 
text-vector similarities.
Data from several test cases conﬁrm the hypothesis that phenotype clustering — seen as high 
similarity between MeSH terms — is the result of underlying mutations that are located in 
genes that are involved in a similar function (ﬁgure 2). The approach was successfully tested 
for Stickler syndrome (BOX 2) and for Pallister–Hall syndrome (BOX 3). These are just two 
selected examples, but an analysis of all data (H.G.B. and M.D., unpublished observations 
(weblink)) shows a clear relationship between the phenotypic similarity scores and genetic 
similarity as measured by the Protein Families Database (Pfam: http://www.sanger.ac.uk/
Software/Pfam), GO-annotations and even sequence alignments. These data strongly indicate 
that the principles that underlie phenotype clusters and syndrome families are relevant to all 
human genetic diseases, and should be explored further.
Limitations of the approach
One limitation of current methods for phenotype clustering relates to imprecisions in our 
methods to accurately and objectively deﬁne the phenotypes. Notably, OMIM is not a 
specialized database for syndromes, and other more comprehensive syndrome databases, 
such as POSSUM or LDDB, still do not provide estimates of the frequencies of the various 
syndrome features[3]. So, phenotype descriptions still contain considerable imprecision, as 
well as a signiﬁcant subjective component.
In addition, the biological level at which the phenotype is determined might vary so that, 
for some syndromes, the unit of similarity is an entire organ or embryonic structure. For 
example, the syndromes that share split hand/foot malformation as one component feature are 
probably united simply because the underlying genes are involved in maintaining the proper 
function of the apical ectodermal ridge during embryogenesis[51].
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Although the examples given here support the idea that genes that are involved in similar 
phenotypes will probably share some functional attribute, this will not always be true. For 
instance, whereas two genes that are involved in various types of osteopetrosis function in the 
acidiﬁcation of the bone matrix[52, 53], another gene for osteopetrosis seems to work through 
a different mechanism[54].
Similarly, in some instances, a multifactorial disease such as atherosclerosis will result 
from genes that are involved in distinct process, such as lipid metabolism and hypertension, 
P E R S P E C T I V E S
natural-killer and myeloid cells, and in the
gene that encodes a ligand for this receptor,
each resulted in this disease phenotype27.
Syndrome families and pathways. What is
true for a single genetically heterogeneous dis-
ease might equally apply to distinct syn-
dromes with phenotypic overlap. One such
syndrome family comprises the WALKER–WAR-
BURG SYNDROME, FUKUYAMA MUSCULAR DYSTROPHY
and muscle–eye–brain disease (MEBD).
These diseases are characterized by abnormal
neuronal migration, variable eye involvement
and congenital muscular dystrophy. Although
these syndromes can usually be distinguished
on clinical grounds alone, there is also a clear
overlap in the features that define them, and it
has previously been suggested that they form
a clinical spectrum of diseases28. Biochemical
staining of muscle specimens has shown that
all three conditions share a defect in the glyco-
sylation of proteins such as α-DYSTROGLYCAN.
The predicted biochemical function for the
three genes that are involved in Walker–
Warburg syndrome, Fukuyama muscular
dystrophy and MEBD is consistent with a
shared role in O-MANNOSYLATION29. So, these
three independent but clinically similar syn-
dromes represent the disruption of different
steps in the same biochemical pathway.
Similar interactions among gene products
occur in USHER SYNDROME types 1B, 1C, 1D and
1G23 and among WAARDENBURG SYNDROME types
1, 2 and 4 (REFS 30,31). The clinical distinction
of Waardenburg syndrome types 1, 2 and 4
pre-dated the identification of the causative
genes by many years. As is common in these
situations, both the clinical differences as well
as the similarities turned out to be relevant
for the various forms of Waardenburg syn-
drome. When the genes were found to be dis-
tinct, the clinical similarities immediately
stimulated research to identify the functional
module that links them together at the level
of transcription.
Given that mutations that affect different
steps in a pathway can cause the same mono-
genic phenotype, in some instances, the com-
bined effect of mutations in different genes
might interact to produce digenic or polygenic
inheritance of human-malformation syn-
dromes. Indeed, several examples of digenic or
triallelic inheritance in humans have been
recorded32. The most striking is BARDET–BIEDL
SYNDROME (BBS). In this syndrome, there is
genetic interaction between several of the loci.
Although the functions of the BBS genes
remain largely unknown, the additive effect of
mutations at BBS1,BBS2,BBS4,BBS6 (MKKS)
and BBS7 indicates that the products of the
different BBS genes share at least part of their
is an autosomal recessive disorder that is
associated with cardiac, renal and limb mal-
formations, as well as dermal pigmentary
changes. Progressive bone-marrow disease
can lead to bone-marrow failure and leu-
kaemia. Somatic-cell hybrid studies that
defined multiple co plementation groups
first showed that FA was genetically hetero-
geneous24; since then, at least nine FA loci
have been identified and seven genes have
been cloned. The function of each of these
genes was unknown at the time that they
were identified, although given that at the
cellular level, FA was characterized by chro-
mosome breakage, it was probable that
these genes were involved in DNA repair.
Subsequently, it was shown that the proteins
that the FA genes A, C, F, E and G encode
indeed form a complex that functions in
DNA repair. The FA D2 protein (FANCD2)
functions as a downstream effector of this
complex, and the latest FA gene to be identi-
fied (FANCL) encodes a putative ubiquitin
ligase that might be responsible for the
mono-ubiquitylation of FANCD219,25. So,
the molecular genetics of a single syndrome
can define a previously unknown multipro-
tein complex, which in this example has an
important role in DNA repair.
The converse process is equally frequent
in human molecular genetics. If a molecular
pathway is already known, this knowledge
can be used to accelerate the gene-finding
process for a genetically heterogeneous dis-
ease. This candidate-gene approach was
used to show that recessive mutations in
each of the five subunits of translation initi-
ation factor eIF2B cause the same recessively
inherited leukoencephalopathic brain dis-
ease, which is characterized by vanishing
white matter26.
There are also several examples for which
the same phenotype is caused by the muta-
tion of either the receptor or the ligand gene
for a signalling step. A striking example of
this is the combined phenotype of pre-senile
dementia and bone cysts. Mutations in a
gene that encodes a membrane receptor on
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Figure 2 | Phenotype clustering. Each arrow represents a KEYWORD VECTOR. The components in a
keyword vector correspond to terms in the document (for example, ‘myopia’, ‘joints’, and so on).
Vectors that point in the same direction are more alike. Three documents that describe three
syndromes are shown (red: STICKLER SYNDROME; green: MARSHALL SYNDROME; and blue: PALLISTER–HALL
SYNDROME). Stickler and Marshall syndromes have similar phenotypes and share common terms
(‘myopia’, ‘palate’, ‘hearing loss’) in their keyword vectors. Pallister–Hall syndrome is clearly different,
and shares few terms with Stickler and Marshall, and therefore, the vector points in a different
direction. Some terms are more important than other terms. Terms are assigned different weights by
computing the INVERSE DOCUMENT FREQUENCY, which gives a weight factor to each term in the
collection. Terms in bold contribute the most to vector direction. Flat mala, low cheekbones;
hypertelorism, widely-spaced eyes.
Figure 2 Phenotype clustering. Each arrow represents a keyword vector. The components in a keyword 
vector correspond to terms in the document (for example, ‘myopia’, ‘joints’, and so on). Vectors that 
point in the same direction are more alike. Three documents that describe three syndromes are shown 
(red: Stickler syndrome; green: Marshall syndrome; and blue: Pallister–Hall syndrome). Stickler and 
Marshall syndromes have similar phenotypes and share common terms (‘myopia’, ‘palate’, ‘hearing 
loss’) in their keyword vect s. Pallister–H ll syndrome (w blink) is clearly ferent, and hares 
few terms with Stickler and arshall, and therefore, the vector points in a different direction. Some 
terms are more important than other terms. Terms are assigned different weights by computing the 
inverse document frequency, which gives a weight factor to each term in the collection. Terms in bold 
contribute the most to vector direction. Flat mala, low cheekbones; hypertelorism, widely-spaced eyes. 
(Colour version: see appendix 2)
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without clear molecular relationships. Nonetheless, for a concept to work, it does not need 
to be right all the time. If the syndrome family concept generates testable hypotheses, that 
in itself is sufﬁcient justiﬁcation for its application at the interface between clinical genetics 
and molecular biology. In fact, reports that two inherited forms of rickets, as well as a 
tumour-associated form of the disease, can be explained by abnormalities of the same module 
(involving either ﬁbroblast growth factor 23 (FGF23 (weblink)) or its interacting molecule 
PHEX (weblink)) show that the implications of this concept might sometimes include non-
genetic disease[55, 56].
Box 2 The Stickler syndrome family
Stickler syndrome         OSMED syndrome     Marshall syndrome
COL2A1                          COL11A2                     COL11A1
Stickler Syndrome is characterized by myopia, retinal detachment, hearing loss, cleft 
palate and arthropathy. Using the keyword-vector method for Stickler syndrome, several 
related syndromes were recovered: notably the Marshall and oto-spondylo-megaepiphyseal 
dysplasia (OSMED (weblink)) syndromes have similar facial and skeletal features (see 
ﬁgure) as Stickler syndrome, but differ in other characteristics such as deafness or 
blindness. Marshall and Stickler syndromes have been the subject of a long-standing 
debate about their status as independent entities[46]. Molecular investigations have 
since identiﬁed the mutations that cause these three disorders. Mutations in COL2A1 
(weblink), COL11A2 (weblink) and COL11A1 (weblink) are responsible for the Stickler, 
OSMED and Marshall syndromes, respectively. All three genes encode ﬁbrillar collagens 
that associate to form a single trimeric collagen-11 protein molecule[47]. Interestingly, 
Spranger grouped the Stickler, Marshall and OSMED syndromes together in a single 
chondrodysplasia family (see BOX 1). Figure modiﬁed with permission from ref. [47] © 
(1999) University of Chicago Press and ref. [48] © (1997) Wiley.
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Conclusions
Of the ways in which we predict the function of human genes, mutant phenotypes are among 
the most reliable. Similar phenotypes can be assumed to result from the mutation of genes 
that are involved in the same biological process, until proved otherwise. By establishing the 
Box 3 A family-syndrome approach to Pallister–Hall syndrome
For Pallister–Hall (PH) syndrome, a query with the keyword vector returns Smith–Lemli–
Opitz (SLO (weblink)) syndrome as its nearest phenotypic neighbour (see ﬁgure part a; 
note that numbers in brackets after syndrome name refer to OMIM numbers; numbers in 
column to the right of the syndrome indicate proportion of keywords shared with Pallister–
Hall syndrome) — these phenotypes share 152 keywords out of the 259 that describe SLO 
and the 228 that describe PH syndrome (see ﬁgure part b). This phenotypic similarity 
has been noted before[49]. It is now clear that the SLO mutation in DHCR7 (weblink) 
decreases cholesterol synthesis, and that this impairs sonic hedgehog (SHH) function. 
One of the downstream effectors of SHH is GLI3 (weblink), the gene that is mutated in 
Pallister–Hall syndrome (see ﬁgure part b). It would therefore seem that the sharing of 
phenotypic features between these syndromes might result from the fact that the causative 
mutations each disrupt SHH signalling through GLI3. Interestingly, a mutation of GLI3 also 
causes PIV (weblink) (polydactyly, imperforate anus and vertebral anomalies)[50]. Note 
also that other syndromes in the list given in part a either involve an apparently unrelated 
molecular mechanism (Opitz G syndrome (weblink)), or have not yet been determined 
at the molecular level (Mohr syndrome (weblink)). 7-DHCR, 7-dehydrocholesterol; CR, 
cholesterol; DHCR7, 7-dehydrocholesterol reductase; GLI3, zinc ﬁnger protein GLI3; 
PTCH, patched protein homologue 1; SMO, smoothened homologue precursor.
P E R S P E C T I V E S
all data (H.G.B. and M.B., unpublished obser-
vations; see online links box) shows a clear
relationship between the phenotypic similar-
ity scores and genetic similarity as measured
by the Protein Families Database (Pfam; see
online links box), GO-annotations and even
sequence alignments. These data strongly
indicate that the principles that underlie phe-
notype clusters and syndrome families are rel-
evant to all human genetic diseases, and
should be explored further.
Limitations of the approach
One limitation of current methods for phe-
notype clustering relates to imprecisions in
our methods to accurately and objectively
define the phenotypes. Notably, OMIM is
not a specialized database for syndromes,
and other more comprehensive syndrome
databases, such as POSSUM or LDDB, still
do not provide estimates of the frequencies
of the various syndrome features3. So, phe-
notype descriptions still contain consider-
able imprecision, as well as a significant
subjective component.
In addition, the biological level at which
the phenotype is determined might vary so
that, for some syndromes, the unit of similar-
ity is an entire organ or embryonic structure.
For example, the syndromes that share split-
hand/foot malformation as one component
feature are probably united simply because
clustering for the prediction of disease genes
have been undertaken7,41.
OMIM contains 15,000 full-text records2.
Of these, 5,000 describe a human pheno-
type, including some 2,000 syndromes. For
approximately 1,200 human phenotypes, the
corresponding genes are known. OMIM
therefore holds data that can be used to vali-
date ideas about phenotype-to-genotype
relationships. However, although OMIM
provides a wealth of information, its full-text
character makes it difficult to analyse sys-
tematically. OMIM also lacks a standardized
vocabulary and knows few rules for the
organization and representation of its data.
Other more specialized syndrome databases
are not yet accessible through the Internet,
and also lack a clear system for assigning the
relative importance of the various syndrome
features3. Finding similar phenotypic descrip-
tions in such databases therefore requires
text-analysis techniques.
Freudenberg and Propping manually
extracted and analysed nearly 1,000 OMIM
phenotype entries of diseases with known
genetic origin using episodic occurrence, pri-
mary aetiology, primary tissue, mode of in-
heritance and age of onset as classification
indices7. They collected approximately 10,000
GENE ONTOLOGY (GO)-annotated genes, and
showed a good correlation between pheno-
typic clusters and GO-annotation clusters.
Indeed, with stringent cutoffs, the correct
gene was among the top 1.5% of the list in
one-third of all cases.
We have used fully automated text min-
ing to analyse all OMIM disease records. We
used the medical subject headings (MeSH)
as a repository of keywords. The MeSH sys-
tem is organized as a hierarchical tree, in
which ‘nail’ is part of ‘finger’, finger is part of
‘hand’ and hand is part of ‘extremity’. In this
way, it is possible to correct for differences
in the level of detail of a description. To
allow this process to be automated, the
keyword frequencies were represented as
vectors, with one vector per OMIM record
(FIG. 2). Similar phenotypic descriptions
have similar keyword frequencies, and there-
fore similar keyword vectors. We corrected
for the length of the record, and applied the
inverse-document-frequency technique to
compensate, at least partly, for keyword-
frequency differences42. We then determined
text-vector similarities.
Data from several test cases confirm the
hypothesis that phenotype clustering — seen
as high similarity between MeSH terms — is
the result of underlying mutations that are
located in genes that are involved in a similar
function (FIG. 2). The approach was success-
fully tested for Stickler syndrome (BOX 2) and
for Pallister–Hall syndrome (BOX 3). These are
just two selected examples, but an analysis of
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Box 3 | A family-syndrome approach to Pallister–Hall syndrome
For Pallister–Hall (PH) syndrome, a
query with the keyword vector returns
Smith–Lemli–Opitz (SLO) syndrome as
its nearest phenotypic neighbour (see
figure part a; note that numbers in
brackets after syndrome name refer to
OMIM numbers; numbers in column to
the right of the syndrome indicate
proportion of keywords shared with
Pallister–Hall syndrome) — these
phenotypes share 152 keywords out of
the 259 that describe SLO and the 228
that describe PH syndrome (see figure
part b). This phenotypic similarity has
been noted before55. It is now clear that
the SLO mutation in DHCR7 decreases
cholesterol synthesis, and that this
impairs sonic hedgehog (SHH) function.
One of the downstream effectors of SHH
is GLI3, the gene that is mutated in
Pallister–Hall syndrome (see figure part
b). It would therefore seem that the
sharing of phenotypic features between these syndromes might result from the fact that the causative mutations each disrupt SHH signalling through
GLI3. Interestingly, a mutation of GLI3 also causes PIV (polydactyly, imperfo ate anus and vertebral anomalies)56. Note also that other syndromes in
the list given in part a either involve an apparen ly unrelated molecular mechanism (Op z G syndrome), or have not yet been determined at the
molecular level (Mohr syndrome). 7-DHCR, 7-dehydrocholesterol; CR, cholesterol; DHCR7, 7-dehydrocholesterol reductase; GLI3, zinc finger
protein GLI3; PTCH, patched protein homologue 1; SMO, smoothened homologue precursor.
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relationships among genes at the phenotype level, we can make predictions about interactions 
at the protein level. Viewed in this way, the human-phenotype collection is a powerful 
functional genomics tool.
To fully exploit the power of human phenotypes, the ﬁrst requirement is that we develop 
more objective ways to deﬁne and quantify them. This is an important undertaking that 
requires that the presence or absence of features is rigorously documented in large numbers 
of patients[8]. Having a more objective assessment of the relative weights of features for a 
speciﬁc syndrome diagnosis is a further requirement. In addition, we have yet to develop new 
ways of performing multilocus linkage and association analysis that incorporate information 
on gene functions and gene relationships to pinpoint functional modules that could be causally 
involved in the disease under study. These reservations notwithstanding, we might expect 
that phenotype comparisons will continue to hint at molecular interactions and pathways that 
await discovery. In this sense, the future looks bright for phenotype clustering as a functional 
genomics tool.
Databases
(weblinks; see also appendix 1)
The following terms in this article are linked online to:
Entrez: http://www.ncbi.nih.gov/Entrez
BBS1 | BBS2 | BBS4 | BBS6 (MKKS) | BBS7 | COL11A1 | COL11A2 | COL2A1 | DHCR7 | 
FANCD2 | FANCL | FGF23 | GLI3 | PHEX | XPD (ERCC2)
OMIM: http://www.ncbi.nlm.nih.gov/Omim
achondroplasia | Alzheimer disease | BBS | Fanconi anaemia | Fukuyama muscular dystrophy 
| Mohr syndrome | MEBD | Opitz G syndrome | OSMED | Pallister–Hall syndrome | PIV | 
SLO | TTD | Walker–Warburg syndrome
Further information
H.G.B. and M.D., unpublished observations: http://www.cmbi.kun.nl/articles/
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Abstract
Background
A number of large-scale efforts are underway to deﬁne the relationships between genes and 
proteins in various species. But few attempts have been made to systematically classify all 
such relationships at the phenotype level. Also, it is unknown whether such a phenotype map 
would carry biologically meaningful information.
Results
We have used text-mining to classify over 5.000 human phenotypes contained in the Online 
Mendelian Inheritance in Man (OMIM) database. We ﬁnd that there is a continuum of 
phenotypes. Also, phenotype clusters reﬂect biological modules of interacting functionally 
related genes. Phenotype similarity is positively correlated with a number of measures of gene 
function, including relatedness at the level of protein sequence, protein motifs, functional 
annotation, and direct protein-protein interaction.
Conclusions
Phenotype clustering reﬂects the modular nature of human disease genetics. Thus, the 
phenomap may be used to predict candidate genes for diseases as well as functional relations 
between genes and proteins. Such predictions will further improve if a uniﬁed system of 
phenotype descriptors is developed.
The phenotype similarity data is accessible through a web interface at http://www.cmbi.ru.nl/
MimMiner/.
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Background
Functional annotation of genes an important challenge once the sequence of a genome has been 
completed. Gene annotation encompasses a variety of functional attributes, from structural 
motifs, through cellular function, to associations with speciﬁc functions and processes at the 
level of the organism.
Apart from descriptors at the gene and protein level, the phenotype effect of a mutated 
or deleted gene forms part of its functional annotation. Systematic mutation and RNA 
interference (RNAi) screens have been performed for selected phenotypes in Drosophila 
melanogaster, Caenorhabditis elegans, and Saccharomyces cerevisiae[1-4]. Also for Mus 
musculus, an ambitious project to mutagenize most or all genes has been conceived[5]. 
Previous studies have correlated various attributes of genes, such as predicted function or 
amino acid sequence length with the chance of encoding a human disease gene[6-8]. But only 
limited attention has been awarded to the grouping of phenotypes into a matrix as a means of 
predicting biological relations between genes and proteins. Phenotype analysis may suggest 
that genes act together if they cause a similar range of phenotypes when mutated. Systematic 
grouping of genes by their associated phenotypes may be referred to as phenomics.
Studies of speciﬁc phenotype groups in humans suggest that phenomics is possible in humans 
based on the large numbers of naturally occurring mutations and our detailed knowledge of 
the phenotypes that are associated[9, 10]. Qualitatively, the human mutation dataset surpasses 
that of most model organisms, because we can detect and describe human anomalies in 
more detail than in other species[11]. Speciﬁc examples illustrate that individual genes that 
cause a given phenotype tend to be linked at the biological levels as interacting proteins, as 
components of a multi-protein complex, or as steps in a biochemical pathway (ﬁgure 1). 
We have classiﬁed over 5.000 phenotypes in humans on the basis of their phenotype 
similarities, into a single human phenome system. We have further devised and used a system 
for assigning similarity scores, which allows all genes with known phenotypes to be compared. 
This approach is very different from that which uses an artiﬁcial division into predetermined 
entities[12]. Given that the human phenome reﬂects the biology of the system, any phenotype 
classiﬁcation should at least to some extent reﬂect other measures of gene function. We have 
therefore compared the organization of genes based on this human phenome map to their 
know interactions, and similarities at multiple levels including sequence, protein motifs, 
and assigned Gene Ontology functions. The analysis shows that for similar human disease 
phenotypes there is a consistent association at multiple levels of gene annotation. We propose 
that given more precise and standardized measures of the phenotype in humans the human 
phenome map could be a powerful tool for the prediction of the function of human genes.
The phenotype similarity data is accessible through a web interface. This interface, called 
the “MimMiner”, enables the user to retrieve the similarity ranking for a speciﬁc OMIM 
phenotype. Additionally, a sub tree for this disorder can be generated based on the UPGMA 
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algorithm. The MimMiner is available at http://www.cmbi.ru.nl/MimMiner/. 
Results
Feature vectors
5.132 of the 16.357 OMIM records describe a phenotype, and their TX and CS ﬁelds were 
analysed for the presence of concepts from the anatomy (A) and disease (C) sections in the 
MeSH thesaurus. For 5.080 OMIM records we could match one or more MeSH terms. 3.778 
of the possible 5.436 MeSH terms were found in the OMIM records. The observed concepts 
are stored in feature vectors; one feature vector per OMIM record. The number of concepts 
per record varies from 1 to 242 and the average number of concepts per vector is 16.4. The 
use of hypernyms (eq. 1) increases the average number of concepts per vector to 45.0 (min: 
1; max: 477). This broadens the phenotype description and, more importantly, the number of 
common concepts between pairs of vectors increases from 0.85 to 5.88, allowing for a larger 
number of meaningful comparisons. 
Normalization of the feature vectors by the inverse document frequency (eq. 2) and the 
correction for the record length (eq. 3) does not inﬂuence the number of concepts per vector, 
but this weighting inﬂuences the distances between feature vectors as determined with 
equation 4. The normalization step of equation 3 scales all concept frequencies to values 
between 0 and 1. This reduction is non-linear. For example, a speciﬁc concept like “Hair 
Follicle” becomes 1.7 times more important relative to the less speciﬁc concept “Skin”.
Comparing OMIM records
The 5.080x5.080 pair-wise feature vector similarities form the phenomap. The distribution 
of these similarity scores is shown in ﬁgure 3a. We used different methods to test whether 
the phenotypes form distinct groups. These methods map high-dimensional data to low 
dimensional space and are generally referred to as multi-dimensional scaling (MDS) 
techniques. General drawbacks of the MDS techniques are their computational requirements. 
b) c) d)a)
Figure 1 Types of functional relations. Phenotypes that are similar often reﬂect a close relationship at the 
genotype level. Different types of functional relations can occur. E.g. a) Subunits form one functional 
complex; b) Proteins acting in a pathway; c) DNA binding and regulation; d) Signal transduction via 
a receptor.
Bioinformatics strategies for disease gene identiﬁcation
98
We therefore used a sample that contains only the OMIM records with a CS ﬁeld. The 
phenotype vectors were mapped in a two-dimensional space using Principal Component 
Analysis, Classic Multidimensional Scaling, and Independent Component Analysis[13] 
implementations from the “R” software package[14]. None of the methods showed evident 
clusters, suggesting that the human phenotypes are a continuum rather than distinct classes 
(data not shown). 
We next examined in more detail those phenotype pairs that were characterized by a low 
average phenotype similarity. We found that phenotypes with a low average similarity score, 
hence a lower “connectivity” to the rest of the phenomap, corresponded to cases such as 
“Tobacco Addiction” (OMIM:188890) and “Atrial Tachyarrhythmia with Short PR Interval” 
(OMIM:108950). These OMIM records are either very small or contain MeSH terms which are 
infrequently found in other records. In contrast, phenotypes such as “Zellweger Syndrome” 
(OMIM:214100) or “Isolated Familial Hypoparathyroidism” (OMIM:146200) show signiﬁcant 
similarity to large numbers of other OMIM records. Among the 500 phenotypes that had the 
lowest average similarity scores, we found that some MeSH sub-categories show over- or 
under representation compared to the average MeSH use in all phenotypes: “Body Regions” 
(A01, -6.5%), “Neoplasms” (C04, +6.3%), “Hemic and Lymphatic Diseases” (C15, +4.2%), 
“Neonatal Diseases and Abnormalities” (C16, -4.9%), and “Immunologic Diseases” (C20, 
+4.7%). Overall, more speciﬁc phenotypes were weakly connected, and more broadly deﬁned 
phenotypes were strongly connected to the rest of the phenomap.
For each OMIM record the most similar of the other 5.079 records was identiﬁed. Figure 3b 
shows the distribution of these 5.080 highest similarity values. We asked whether moderately 
similar phenotype pairs might still yield reasonable hypotheses. This appeared to be the case 
in a number of instances. Even in the 0.3-0.4 bin individual cases displayed potentially relevant 
Figure 3 Histograms of phenotype similarity scores. a) Histogram of all pair-wise phenotype similarity 
scores of the 5.082 phenotype records. The vertical axis is logarithmic; most phenotype-phenotype 
pairs have a low similarity score. b) The best scores for all phenotypes in the disease phenotype dataset 
(nearest neighbour similarity).
a) b)
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phenotypic similarities. For example, “Fibromuscular Dysplasia of Arteries” (OMIM:135580) 
and “Cardiomyopathy, Familial Hypertrophic” (OMIM 192600) have a phenotypic similarity 
score of 0.31, the 9th most similar score. The observation that these conditions are clinically 
interrelated is supported by two case reports[15, 16]. 
Next, we asked if clinically different conditions caused by mutation of the same gene 
were likely to be detected as having signiﬁcant phenotype overlap by our system. Indeed, 
approximately 40% of phenotypes caused by allelic mutations were more similar to each 
other than to any other phenotype in the dataset (data not shown).
The conclusion is that we cannot deﬁne a general cut-off for similarity scores because 
even low-scoring OMIM records can occasionally contribute to our understanding of the 
diseases.
Phenotype - sequence similarity correlations
We asked whether the similarity at the phenotype level predicts similarity in gene/protein 
function. The causative gene/protein is known for 1.653 of the 5.080 OMIM records that 
describe a phenotype. These 1.653 phenotypes linked to 2.168 corresponding protein 
sequences (1.401 unique sequences). Sequences were extracted from the UniProt database 
and used to calculate all-against-all Smith-Waterman alignments. The corresponding 
1.653x1.653 phenomap was extracted from the total phenomap. Figure 4a shows the fraction 
of signiﬁcant sequence alignment similarities as a function of the phenotype similarity scores. 
The percentage of phenotype-pairs for which the causative proteins are similar increases with 
increasing phenotype similarity score from 0.6% to a maximum of 26.6%. Approximately 
half of these are due to different mutations in the same gene causing similar phenotypes. For 
example, “Robinow-Sorauf syndrome” (OMIM:180750) and the related “Saethre-Chotzen 
syndrome” (OMIM:101400) are both caused by a mutation in the TWIST1 protein (UniProt:
Q15672). The other relations are due to mutations in different genes that share sequence 
similarity. For example, the “Rufous Oculocutaneous Albinism” (OMIM:278400) and 
“Albinism, Oculocutaneous, Type IB” (OMIM:606952) phenotypes show 0.68 phenotypic 
similarity. These diseases are caused by mutations in the TYRP1 (UniProt:P17643) and 
TYR (UniProt:P14679) proteins, respectively, that are 43% identical at the sequence level. 
Mutations in TYRP1 also cause “Oculocutaneous Albinism Type 3” (OMIM 203290).
Many proteins have multiple functional domains. These domains are not unique but appear 
in different combinations in various proteins. The PFAM system identiﬁes domains through 
multiple sequence analysis and annotates them with their biological function. If two proteins 
share a functional domain, then mutations that inﬂuence the function of that domain may 
cause the disruption of the same or a similar process and thereby lead to similar phenotypes. 
This can be true, even if the full protein sequences do not share signiﬁcant sequence identity. 
Figure 4b shows the percentage sequence pairs that share a PFAM domain as function of 
the phenotype similarity scores. The majority of pairs that share a PFAM domain (67% or 
119/181, disallowing the same gene) in the 0.5-0.6 bin) also share signiﬁcant overall sequence 
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similarity. Only in a minority did sequence comparison based on domain sharing add new 
information compared to overall sequence similarity. For some phenotype pairs the proteins 
lack signiﬁcant overall sequence identity, but do share one or more common structural 
features. For instance, “Long Qt Syndrome 3” (OMIM:603830) caused by a mutation in 
the Sodium Channel Protein Type V Alpha Subunit (SCN5A) (UniProt:Q14524) shares 
phenotypic characteristics with “Jervell And Lange-Nielsen Syndrome” (OMIM:220400) 
that can be caused by a mutation in the Potassium Voltage-Gated Channel Subfamily KQT 
Member 1 (KCNQ1) (UniProt:P51787). These 2 proteins have an “Ion Transporter” domain 
in common (PFAM:PF00520).
Phenotype - protein interaction correlations
The Human Protein Reference Database (HPRD) provides information relevant to the function 
of human proteins, including protein-protein interactions. We checked which of the 1653x1653 
pairs have an interaction described in the HPRD (ﬁgure 4c). Although the HPRD dataset is 
sparser than the other datasets, and thus reveals fewer relations, 54% of these HPRD relations 
were not yet detected by the sequence alignments or the PFAM analyses. We performed a 
detailed inspection on the 212 protein interactions that are listed in the HPRD for pairs that 
have a phenotypic similarity between 0.3 and 0.4. Over 50% of the relations suggested a 
plausible reason for the phenotypic similarities. For example the clinical overlap between 
“Multiple Epiphyseal Dysplasia type 2” (OMIM:600204) and “Congenital Spondyloepiphyseal 
Dysplasia” (OMIM:183900) is not unexpected since they are caused by mutations in COL9A2 
(UniProt:Q14055) and COL2A1 (UniProt:P02458) respectively. Another example in the 0.4-
0.5 bin is the comparison of “Wiskott-Aldrich Syndrome” (OMIM:301000) with “Fleisher 
Syndrome” (OMIM:307200). These syndromes are caused by mutations in WAS (UniProt:
P42768) and BTK (UniProt:Q06187), respectively. WAS and BTK do not share signiﬁcant 
sequence similarity, nor do they share a PFAM domain. However, both are involved in cell 
growth regulation and cytoskeleton processes such as ﬁlopodium formation, podosome 
assembly, chemotaxis, receptor capping and phagocytosis in haematopoietic cells[17]. WAS 
is phosphorylated at Y291 by BTK leading to activation of the actin nucleating assembly 
complex Arp2/3 (actin related protein)[18-21]. In general, despite its sparse nature, the HPRD 
provided biologically plausible information.
Phenotype – functional process correlations
Various excellent databases describing pathway information are available, e.g. KEGG[22], 
BRENDA[23], Reactome[24], etc. Most of these databases focus on metabolic pathways, 
whereas less than 10% of the OMIM phenotype records relate to metabolic disorders. To get 
an impression of possible functional relations between genes/proteins, we compared their GO 
annotations. We deﬁned GO similarity by the sharing of at least three GO annotations the 
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sixth or more detailed GO level. The signal we ﬁnd is well above the average of ten randomized 
matrices with a background percentage of ~7% over all bins (in the GO set, disallowing the 
same gene). The percentage of pairs that share three or more GO annotations increased as a 
function of the phenotypic similarity (ﬁgure 4d). Using the GO set 76% relations were new 
compared to the three other sets. A random set of 50 of the 786 proteins that share 3 or more 
GO annotations and that have a phenotypic similarity between 0.5 and 0.6 were inspected in 
more detail. A plausible reason for the phenotypic similarities was found in 37 of these 50 
cases. Unlike in ﬁgure 4a-c less than half of the relations are due to a defect in the same gene, 
which suggest the criterion of sharing 3 GO annotations at the 6th level is less stringent than 
in the other data sets.
Nevertheless, sharing of GO annotations can be regarded as a relatively non-speciﬁc 
characterization of gene function. This type of relationship has a high noise level (ﬁg. 4d). 
Overall, when the genotype by phenotype relations were normalized using random phenomap 
signals, the HPRD dataset was most efﬁcient in providing non-random gene-gene relationships 
(ﬁg. 5).
Figure 5 - Histogram of normalized genotype relations as a function of phenotype-phenotype similarity.
All values are corrected for random information levels. Although the HPRD data set contains fewer 
relations than the other sets, the normalized signal is more than two times as strong, reﬂecting the 
quality of the HPRD dataset. The 0.8-0.9 and 0.9-1.0 phenotype similarity bins suffer from low counts. 
(Colour version: see appendix 2)
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Discussion
We have developed a text-mining approach to map relationships between more than 5.000 
human genetic phenotypes from the OMIM database. The resulting phenotype matrix has a 
number of characteristics that suggest that it might be a useful addition to other functional 
genomics tools such as the HPRD and KEGG. As expected, we ﬁnd that different phenotypes 
associated with mutations of a single gene show considerable overlap. Such allelic conditions 
are each others best phenotypic hit in 40% of the cases. Conversely, nearest phenotypic 
neighbours shared at least one functional relationship in 50% of the cases. Also, the 
phenotype map reﬂects biologically relevant relationships with other genes. After exclusion 
of allelic conditions, there remained a signiﬁcant positive correlation between phenotypic 
similarity on the one hand, and gene sequence, protein motifs, functional annotation, and 
known protein interactions on the other (ﬁgure 4). This underscores that human phenotypes 
reﬂect disturbance of functional modules, more than of individual genes. Further, the lack 
of obvious clusters in the OMIM phenotype matrix suggests that human disease phenotypes 
form a continuum. This in itself argues for a genome-wide view of phenotypes since any 
classiﬁcation into predetermined classes would lead to a loss of information. One striking 
ﬁnding was that biologically meaningful relationships were mostly detected in the small 
subfraction of the phenotype relations with a similarity score greater than 0.4 (ﬁgure 4). 
The combined data suggests that we may indeed use phenotypic relationships as general 
indicators of biological and functional interactions at the gene and protein levels.
Several applications can be envisaged for the phenomap. First, our analysis suggests that 
the phenotype matrix may aid in the prediction of candidate genes for the 3.400 traits listed 
in OMIM whose molecular basis remains to be deﬁned. Second, it is conceivable that one 
would take phenotypic relationships as the starting point for biochemical and cell biological 
experiments in order to prove a suspected link at the gene and protein levels. Experiments of 
this type have been shown to be successful (e.g. polycystic kidney disease (PKD1, PKD2), 
tuberous sclerosis (TSC1, TSC2), breast and ovarian cancer (BRCA1, BRCA2), and Fanconi 
anemia (FANCA-G))[25-28].
Finally, there may well be a point in pursuing large-scale phenotype analyses using more 
precise measures of the phenotypes themselves. OMIM was not designed as a structured 
database for phenotype analysis. Indeed, it does not contain rules for feature assignment 
and most of the phenotype information collected by our text-mining approach derives from 
free text ﬁelds. A more standardized method for phenotype description including frequency 
estimates for each feature would greatly increase the yield of the analyses of genotype-
phenotype correlations.
Conclusions 
Phenotype clustering reﬂects the modular nature if human disease genetics. Thus, the 
phenomap may be used to predict candidate genes for diseases as well as functional relations 
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between genes and proteins. Such predictions will further improve if a uniﬁed system of 
phenotype descriptors is developed.
Methods
The OMIM database
The Online Mendelian Inheritance in Man (OMIM; http://www.ncbi.nlm.nih.gov/omim/, 
November 25 2004) database is a catalogue of human genes and genetic disorders[29]. Each 
record in the OMIM database contains textual information, about one gene or one genetic 
disorder, literature references and links to other databases. The data are divided over different 
ﬁelds. We have used the full-text (TX) and the clinical synopsis (CS) ﬁeld of all records that 
contain genetic disorders. We will refer to this combination of the TX and CS ﬁelds as a 
“record”. 
The OMIM database is a rich dataset containing 16.357 full-text records of which 5.132 
describe an actual phenotype. The remaining 11.225 records contain variation, mutation, 
gene/protein, or other information. Approximately 33% of these 5.132 disease phenotypes 
are characterized at the gene level. OMIM was originally designed as a resource to be used 
manually. Reading OMIM with a computer program or database is therefore not trivial. We 
have automatically extracted the phenotypic features from each OMIM record using a series 
of text analysis techniques.
Creation of “ feature vectors”
Retrieval of text-based information can be done on a keyword basis, or e.g. through natural 
language parsing[30], commonly referred to as “information retrieval” (IR). IR considers 
text to consist of documents and terms. In this analysis each OMIM record is a document. 
All words in the OMIM records were considered as terms. We did not use all words, but only 
those found in the anatomy (A) and the disease (C) sections of the Medical Subject Headings 
vocabulary (MeSH, http://www.nlm.nih.gov/mesh/meshhome.html). Each MeSH entry is a 
collection of phenotype-related terms with synonyms and plurals, which together we call 
a concept. Each concept is uniquely identiﬁed by a descriptor. For example, the concept 
“Neuron” also contains the synonym “Nerve Cell” and the plurals “Neurons” and “Nerve 
Cells”, and is identiﬁed by the descriptor D009474. The MeSH concepts, rather than single 
keywords (like in keyword vectors) as used usually in IR, served as features characterizing 
OMIM records: every entry in the feature vectors represent a MeSH concept.
Each OMIM record was screened for concepts by matching the words in the records with 
MeSH terms. The number of times the terms of a given concept are found in an OMIM record 
reﬂects the concept’s relevance to the phenotype. Some concepts cannot be described by a 
single term, e.g. “cleft palate”. In such cases only the longest, most speciﬁc term was counted. 
So, “cleft palate” is used but not the single words “cleft” or “palate”. A term was not allowed 
to span two sentences separated by a full stop. Non-speciﬁc concepts like “syndrome” or 
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“disease” were excluded. This list of descriptor frequencies per OMIM record constitutes the 
initial feature vector.
Sense Organs [A09]
Ear [A09.246] +
Eye [A09.371]
Anterior Eye Segment [A09.371.060] +
Conjunctiva [A09.371.192]
Eyelids [A09.371.337] +
Lacrimal Apparatus [A09.371.463] +
Lens, Crystalline [A09.371.509] +
Oculomotor Muscles [A09.371.613]
Pigment Epithelium of Eye [A09.371.670]
Retina [A09.371.729]
Amacrine Cells [A09.371.729.050]
Blood-Retinal Barrier [A09.371.729.055]
Fundus Oculi [A09.371.729.313]
Macula Lutea [A09.371.729.522] +
Optic Disk [A09.371.729.690]
Photoreceptors [A09.371.729.727] +
Retinal Ganglion Cells [A09.371.729.765]
Sclera [A09.371.784]
Uvea [A09.371.894] +
Vitreous Body [A09.371.943]
Nose [A09.531] +
Taste Buds [A09.846]
D010786 = 2
Hypernym
nd = 7; D012160 = 1/7 * 2 = 0.29
nd = 11; D005123 = 1/11 * 1/7 * 2 = 0.026
Hypernym
Figure 2 Example of concept expansion using the MeSH hierarchical structure. The concept 
“Photoreceptors” (with MeSH descriptor: D010786) is found twice in an OMIM record. Expansion 
of this concept gives the hypernym “Retina” (D012160). The relevance of the concept “Retina” is 
derived from “Photoreceptors” according to equation 1. “Retina” has 7 descendants or hyponyms, 
thus its relevance becomes 1/7 * 2 (for 2 times “Photoreceptors”). Similarly, Retina’s hypernym “Eye” 
(D005123) has 11 hyponyms, so that “Photoreceptors” contributes 1/11 * 1/7 * 2 (= 0.026) to the 
relevance of “Eye”. (Squared brackets indicate the MeSH tree position and a “+” sign that there are 
more speciﬁc concepts underneath).
Equation 1: For any concept c, its relevance r
c
 becomes the actual count of the concept in a document 
r
c,counted
 plus the relevance sum of the concept’s hyponyms r
hypo’s
. This sum is divided by the number of 
hyponyms n
hypo,c
. This equation is applied iteratively from the most detailed level in the MeSH tree, 
till the highest hypernym level is reached. For example, “Sense organ” is a hypernym of the concepts 
“Eye”, “Ear”, “Nose”, and “Taste buds”. Therefore “Sense Organs” receives ¼ of the counts of each of 
those four hyponyms.
Σr
c := rc,counted +
r
hypo’s
n
hypo,c
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Reﬁnement of the feature vectors
MeSH concepts can be very broad like “Eye” or more speciﬁc like “Retina”. MeSH includes 
a concept hierarchy that describes relationships such as “Eye”-“Retina”-“Photoreceptors”. 
“Eye” is called a hypernym of “Retina”, which in turn is a hypernym of “Photoreceptors”, 
etc. Conversely, “Retina” is called a hyponym of “Eye”, etc. To ensure that, for example, the 
concepts “Eye” and “Retina” are recognized as similar, we use the MeSH hierarchy to encode 
this similarity in the feature vectors by increasing the value of all hypernyms as described in 
equation 1 (ﬁgure 2). Obviously, the value of hypernyms can be increased due to the presence 
of hyponyms, but not the other way around. Note that we use ‘hypernym’ and ‘hyponym’ 
not only to indicate true linguistically hypernyms/hyponyms, but also to indicate “part of” 
relationships.
Not all concepts in the OMIM records are equally informative. For example, “Retina Pigment 
Epithelium” occurs rarely, and thus provides more speciﬁc information than very frequently 
occurring terms like “Brain”. In practice this means that the overall importance of a concept 
depends on its total frequency of occurrence summed over all OMIM records; the more often 
it occurs, the less important it is. These differences in importance of concept frequencies in 
feature vectors were incorporated using the inverse document frequency measure of Wilbur 
and Yang[31] as explained in equation 2.
Not all OMIM records contain equally extensive descriptions. These differences will make 
a comparison between records difﬁcult, because in the large records the diversity and the 
frequency of concepts will be higher than in the small records. The total number of concepts 
per feature vector theoretically can vary between 1 and 5436 MeSH entries. Equation 3[31] 
was used to (partly) correct for these record size differences.
The three feature vector corrections give a different result when applied in a different order. 
We ﬁrst expanded all concepts via the MeSH hierarchical structure (eq. 1). Subsequently, 
all feature vectors were corrected using the inverse document frequency measure (eq. 2) 
followed by the local weight correction (eq. 3).
Equation 2: The inverse document frequency or global weight of concept c (gw
c
) is the logarithm of the 
total number of records analysed (N; N=5.080) divided by the number of records that contain concept 
c, n
c
.
Equation 3: The local weight of concept c in a record is a function of the concept’s frequency r
c
 divided 
by the frequency of the most frequent concept in that record, r
mf
.
r
c = rc . gwc= rc . log2
N
n
c
r
c = 0.5 + 0.5 
. 
r
c
r
mf
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Comparing OMIM records
The similarity between OMIM records can be quantiﬁed by comparing the feature vectors 
that are expanded and corrected by the two correction measures. Similarities between feature 
vectors were determined by the cosines of their angles (eq. 4)[30].
Phenotype-Genotype correlations
The matrix of all pair-wise vector similarities was denoted the phenomap. A subset of this 
phenomap contains all OMIM records for which the causative gene and protein are known, 
was used as a starting point for determining the relation between phenotypic similarities on 
the one hand and genotypic similarities on the other. All 1.653 phenotypes associated with 
a protein in the UniProt database[32] (http://www.uniprot.org) were then compared to four 
genotype-related datasets. The average of ten randomized phenomaps was used as a control 
for background signal.
The PFAM database[33] (http://www.sanger.ac.uk/Software/Pfam/) is a collection of 
multiple sequence alignments and hidden Markov models, typically used to study the domain 
organization of proteins. We used PFAM to determine whether pairs of genes share similar 
domains.
We compared the proteins associated with the 1.653 phenotypes from the UniProt database 
in an all-against-all Smith-Waterman analysis[34]. We used a Paracel computer (Blosum-
90, version 5.03-88, Paracel Inc., Pasadena CA, USA) to check if genes are similar at the 
sequence level. Sequence pairs with an alignment e-value better than 10-6 were considered 
similar[35].
Protein-protein interactions were extracted from the interaction section of the HPRD 
database[36] (http://www.hprd.org/) and used to check whether the proteins are part of the 
same complex or interact in any other way.
The Gene Ontology (GO) database[37] (http://www.geneontology.org/) and the GO 
annotations (GOA)[38] (http://www.ebi.ac.uk/GOA/) were used to determine if two genes are 
part of the same functional category. The GO database provides three categories of terms to 
describe gene products. The “molecular function” category describes the tasks performed by 
gene products (e.g. ATPase activity); the “biological process” category describes biological 
Equation 4: The similarity between the feature vectors X and Y (s(X,Y)) is a function of their respective 
concept frequencies x
i
 and y
i
. This equation is also known as the cosine rule and x
i 
y
iΣ
i = 1
l
is commonly 
known as the inner product of the vectors X and Y. The index i runs from 1 to the number of MeSH 
concepts l.
s(x, y)
 = 
 
x
i 
y
iΣ
i = 1
l
x
i
2Σ
i = 1
l
y
i
2Σ
i = 1
l
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mechanisms (e.g. mitosis); and the “cellular component” category describes sub-cellular 
structures, locations, and macromolecular complexes (e.g. nucleus, haemoglobin complex). 
The GO terms are hierarchically organized. 
Two genes/proteins were considered related when they shared at least three GO terms at the 
sixth annotation level. Annotations at the more detailed levels (level 7, 8, etc) were converted 
to the corresponding annotation at the 6th level. For example, the RDS protein (UniProt:
P23942) has the detailed annotation “visual perception” at level 7 (GO:0007601), which gets 
converted to the more general “sensory perception of light” (GO:0050953) at level 6. 
Clustering
The conclusions drawn from clustering studies tend to depend on the level of detail of the 
clusters and thus on the number of clusters generated. A cluster study of the phenomap 
reveals that the phenotypes seem more continuously related, which makes every clustering 
attempt intrinsically subjective. In order to objectively visualize the relations between the 
phenotypes, we performed a hierarchical clustering that results in a tree-structure. Clustering 
was performed with the Unweighted Pair Group Method with Arithmetic Mean[39]. UPGMA 
is a simple and fast method that allows the user to cut the tree at any desired value after which 
the corresponding clustering is automatically generated.
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The aim of this research was to reveal some general principles underlying human genetic 
disease and to design bioinformatics strategies for the identiﬁcation of disease genes. We 
combined information from gene speciﬁc databases and phenotype descriptions to achieve 
our goal. Two routes were followed. First, we selected genes within disease critical region. We 
selected genes that are expressed in the affected tissue(s) or where mutations in homologous 
genes in model organisms cause a similar phenotype. The technical implementation does not 
require extensive data warehousing, but uses a distributed model (chapter 2 and 3). Second, 
we explored the potential use of natural occurring disease phenotypes for function annotation. 
In chapter 4 we explore how phenotypes relate to one another and whether a comparison 
between phenotypic features may tell us what genes are involved. Also to what extent do 
phenotypic similarities reﬂect known and new molecular mechanisms. We devised a method 
for comparing phenotypes derived from the OMIM database that uses a textual similarity 
measure by an automated full text-analysis technique and analysed the phenotype-genotype 
relations (chapter 5).
Candidate gene prioritisation in syndromes by combining a pattern of organ involvement 
and positional information and utilization of mouse phenotypic data has been shown to be 
effective[1, 2]. This approach has been successfully implemented in silico. While the results of 
GeneSeeker on average lead to a tenfold reduction of the positional candidate genes, there are 
several limitations. These are the incompleteness of the databases, a lack of standardization 
for gene expression data and for phenotype and tissue descriptions. Also, the success of the 
method depends on a relatively strong relation between genotype and phenotype. 
The phenotype is a representation of both genotype and environment. Phenotype relationships 
are a powerful method for function prediction[3-5]. We can therefore use the human 
phenotype collection and the underlying gene-phenotype relations as a tool for functional 
genomics. Several improvements can made to make full use of the phenotype potential as a 
functional genomics tool. These include clear and standardized deﬁnitions and (weighted) 
feature descriptions of human genetic disorders, other phenotype variations, and phenotype 
characteristics of gene knock-outs in model species. 
So, how do our approaches to candidate gene identiﬁcation and phenotype classiﬁcation 
relate to other efforts within the ﬁeld of human genetics and bioinformatics involving 
candidate gene prioritisation and phenotype classiﬁcation? Identiﬁcation of candidate gene is 
most likely to be successful when positional and functional routes are integrated. Different 
efforts have been made to incorporate both. Integration of data based on genomic context 
like in the UCSC genome browser and Ensembl[6, 7] resulted in step-by-step interfaces (e.g. 
EnsMart[8]) to extract data based on e.g. chromosomal position, expression[9], and Gene 
Ontology[10]. The enrichment for disease candidate genes using these database interfaces 
depends on the skills of the operating researcher. Only recently methods have been developed 
to systematically explore datasets for candidate disease genes. Four different approaches can 
be distinguished.
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First, annotation data have been used to group genes with the same functional characteristics. 
This approach, developed by Perez-Iratxeta et al.[11], links Medline abstracts via MeSH 
and GO to RefSeq proteins[10, 12-14], and there by allows prioritisation of genes in disease 
loci. They tested 450 diseases were previously mapped to a speciﬁc locus but without a 
particular gene assigned. The resulting scores were compared to 100 diseases where the gene 
was known[11]. On average Perez-Iratxeta et al. tested 30Mb candidate regions. Assuming 
20.000-25.000 human genes[15, 16], and an average gene density of 1 gene per 120kb, an 8-31 
fold enrichment was calculated for this method.
Turner et al. prioritised candidate disease genes based on over-representation of functional 
annotation (GO) between loci for the same disease[17]. They tested 29 diseases and achieved 
an enrichment between 12 and 42-fold.
As a second approach, gene speciﬁc characteristics have been used in candidate disease gene 
identiﬁcation. Sequence analysis of human/eukaryotic genes showed that human proteins 
with multiple long amino acid runs are more often linked with genetic disease than are 
shorter proteins[18]. Also, proteins involved in genetic diseases tend to be long, conserved, 
and without close paralogues[19]. Disease genes are more frequently found to be conserved 
in other species, but this can be due the preferential sequencing of known (disease) genes. 
Adie et al. tested sequence property analysis using alternating decision trees[20]. They 
found differences between random genes and disease genes based on a number of features, 
including: gene/cDNA/protein/3’ UTR length, number of exons, distance to adjacent gene, 
higher level of conservation in mouse, signal peptide encoding, and 5’ CpG islands. Their 
tests for candidate gene identiﬁcation showed 2-25 fold enrichment. Smith et al. found similar 
differences between disease and non-disease genes. Using discriminant analysis they showed 
that these differences may help to predict human disease genes[21].
An approach to disease gene identiﬁcation makes use of the multitude of gene and protein 
expression data that is produced by methods like RNA expression micro array analysis and 
SAGE. For example, Tiffen et al. developed a method which uses an anatomical ontology 
(eVOC)[9] to integrate biomedical literature and human gene expression data[22]. Using 
a controlled vocabulary, their method can be used without prior clinical knowledge. The 
enrichment reached is 1.5-3-fold and the correct gene was found in more than 85% of the 
cases.
A more clinically oriented fourth approach correlates clinical features of genetic disease with 
the functional classiﬁcation of their underlying disease genes[23]. Freudenberg and Propping 
developed a method to cluster genetic diseases based on their phenotype similarity[24]. They 
manually attributed the disease phenotypic manifestations. In total, 878 diseases were tested 
for 10.672 candidate disease genes, achieving enrichment between 7 and 33-fold. 
Similarly, Cantor et al. clustered OMIM[25] records based on the clinical synopsis section[26]. 
They reduced the disease characteristics to ﬁfty categories. In a test of two diseases they 
found relations at the genotype level. Since the authors only intended a proof of principle 
on using OMIM for phenotype clustering they did not systematically analyse phenotype-
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genotype relations.
Evaluation of the different methods does not allow direct comparison between them. Except 
for the method of Tiffen et al. [22] they all perform similarly, giving 7-10 fold enrichment in 
most cases. GeneSeeker (chapter 2 and 3) can be positioned in the third group. The GeneSeeker 
uses human as well as mouse expression/phenotypic data that is stored in various databases. 
This information is combined with positional data of both species. The GeneSeeker approach 
differs from the other candidate prioritisation approaches because of utilizing cross-species 
data. We achieved a 7-25 fold enrichment of candidate disease genes. However, GeneSeeker 
requires considerable prior clinical knowledge. In light of the comparable enrichment levels 
achieved with the different methods, it is likely that they can complement each other.
One question that we attempted to answer in these studies was whether the use of phenotype 
descriptions for automated candidate disease gene identiﬁcation/enrichment is possible. 
Our studies and those of others suggest that this is the case (chapter 2 and 5). We found 
that phenotype similarity based on automatic quantiﬁcation, correlates positively with a 
number of measures of gene function, including protein sequence, similarity shared protein 
motifs, functional annotation, and direct protein-protein interaction. The data suggests that 
phenotypic relationships may be used as indicators of biological and functional interactions 
at gene and protein levels (chapter 5).
To make the most of candidate disease prioritisation and phenotype information, a number of 
improvements are possible: 
1. Develop new methods for sequence analysis
Gene identiﬁcation is still not complete at the moment and a signiﬁcant number of human 
genes remains to be elucidated[16]. Even more non-coding RNA genes (ncRNAs) await 
identiﬁcation. Comparative genomics studies have shown highly conserved sequences in 
mammalian genomes[27]. The functional role of these conserved nongenic sequences (CNG) 
remains unknown and it is not unlikely that variations in CNGs are associated with phenotype 
variability and disease. If CNGs are important for human genetic disease, then clearly the 
current methods for disease gene identiﬁcation will fail to identify them. Involvement of 
ncRNAs in human genetic disorders has been shown[28] and new methods to identify these 
genes have to be developed in order to broaden the view on disease mechanisms. 
2. Expand experimental data, unify and integrate data sources
Much of the data that can be used for candidate gene prioritisation is scattered over various 
databases and suffers from incompleteness and errors. Standardization and protocols are 
needed to complete new and existing datasets. Initiatives such as MIAME (Minimum 
Information About a Microarray Experiment)[29] are a start, but still need a broader 
implementation and acceptance. Furthermore, more, structured, and detailed data on gene/
protein expression, protein-protein interactions, regulation and other biological systems will 
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be essential for computational analysis of bionetworks, including DNA variations and their 
phenotypical consequences. If we are to achieve a comprehensive view of (human) biology 
these different (omics) dataset must be integrated. Data storage solutions and schemes are 
currently under development[30-32]. 
The different omics can be placed in layers creating an omics-space[31]. As the different 
types of omics evolve, links will be created between these layers. Ultimately, this results in 
a model of the organism, which is referred to as systems biology. Currently, omics data is 
mostly analysed by clustering methods. It is likely that new methodologies will be developed 
to study and make predictions across omics-space. Methods that may be used for the analysis 
of omics data include various statistical methods, network analysis, sequence analysis, 
machine learning, data mining, and visualization systems.
3. Improving statistical methods for linkage and association studies
The current shift from monogenetic to complex multifactorial genetic diseases emphasizes 
the need for genome-wide association studies for mapping of disease genes. The practical 
problems of data generation are expected to be solved in the not too distant future[33, 34]. 
However, study design and data analysis for these genome-wide association studies is not 
straight-forward and requires care[33]. Furthermore, concepts such as the likelihood of 
interacting loci, also known as epistasis, are frequently ignored in complex genetic trait 
studies[35]. New methods for multilocus linkage and association should take these concepts 
and mechanisms into account.
4. Elaboration and standardization of phenotype descriptions.
Current approaches to deﬁne (disease) phenotypes are inadequate for the generation of a 
reliable phenotype map. To begin with, there are different deﬁnitions of what a phenotype 
is[36]. For human diseases, ICD, SNOMED, and UMLS (http://www.who.int/classiﬁcations/
icd/en/; http://www.snomed.org/; [37]) are three of the classiﬁcation systems that are used to 
describe phenotypes. These systems are for the most part founded on clinical observations 
rather than on biological phenotype characteristics, which results in a gap between clinical 
and biological data. A central and standardized phenotype classiﬁcation system awaits 
development and acceptance. Such a system should encompass deﬁnitions of phenotype 
features. Quantitative comparison of aberrant versus normal phenotypes is needed for 
weighting of those features, which calls for studies on ‘normal’ phenotypic (morphological) 
variation. Additionally, phenotype characteristics of model species/knock-out models can be 
used for comparative phenomics[38]. 
Phenotypic characters are not simple and they might change during development, ageing, and 
other environmental change. However, a detailed anatomical spatio-temporal atlas[39, 40] 
is feasible at this moment with medical imaging techniques. Integration and development of 
phenotype ontologies, such as Phenotype Attribute Ontology (PAtO) (http://obo.sourceforge.
net/) or Mammalian Phenotype Ontology [41] will simplify phenotypic analysis. Moreover, 
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free public access to both biological and clinical phenotype related databases is essential for 
further development of this ﬁeld. Without doubt, our perception and description of phenotypic 
characters will change with our understanding of the biological basis of phenotypes.
5. Improve and integrate methods for candidate disease gene identiﬁcation and phenotype 
classiﬁcation.
The various methods to identify candidate disease genes in humans cover different concepts 
(ﬁgure 1). They either use functional and literature data, gene speciﬁc characteristics, 
anatomy based gene/protein expression data, or phenotype comparison analyses. As discussed 
earlier the current performance of the individual methods is comparable. These methods can 
complement each other and such combinations can improve the predictive performance. It 
will be essential to establish cross database and cross species ontologies, and to develop 
heuristics for candidate gene prioritisation that evaluates data and phenotype knowledge.
In conclusion, we developed an approach that with the current set of databases, can be used 
for candidate disease gene prioritisation (chapters 2 and 3). In silico prioritisation methods 
are evolving and improvements can be made by integrating these methods (ﬁgure 1), by 
completion of datasets, and by development of standardized ontologies across databases 
Sequence
features
Expression/
disease features
PhenotypeFunctional
annotation
(Position)
Model
organisms
High-
Throughput data/
interactions
Lopez-Bigas
et al.[19]
Adie et al.[20]
Perez-Iraxeta et al.[11]
Turner et al.[17]
Freudenberg et al.[24]
Cantor et al.[26]
Van Driel et al. (chapter 5)
Tiffen et al.[22]
Integration
Van Driel et al. (chapter 2, 3)
Franke et al.
(in prep.)
Jiminez-Sanchez et al.[23]
Smith et al.[21]
Figure 1 The various methods to identify candidate disease genes in humans are located relative to 
the different concepts (sequence features, expression/disease features, functional annotation, and 
phenotype).
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and species. We believe that phenotype relationships are powerful predictors for biological 
function (chapters 4 and 5). These relationships reﬂect the modular nature of biology and 
may be used for candidate disease gene predictions. A uniﬁed system is needed and should 
recognize distinct phenotypic characters and classify them in a spatio-temporal model. New 
ways to perform and analyse multilocus linkage and association data, in combination with 
such a phenome system may further improve the performance of computational methods for 
candidate disease gene identiﬁcation. 
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Disease gene identiﬁcation based on chromosomal localisation is sometimes difﬁcult and 
often time-consuming. It requires collecting as much information on the disease as possible. 
Combining positional information with disease characteristics might give hints by which 
candidate disease genes can be selected. We combined data from various computer databases 
and developed bioinformatics strategies to explore the systematic identiﬁcation of disease 
genes.
Genetic diseases are caused by changes called mutations in our hereditary material (DNA). 
In the western world genetic conditions are a major cause of neonatal and childhood diseases, 
and of infant death. Disease causing mutations play an important role in our understanding 
of human genetic diseases, and the molecular roles of genes and proteins in development. 
This knowledge can be utilized in genetic counselling, in genetic diagnosis, and in further 
research. Knowledge on disease genes may ultimately open possibilities for treatment.
Important indications for the identiﬁcation of causes and mechanisms of disease come from 
clinical disease characteristics (the disease phenotype). Deﬁnition and classiﬁcation of 
diseases are essential, both for clinical as well as for research purposes. Various classiﬁcation 
systems have been developed and are used for this purpose. However, none of these systems 
is universally accepted and consequently a lot of clinical information is still stored in free-text 
literature databases.
Here, we present two bioinformatics strategies to identify human candidate disease genes 
(chapter 2, 3) and classify human disease phenotypes (chapter 4, 5). Our hypothesis was 
that internet databases, which contain gene speciﬁc data as well as databases that contain 
phenotype descriptions, can be utilized systematically to achieve our goals.
We developed a system (chapter 2 and 3; GeneSeeker) aiming to assist in the candidate gene 
identiﬁcation process. A commonly applied strategy is to prioritise genes in the chromosomal 
interval obtained via pedigree studies. Prioritisation is based on gene characteristics such 
as expression in the affected tissue(s) and mutant phenotypes in model organisms. The 
GeneSeeker mimics this process in silico. In general, linkage analysis data restricts the 
disease gene to a chromosomal region of 20-200 genes. The system combines positional and 
expression/phenotype data from human and mouse. Chapter 2 describes the analysis of ten 
syndromes. For all syndromes tested including two which were novel at that moment, the 
candidate disease gene lists were reduced 7-25 fold while preserving the disease genes. 
A more technical discussion on the GeneSeeker can be found in chapter 3. The program 
queries information from various databases directly on the World Wide Web. It retrieves 
information from nine different databases and the modular setup allows addition of other 
databases if needed. Direct searches via the original database web interfaces guarantee that 
the most recent data are queried, and this obviates the need for data warehousing. GeneSeeker 
makes candidate gene selections, thereby reducing the number of genes to be screened for 
mutation analysis.
GeneSeeker will only work for those syndromes in which the disease gene displays altered 
expression patterns in the affected tissue(s). In such cases, it provides a signiﬁcant reduction 
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in time spent on wet-lab experiments by giving helpful clues which genes to examine ﬁrst 
for mutations. The ﬁeld of candidate gene prediction and prioritisation is new and only a 
few efforts have been published using different data sources. Compared to these methods 
GeneSeeker performs similar. GeneSeeker requires prior clinical knowledge. However, it is 
the only method so far that incorporates localisation, expression, and phenotypic data from 
the mouse.
Chapter 4 discusses relationships at the phenotype level, and how phenotype information 
deﬁnes syndrome families which can then be explored as a tool for functional genomics. 
In this chapter we explore, using a number of examples form the literature, how similar 
syndromes/phenotypes relate to each other, and whether they can indicate what genes are 
involved. We argue that these similarities tend to reﬂect the biological relationships in the 
cell. Additionally, we argue about the applicability of a phenotype map for the identiﬁcation 
of disease genes, including multifactorial/complex disorders.
In chapter 5 we describe a method devised to extract disease phenotypes from the full text 
descriptions in the OMIM database. Text mining techniques were used to identify phenotype 
concepts. In contrast to manually predeﬁned categories, we used an automated method for 
systematic phenotypic feature identiﬁcation and comparison. We have analysed the phenomap 
for the presence of biologically meaningful information and found that phenotype similarity 
is positively correlated with gene function at the level of protein sequence, motifs, functional 
annotation, and protein-protein interactions derived from the literature. The analysis 
suggests that the automatically derived phenotype map can serve as an indicator of biological 
relationships.
The aim of this research was to reveal some general principles of human genetic disease and 
the bioinformatics strategies to explore them for the identiﬁcation of disease genes. Phenotype 
analysis is equally relevant to disease gene identiﬁcation as it is to the functional annotation 
of the human genome: Over the course of the coming years major improvements are to be 
expected with regard to gene identiﬁcation methods for monogenic, and multifactorial diseases, 
mutation detection, and various methods for cross-species comparisons. Bioinformatics 
approaches such as those described here, should be a useful addition to sequence and 
gene-based analyses. While much remains to be discovered from systematic phenotype-
genotype analyses, an essential prerequisite will be the development of a standardized and 
internationally agreed nomenclature for phenotype deﬁnition that is applicable to humans as 
well as to the major model organisms that are in use today.
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α-DYSTROGLYCAN - A glycoprotein that 
binds to dystrophin, and helps to provide 
linkage between the sarcolemma and 
extracellular matrix in muscle.
ACHONDROPLASIA - The most common 
of the many types of short-limbed dwarﬁsm. 
Achondroplasia is characterized by abnormal 
bone growth that results in short stature with 
disproportionately short arms and legs, a 
large head and characteristic facial features.
ACRO-DERMATO-UNGUAL-LACRIMAL-
TOOTH (ADULT) SYNDROME - A 
syndrome with a variable expression that is 
similar to EEC syndrome. ADULT syndrome 
is characterized by skeletal, nail, breast, 
teeth, and other anomalies (see also OMIM: 
103285).
ALAGILLE SYNDROME - Alagille syndrome 
is a multi-system hereditary disorder. 
Common ﬁndings in patients with this 
syndrome are reduced bile ﬂow, congenital 
heart disease, bone defects, eye ﬁndings, 
and other (typical facial) features (see also 
OMIM: 118450).
ALBINISM, OCULOCUTANEOUS, TYPE 
IB - An autosomal recessive disorder 
characterized by absence of pigment in hair, 
skin, and eyes. Patients suffer from various 
eye problems such as reduced vision and 
photophobia (see also OMIM: 606952).
ATHEROSCLEROSIS - Age, lifestyle, diet 
and gene-related degeneration of arteries 
owing to deposition of lipoid plaques 
(atheromas) on inner arterial walls; it is the 
main cause of coronary artery disease and a 
leading cause of death.
ATRIAL TACHYARRHYTHMIA WITH 
SHORT PR INTERVAL - A condition 
characterized by heart rhythm abnormalities 
and a typical electrocardiographic pattern 
(see also OMIM: 108950).
BARDET–BIEDL SYNDROME - A genetic 
disorder that is linked to chromosomes 3, 
15 and 16 that causes progressive blindness, 
obesity, extra ﬁngers and toes, and mental 
retardation.
CARDIOMYOPATHY, FAMILIAL 
HYPERTROPHIC - A genetic disease of the 
heart muscle, which involves a thickening of 
the heart muscle (see also OMIM: 192600).
CHONDRODYSPLASIA - A disturbance 
in the development of cartilage, primarily 
the long bones. This can result in arrested 
growth and dwarﬁsm.
CLASSIC MULTIDIMENSIONAL SCALING 
- Statistical technique reducing the number 
of dimensions of the data set.
CONGENITAL SPONDYLOEPIPHYSEAL 
DYSPLASIA - A genetic disease that features 
abnormal growth of the growing ends of 
bones in the spine, resulting in short trunk 
dwarﬁsm and other problems (see also 
OMIM: 183900).
DYSMORPHOLOGY - The systematic 
examination and classiﬁcation of abnormal 
external features.
E C T R O D A C T Y L Y - E C T O D E R M A L 
DYSPLASIA-CLEFTING SYNDROME (EEC) 
- A congenital disease characterized by split 
hand/feet, cleft lip, cleft palate, decreased 
hair growth, and other abnormalities of nail, 
teeth, and skin (see also OMIM: 604292).
ELLIPTOCYTOSIS - A hereditary 
abnormality of red blood-cell shape.
FANCONI ANEMIA - A genetically inherited 
bone marrow failure syndrome (see also 
OMIM: 227650).
FEATURE VECTOR - A numerical 
representation of the frequencies and weights 
of the different (predeﬁned) features in a 
document. Features are the items which 
documents (e.g. phenotype descriptions) 
share or those in which they differ.
FIBROMUSCULAR DYSPLASIA OF 
ARTERIES - An arterial disease that produces 
stroke, hypertension, poor supply of oxygen 
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to the muscles or myocardial infarction (see 
also OMIM: 135580).
FILOPODIUM - A thin protrusion from a 
cell, ﬁlled with a bundle of actin ﬁlaments that 
function in sensing environmental triggers to 
guide cell migration or axon extension.
FLEISHER SYNDROME - A growth hormone 
deﬁciency with a low level of antibodies, 
which results in frequent infections and other 
problems (see also OMIM: 307200).
FRIEDREICH’S ATAXIA - Friedreich’s 
Ataxia is a slowly progressive disorder of 
the nervous system and muscles (see also 
OMIM: 229300).
FUKUYAMA TYPE MUSCULAR 
DYSTROPHY - A rare form of autosomal 
recessive muscular dystrophy, the symptoms 
of which begin before the age of 9 months 
and include mental retardation, loss of muscle 
tone or tension and weakness of the muscles 
(see also OMIM: 253800).
FUNCTIONAL GENOMICS - Global analysis 
of the function of genes in isolation and in 
concert with one another is the foundation of 
functional genomics. This includes analysis 
of genomic expression or transcriptome, and 
the resulting proteins or proteomics. 
GENE ONTOLOGY - (GO). A hierarchical 
organization of concepts (ontology) with 
three organizing principles: molecular 
functions (the tasks done by individual gene 
products), biological processes (for example, 
mitosis) and cellular components (examples 
include the nucleus and the telomere).
GENETIC HETEROGENEITY - Clinically 
similar phenotypes caused by mutations in 
different genes or a combination of genes.
HAND-FOOT-UTERUS SYNDROME - 
Besides hand, foot, and uterus abnormalities 
patients with this genetic disease also have 
genital tract and eye problems (see also 
OMIM: 140000).
HOLT-ORAM SYNDROME - This inherited 
disorder is also called heart-hand syndrome, 
and causes abnormalities of the upper limbs 
and heart (see also OMIM: 142900).
INDEPENDENT COMPONENT ANALYSIS 
- Technique that ﬁnds statistical independent 
components in the input data set.
INDEX CASE - The ﬁrst diagnosed case in 
a family.
INTERACTOME - A complete set of 
macromolecular interactions (physical and 
genetic). Current use of the word tends to 
refer to a comprehensive set of protein–
protein interactions.
INVERSE DOCUMENT FREQUENCY - A 
weight factor that is deﬁned as the logarithm 
of the number of documents divided by the 
number of documents that contain that term.
ISOLATED FAMILIAL 
HYPOPARATHYROIDISM - An inheritable 
form of Hypoparathyroidism (reduction 
or absence of secretions of the parathyroid 
gland), which is characterized by low calcium 
levels in the blood and elevated phosphate 
levels (see also OMIM: 146200).
JERVELL AND LANGE-NIELSEN 
SYNDROME - Genetic functional heart 
disease with an abnormal electrocardiographic 
pattern, which can result in sudden death. 
Additionally, patients suffer from hearing 
loss (see also OMIM: 220400). 
KEYWORD VECTOR - A numerical 
representation of the frequencies and 
weights of the different terms/keywords in a 
document.
LARSEN SYNDROME - A syndrome 
of multiple congenital dislocations and 
characteristic faces, notably with a 
prominent forehead, depressed nasal bridge 
and widely spaced eyes (see also OMIM: 
150250/245600).
LEUKOENCEPHALOPATHIC BRAIN 
DISEASE - Leukoencephalopathy is the 
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destruction of the myelin sheaths (white 
matter), which cover nerve ﬁbers (see also 
OMIM: 603896).
LONG QT SYNDROME 3 - Genetic 
functional heart disease with an abnormal 
electrocardiographic pattern (see also 
OMIM: 603830).
MARSHALL SYNDROME - Rare genetic 
disorder that is characterized by a ﬂattened 
nasal bridge, nostrils that tilt upwards, 
widely-spaced eyes, myopia, cataracts and 
hearing loss (see also OMIM: 154780).
METABOLOME - The collection of all 
metabolic units and pathway motifs in a cell, 
tissue, organ, etc.
MICRORNA - RNA (single-stranded), which 
is thought to play a regulatory role in gene 
expression. MicroRNAs (miRNAs) are 
typically ~20-25 nucleotides and transcribed 
normally from DNA, but they are not 
translated into protein.
MOHR SYNDROME - This syndrome shows 
several birth defects such as cleft palate, and 
other facial abnormalities, shortened limbs, 
and  hands and feet malformations (see also 
OMIM: 252100).
MULTIPLE EPIPHYSEAL DYSPLASIA 
TYPE 2 - Genetic disease that features 
abnormal skeletal growth resulting in short 
stature and various limb problems (see also 
OMIM: 600204).
MULTIPLE SYNOSTOSES SYNDROME 1 
- Patients with this syndrome suffer from 
abnormal bone fusions that lead to body 
width malformations in skeleton, head, neck, 
skin, and nails (see also OMIM: 186500).
MUSCLE-EYE-BRAIN DISEASE - Genetic 
disease that features weakness and 
dysfunction of the muscles, atypical neuronal 
migration, and various eye defects (see also 
OMIM: 253280).
NOONAN SYNDROME - The disease 
features include inborn heart defects, short 
stature, learning problems, indentation of the 
chest, blood clotting issues, and a distinctive 
appearance (see also OMIM: 163950).
OCULOCUTANEOUS ALBINISM TYPE 
3 - A genetic trait with partial absence of 
pigmentation in skin, but normal retinal 
pigmentation (see also OMIM: 203290).
OLIGOGENIC - A trait is considered to be 
oligogenic if two or more genes work together 
to produce the phenotype. An oligogenic trait, 
which implies that few genes are involved, 
should be contrasted with a polygenic trait, 
which implies that many genes are involved 
in phenotype expression.
O-MANNOSYLATION - A form of 
glycosylation of proteins that begins by 
adding a mannose at serine and threonine 
residues.
OMICS - Omes is derived for the Greek for 
all/complete. In biology the sufﬁx -omics is 
often used to describe biological subﬁelds that 
involve large-scale data collection/analysis. 
Examples are genomics (DNA), proteomics 
(proteins), metabolomics (small molecules).
OTO-PALATO-DIGITAL SYNDROME - An 
X-linked condition with deafness, cleft palate, 
characteristic faces and a generalized bone 
dysplasia (see also OMIM: 311300/304120).
OPITZ G SYNDROME - OPITZ G syndrome 
is characterized by abnormality of eyes, 
penis, testes, and anus. Patients suffer from 
facial clefting, swallowing defects, and 
often there is a brain malformation (see also 
OMIM: 300000).
OSMED - OtoSpondyloMegaEpiphyseal 
Dysplasia is a very rare, more severe variant 
of the Stickler syndrome (see also OMIM: 
215150).
OSTEOPETROSIS - Part of a range of diseases 
that are characterized by a generalized 
increase in skeletal density.
PALLISTER–HALL SYNDROME - An 
extremely rare genetic disorder that can be 
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apparent at birth (congenital), the symptoms 
of which vary greatly in range and severity 
from case to case and can include a benign 
tumour of the hypothalamus, decreased 
pituitary function and the presence of 
extra ﬁngers and/or toes (see also OMIM: 
146510).
PHENOME - The physical totality of all traits 
of an organism or of one of its subsystems is 
called the phenome.
PHENYLKETONURIA - A genetic disorder 
in which a liver enzyme (phenylalanine 
hydroxylase) is defective, leads to mental 
retardation unless a special diet is followed 
(see also OMIM: 261600).
PIV SYNDROME - PIV (Polydactyly, 
Imperforate anus, and Vertebral anomalies) 
syndrome is characterized by the presence 
of more than the normal number of ﬁngers 
or toes, partial or complete obstruction of 
the anus and vertebral anomalies (see also 
OMIM: 174100).
PODOSOME - Cell membrane structures 
that are involved in the adhesion process of 
various cells to a solid substrate.
POLYCYSTIC KIDNEY DISEASE - A genetic 
disease in which patients suffer from the 
growth of numerous cysts in the kidneys (see 
also OMIM: 601313).
PRINCIPAL COMPONENT ANALYSIS 
- Statistical technique that can be used to 
simplify a dataset by reducing the number 
of dimensions while retaining those 
characteristics of the dataset that contribute 
most to its variance.
PROTEOME - The complete set of proteins 
present in a cell, organ, etc.
RENAL-COLOBOMA SYNDROME - Genetic 
condition with kidney abnormalities and a 
cleft or defect in the eye (see also OMIM: 
120330).
ROBINOW-SORAUF SYNDROME - An 
inherited disorder causing abnormalities of 
the skull and face and the hands and feet (see 
also OMIM: 180750).
ROBINOW SYNDROME - A syndrome 
characterized by abnormal face (resembling 
an early foetus), short forearms, 
and underdeveloped genitals, but no 
achondroplasia. This leads to dwarﬁsm 
without mental retardation (see also OMIM: 
268310).
RUFOUS OCULOCUTANEOUS ALBINISM 
- This trait is most common autosomal 
recessive disorder among native southern 
Africans and is characterized by bright 
copper-red coloration of the skin and hair 
and dilution of the colour of the iris (see also 
OMIM: 278400).
SAETHRE-CHOTZEN SYNDROME - 
Saethre-Chotzen syndrome is characterized 
by craniofacial and limb anomalies (see also 
OMIM: 101400).
SCALE-FREE NETWORKS - Networks 
consist of nodes and the connections between 
them. In a scale-free network, some nodes 
exhibit extremely high number of connections 
(called hubs). The vast majority of nodes are 
relatively poorly connected.
SERTOLI CELLS - Cells in the testis that are 
nurturing the developing sperm cells during 
the process of spermatogenesis.
SKELETAL DYSPLASIAS - Genetic disorders 
of the skeleton.
STICKLER–KNIEST FAMILY - The overlap 
between these two inherited disorders of the 
skeletal system.
STICKLER SYNDROME - This group of 
hereditary syndromes involves a characteristic 
facial appearance, eye abnormalities, hearing 
loss and joint problems. Many individuals 
are born with cleft palates (an opening in 
the roof of the mouth) (see also OMIM: 
108300/604841/ 184840).
SYNDROME - The group or recognizable 
pattern of symptoms or abnormalities that 
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indicate a particular trait or disease.
SYNDROMOLOGY - The recognition 
and classiﬁcation of patterns of multiple 
congenital anomalies.
TOWNES-BROCKS SYNDROME - Clinical 
features of this syndrome are abnormal anus, 
and hand, foot and ear anomalies (see also 
OMIM: 107480).
TRANSCRIPTOMICS - The complete set of 
transcripts (RNAs) present in a cell, organ, 
etc.
TRICHO-DENTO-OSSEOUS SYNDROME 
- A hereditary condition that mainly involves 
the hair, teeth, and bones. Individuals are 
born with a full head of kinky hair. Nails are 
thin and likely to peel or fracture, but bones 
are denser (see also OMIM: 190320).
TRICHOTHIODYSTROPHY - Patients 
have brittle hair and nails, and their skin 
is dry, thickened and darker. They suffer 
from physical and mental retardation and 
approximately half of the patients are 
sensitive to light (see also OMIM: 601675).
TRISMUS-PSEUDOCAMPTODACTYLY 
SYNDROME - A genetic disorder 
characterized by the inability to completely 
open the mouth. Abnormal short muscle-
tendons in the ﬁngers cause the ﬁngers to 
curve or bend (not permanent) when the hand 
is bent back (see also OMIM: 158300).
TUBEROUS SCLEROSIS - A genetic disorder 
with non-cancerous (benign) tumours in the 
kidneys, brain, eyes, heart, lungs, and skin. 
It is associated with mental retardation and 
seizures (see also OMIM: 191100).
ULNAR-MAMMARY SYNDROME -
This genetic disorder is characterized by 
abnormalities affecting the bones of the 
forearms and hands and/or underdevelopment 
and dysfunction of certain sweat glands and/
or the breasts (see also OMIM: 181450).
UPGMA - Unweighted Pair Group Method 
with Arithmetic mean (UPGMA) is a data 
clustering method. This method is often used 
to construct phylogenetic trees.
USHER SYNDROME - Recessively inherited 
deafness and retinitis pigmentosa.
WAARDENBURG SYNDROME - Dominantly 
inherited white forelock, unequal or reduced 
pigmentation of the iris and deafness.
WALKER–WARBURG SYNDROME - A rare 
autosomal recessive genetic disorder, the 
most consistent features of which are a lack 
of normal folds in the brain (lissencephaly), 
malformations of the back portion of the brain 
(cerebellum), abnormalities of the retina 
of the eye, and progressive degeneration 
and weakness of the voluntary muscles 
(congenital muscular dystrophy) (see also 
OMIM: 236670).
WISKOTT-ALDRICH SYNDROME - An 
X-linked recessive disease characterized 
by eczema, low platelet counts, immune 
deﬁciency, and bloody diarrhoea (see also 
OMIM: 301000).
XERODERMA PIGMENTOSUM - An 
inherited childhood skin eruption that is 
characterized by multiple pigmented spots 
(that resemble freckles) and larger atrophic 
lesions, eventually resulting in a glossy white 
thinning of the skin.
ZELLWEGER SYNDROME - A genetic 
disease characterized by the reduced ability 
to process toxic substances in cells of the 
liver, kidneys, and brain. Abnormal brain 
and nerve insulator development result and 
lead to mental retardation and other features 
(see also OMIM: 214100).
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Databases and other web addresses 
Genome Browsers
Name URL Description Reference
Ensembl
http://www.
ensembl.org/
The project provides a comprehensive 
and integrated source of annotation of 
large genome sequences
[1]
UCSC genome 
browser 
http://genome.
ucsc.edu/
Contains reference sequence and 
working draft assemblies for a large 
collection of genomes.
[2]
NCBI Map 
viewer
http://www.ncbi.
nlm.nih.gov/
mapview/
Map Viewer supports search and 
display of genomic information by 
chromosomal position.
[3]
Nucleic acid sequences
EMBL
http://www.ebi.
ac.uk/embl/
Europe’s primary nucleotide sequence 
resource. Containing DNA and RNA 
sequences from direct submissions 
from individual researchers, genome 
sequencing projects and patent 
applications.
[4]
Genbank
http://www.ncbi.
nlm.nih.gov/
Genbank/
GenBank contains publicly available 
DNA and RNA sequences for more 
than 140.000 named organisms, 
submitted by individual researchers 
and batch submissions from large-scale 
sequencing projects.
[5]
DDBJ
http://www.ddbj.
nig.ac.jp/
DNA Database of Japan [6]
Protein sequences
SwissProt/
UniProt
http://www.
uniprot.org
UniProt is a comprehensive, fully 
classiﬁed, and annotated protein 
sequence knowledgebase with cross-
references.
[7]
PIR
http://pir.
georgetown.edu/
home.shtml
The Protein Information Resource 
(PIR) is an integrated public resource of 
protein informatics.
[8]
RefSeq
http://www.ncbi.
nlm.nih.gov/
RefSeq/
Provides a non-redundant collection of 
sequences representing genomic data, 
transcripts and proteins.
[9]
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Protein families, domains and functional sites
InterPro
http://www.ebi.
ac.uk/interpro
An integrated documentation resource 
of protein families, domains and 
functional sites, was created to integrate 
the major protein signature databases.
[10]
PROSITE
http://www.expasy.
org/prosite/
Consists of a large collection of 
biologically meaningful signatures that 
are described as patterns or proﬁles.
[11]
Pfam
http://www.sanger.
ac.uk/Software/
Pfam/
Large collection of protein families and 
domains.
[12]
PRINTS
http://umber.
sbs.man.ac.uk/
dbbrowser/
PRINTS/
A compendium of protein ﬁngerprints 
(a group of conserved motifs used to 
characterise a protein family)
[13]
ProDom
http://prodes.
toulouse.inra.
fr/prodom/current/
html/home.php
A comprehensive set of protein domain 
families automatically generated from 
the SwissProt and TrEMBL sequence 
databases.
[14]
SMART
http://smart.embl-
heidelberg.de/
Simple Modular Architecture Research 
Tool, allows the identiﬁcation and 
annotation of genetically mobile 
domains and the analysis of domain 
architectures.
[15]
TIGRFAMs
http://www.tigr.
org/TIGRFAMs/
TIGRFAMs is a collection of manually 
curated protein families consisting 
of hidden Markov models, multiple 
sequence alignments, commentary, 
Gene Ontology assignments, literature 
references and pointers to related 
TIGRFAMs, Pfam and InterPro models
[16]
PIRSF
http://pir.
georgetown.edu/
pirsf/
PIR has extended its superfamily 
concept and developed the SuperFamily 
(PIRSF) classiﬁcation system.
[17]
CATH
http://www.
biochem.ucl.ac.uk/
bsm/cath/
Database of protein domain structures 
containing domains classiﬁed into 
superfamilies and sequence families.
[18]
PANTHER
http://panther.
appliedbiosystems.
com
Large collection of protein families that 
have been subdivided into functionally 
related subfamilies, using human 
expertise.
[19]
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Structural databases
PDB
http://www.rcsb.
org/pdb/
The single worldwide repository for 
the processing and distribution of 3-D 
biological macromolecular structure 
data.
[20]
DSSP
http://swift.cmbi.
ru.nl/gv/dssp/
Containing secondary structure 
assignments for all protein entries in the 
Protein Data Bank (PDB).
[21]
HSSP
http://swift.cmbi.
ru.nl/gv/hssp/
Multiple sequence alignments for all 
proteins in the PDB.
[22]
Organism speciﬁc databases
SGD
http://www.
yeastgenome.org/
A database of the molecular biology and 
genetics of the yeast Saccharomyces 
cerevisiae.
[23]
FlyBase http://ﬂybase.org/
FlyBase is a database of genetic and 
molecular data for Drosophila. FlyBase 
includes data on all species from the 
family Drosophilidae; the primary 
species represented is Drosophila 
melanogaster.
[24]
WormBase
http://www.
wormbase.org
Wormbase is the model organism 
database for information about 
Caenorhabditis elegans and related 
nematodes.
[25]
MGI(/MGD)
http://www.
informatics.jax.org
The Mouse Genome Informatics 
Database provides integrated access 
to data on the genetics, genomics and 
biology of the laboratory mouse.
[26]
GDB
http://gdbwww.
gdb.org/
The Genome Database is a public 
repository of data on human genes, 
clones, STSs, polymorphisms and maps.
[27]
Classiﬁcation systems and related resources
ICD
http://www.who.
int/classiﬁcations/
icd/en/
This system was designed to promote 
international comparability in the 
collection, processing, classiﬁcation, 
and presentation of mortality statistics
see URL
SNOMED
http://www.
snomed.org/
Systematized Nomenclature of 
Medicine is a reference terminology 
for describing a complete medical ﬁle, 
including diagnosis and treatment.
see URL
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ULMS
http://www.nlm.
nih.gov/research/
umls/
The purpose of the Uniﬁed Medical 
Language System is to aid the 
development of computer systems, 
which ‘comprehend’ the meaning of the 
medical texts
[28]
MeSH
http://www.nlm.
nih.gov/mesh/
The Medical Subject Headings is a 
controlled vocabulary used for indexing 
articles for MEDLINE/PubMed. MeSH 
terminology provides a consistent way 
to retrieve information that may use 
different terminology for the same 
concepts.
[29]
PubMed
http://www.ncbi.
nlm.nih.gov/
pubmed/
PubMed is the main life science 
literature source, including over 15 
million citations for biomedical articles 
back to the 1950’s.
[3]
Disease/variation databases
HGMD
http://www.hgmd.
org/
The Human Gene Mutation Database 
constitutes a comprehensive core 
collection of data on germ-line 
mutations in nuclear genes underlying 
or associated with human inherited 
disease.
[30]
dbSNP
http://www.ncbi.
nlm.nih.gov/SNP/
A repository for single base nucleotide 
substitutions and short deletion and 
insertion polymorphisms that contains 
9.8 million human SNPs as well as 
about 5 million from a variety of other 
organisms.
[3]
OMIM
http://www.ncbi.
nlm.nih.gov/
Omim/
A catalogue of human genes and genetic 
disorders.
[31]
LDDB
http://www.
hgmp.mrc.ac.uk/
DHMHD/lddb.
html
The London Dysmorphology Database 
contains over 3.000 non-chromosomal, 
multiple congenital anomaly syndromes 
that can be used both as an aid to 
diagnosis for the clinician and as a 
reference source.
[5]
DHMHD
http://www.
hgmp.mrc.
ac.uk/DHMHD/
dysmorph.html
The Dysmorphic Human-Mouse 
Homology Database contains mouse/
human malformation and mapping data.
[32]
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POSSUM
http://www.
possum.net.au/
Pictures of Standard Syndromes 
and Undiagnosed Malformations is 
a computer-based system that helps 
clinicians to diagnose syndromes in 
their patients.
[33]
Pathway databases
KEGG
http://www.
genome.jp/kegg/
Kyoto Encyclopedia of Genes and 
Genomes aiming to represent the cell 
and the organism in the computer
[34]
Reactome
http://www.
reactome.org/
A curated resource of core pathways 
and reactions in human biology.
[35]
BRENDA
http://www.brenda.
uni-koeln.de/
BRaunschweig ENzyme Database 
represents a comprehensive collection 
of enzyme and metabolic information, 
based on primary literature.
[36]
Expression databases
Unigene
http://www.ncbi.
nlm.nih.gov/
UniGene/
UniGene is an experimental system for 
automatically partitioning GenBank 
sequences into a non-redundant set of 
gene-oriented clusters.
[3, 37, 
38]
SMD
http://smd.stanford.
edu/
Stanford Microarray Database functions 
as a public providing microarray data 
published by SMD users.
[39]
SAGEmap
http://www.ncbi.
nlm.nih.gov/
SAGE/
SAGEmap is a SAGE data resource for 
the query and retrieval and analysis of 
SAGE data from any organism.
[40]
GEO
http://www.ncbi.
nlm.nih.gov/geo/
The Gene Expression Omnibus is a 
high-throughput gene expression data 
repository, as well as a curated, online 
resource for gene expression data 
browsing, query and retrieval.
[41]
Interaction databases
BIND http://bind.ca
Biomolecular Interaction Network 
Database archives biomolecular 
interaction, reaction, complex and 
pathway information.
[42]
HPRD
http://www.hprd.
org/
Human Protein Reference Database 
integrates and visualizes information 
pertaining to domain architecture, post-
translational modiﬁcations, interaction 
networks and disease association for 
human proteins.
[43, 44]
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MIPS http://mips.gsf.de/
Munich Information Center for Protein 
Sequences provides protein sequence-
related information based on whole-
genome analysis.
[45]
DIP
http://dip.doe-mbi.
ucla.edu/
Catalogs experimentally determined 
interactions between proteins. It 
combines information from a variety of 
sources to create a single, consistent set 
of protein-protein interactions.
[46]
Orthology databases
COG
http://www.ncbi.
nlm.nih.gov/COG/
Clusters of Orthologous Groups are a 
phylogenetic classiﬁcation of proteins 
encoded in complete genomes
[47]
KOG
http://www.ncbi.
nlm.nih.gov/COG/
new/shokog.cgi
Similar to COG, but for eukaryotic 
genomes
[48]
OrthoDisease
http://orthodisease.
cgb.ki.se
OrthoDisease is a comprehensive 
database of model organism genes that 
are orthologous to human disease genes.
[49]
Miscellaneous 
GO
http://www.
geneontology.org/
Gene Ontology is a controlled 
vocabulary and is a collaborative effort 
to address the need for consistent 
descriptions of gene products in 
different databases.
[50]
GOA
http://www.ebi.
ac.uk/GOA/
Aims to provide high-quality electronic 
and manual annotations to UniProt 
(Swiss-Prot, TrEMBL and PIR-PSD) 
using the standardized vocabulary of the 
Gene Ontology (GO).
[51]
GeneCards
http://bioinfo.
weizmann.ac.il/
cards/
GeneCards is a database of human 
genes, their products and their 
involvement in diseases.
[52]
Linkage
http://linkage.
rockefeller.edu/
Web resources of genetic linkage 
analysis
see URL
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Chapter 1 - Figure 1 An Oxford-grid. The grid shows the relationship between human and mouse 
chromosomes. Chromosome location of either of the species often predicts the chromosome location in 
the other species. The colours indicate the number of orthologies: Grey (1), Blue (2-10), Green (11-25), 
Orange (26-50), Yellow (>50). From the Mouse Genome Database (MGD), Mouse Genome Informatics, 
The Jackson Laboratory, Bar Harbor, Maine. (http://www.informatics.jax.org, April, 2005).
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that are coded as independent entities in
expert databases, such as OMIM, the London
DYSMORPHOLOGY Database (LDDB) or the
Pictures of Standardized Syndromes and
Undiagnosed Malformations (POSSUM)
database2,3 (see online links box). In spite of
these limitations, the syndrome-family con-
cept has been remarkably successful in pre-
dicting allelic mutations, as in several SKELETAL
DYSPLASIAS (BOX 1).
Biology of syndrome families
It is not immediately obvious that phenotypic
overlap should be a reliable indicator of
shared function. Perhaps perceived pheno-
typic similarities between syndromes are sim-
ply the result of our inability to appreciate the
relevance of various discriminating features.
For instance, we can ask whether the assign-
ment of what seems to be a single human
genetic disease to different genes represents
diagnostic failure or shared biological mecha-
nisms. From the examples given below, the
latter would seem to be much more common.
The fact that mutations at different loci
could lead to apparently the same human
genetic disease was first recognized almost 50
years ago, when N. Morton showed that
although some families with ELLIPTOCYTOSIS
were genetically linked to the Rhesus blood-
group locus, other families were not18. It has
since become clear that non-allelic genetic
heterogeneity is frequent in Mendelian dis-
eases, and that it can be extensive19–23. Genetic
heterogeneity is commonly regarded as an
obstacle to understanding human genetic dis-
ease, because it results in more ambiguous
linkage assignments and slows down the
gene-finding process. However, genetic het-
erogeneity can also be viewed in a different
light: it might reflect interactions at the pro-
tein level, such as ligand–receptor interac-
tions, the different subunits of a multiprotein
complex or proteins that function at different
steps of a metabolic pathway.
Such interactions have two implications:
not only could we find the other genes more
effectively once the first gene is found, but
we can also speculate that apparently unre-
lated genes that are involved in the same
phenotype will ultimately be shown to have
a functional relationship. In this way, clinical
classification could precede molecular verifi-
cation, and SYNDROMOLOGY could become a
functional genomics tool.
From genetic heterogeneity to molecular inter-
actions and pathways. Fanconi anaemia (FA)
is an example of a heterogeneous syndrome
that has provided important information on
the pathways that underlie it. This syndrome
to this variability14. Furthermore, as muta-
tions in different genes can cause the same or
related phenotypes, a strictly molecular clas-
sification would obscure the relationship
between molecularly distinct syndromes at
the phenotype level15.
It has been recognized for many years that
overlapping syndrome phenotypes might
reflect biological relationships16. Designated
‘phenotype communities’ or ‘syndrome fami-
lies’, these terms refer to groups of syndromes
that share a large proportion of their key fea-
tures. Because the process of syndrome delin-
eation is iterative, syndrome phenotypes tend
to evolve as more information becomes avail-
able. For this reason, and because of advances
in molecular genetics, syndromes can merge
or split over time, and can even disappear17.
Consequently, syndrome families can only be
arbitrarily defined as groups of syndromes
members, and to exclude the INDEX CASES from
the analyses10. Reports on patients with partly
overlapping phenotypes frequently lead to
debates between ‘splitters and lumpers’11. As
syndrome definition is initially intuitive and
analytic, clinical arguments alone rarely res-
olve such debates. Only a few reports describe
mathematical approaches to syndrome defi-
nition12,13, and syndrome diagnosis remains
largely a matter of comparison with the
‘ideal’ aspect of the given syndrome. Once
the gene for a syndrome has been found, a
clearer picture emerges of what constitutes
the core phenotype and its variants. How-
ever, having a molecular definition of a
syndrome does not completely solve the
problem of understanding its phenotypic
variability: allelic mutations can be associ-
ated with considerable phenotypic diversity,
and the action of modifier genes further adds
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Figure 1 | Integrating functional relationships and linkage analysis. Three separate genome scans
for a hypothetical multifactorial disease result in multiple peaks of possible linkage (red traces) on 3
different human chromosomes (1, 6 and 12). Integrating linkage results with data from other sources,
such as gene/protein networks (A … Z), points to a set of functionally related candidate genes (H, G and
K) that together might explain the linkage patterns. Numbers along the highlighted chromososmes
indicate the corresponding chromosome bands.
Chapter 4 - Figure 1 Integrating functional relationships and linkage analysis. Three separate genome 
scans for a hypothetical multifactorial disease result in multiple peaks of possible linkage (red traces) on 
3 different human chromosomes (1, 6 and 12). Integrating linkage r sults with data from other sources, 
such s gene/p otein networks (A … Z), point  to a set of fu ctionally related candidate g nes (H, G 
and K) that together might explain the linkage patterns. Numbers along the highlighted chromosomes 
indicate the corresponding chromosome bands.
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natural-killer and myeloid cells, and in the
gene that encodes a ligand for this receptor,
each resulted in this disease phenotype27.
Syndrome families and pathways. What is
true for a single genetically heterogeneous dis-
ease might equally apply to distinct syn-
dromes with phenotypic overlap. One such
syndrome family comprises the WALKER–WAR-
BURG SYNDROME, FUKUYAMA MUSCULAR DYSTROPHY
and muscle–eye–brain disease (MEBD).
These diseases are characterized by abnormal
neuronal migration, variable eye involvement
and congenital muscular dystrophy. Although
these syndromes can usually be distinguished
on clinical grounds alone, there is also a clear
overlap in the features that define them, and it
has previously been suggested that they form
a clinical spectrum of diseases28. Biochemical
staining of muscle specimens has shown that
all three conditions share a defect in the glyco-
sylation of proteins such as α-DYSTROGLYCAN.
The predicted biochemical function for the
three genes that are involved in Walker–
Warburg syndrome, Fukuyama muscular
dystrophy and MEBD is consistent with a
shared role in O-MANNOSYLATION29. So, these
three independent but clinically similar syn-
dromes represent the disruption of different
steps in the same biochemical pathway.
Similar interactions among gene products
occur in USHER SYNDROME types 1B, 1C, 1D and
1G23 and among WAARDENBURG SYNDROME types
1, 2 and 4 (REFS 30,31). The clinical distinction
of Waardenburg syndrome types 1, 2 and 4
pre-dated the identification of the causative
genes by many years. As is common in these
situations, both the clinical differences as well
as the similarities turned out to be relevant
for the various forms of Waardenburg syn-
drome. When the genes were found to be dis-
tinct, the clinical similarities immediately
stimulated research to identify the functional
module that links them together at the level
of transcription.
Given that mutations that affect different
steps in a pathway can cause the same mono-
genic phenotype, in some instances, the com-
bined effect of mutations in different genes
might interact to produce digenic or polygenic
inheritance of human-malformation syn-
dromes. Indeed, several examples of digenic or
triallelic inheritance in humans have been
recorded32. The most striking is BARDET–BIEDL
SYNDROME (BBS). In this syndrome, there is
genetic interaction between several of the loci.
Although the functions of the BBS genes
remain largely unknown, the additive effect of
mutations at BBS1,BBS2,BBS4,BBS6 (MKKS)
and BBS7 indicates that the products of the
different BBS genes share at least part of their
is an autosomal recessive disorder that is
associated with cardiac, renal and limb mal-
formations, as well as dermal pigmentary
changes. Progressive bone-marrow disease
can lead to bone-marrow failure and leu-
kaemia. Somatic-cell hybrid studies that
defined multiple complementation groups
first showed that FA was genetically hetero-
geneous24; since then, at least nine FA loci
have been identified and seven genes have
been cloned. The function of each of these
genes was unknown at the time that they
were identified, although given that at the
cellular level, FA was characterized by chro-
mosome breakage, it was probable that
these genes were involved in DNA repair.
Subsequently, it was shown that the proteins
that the FA genes A, C, F, E and G encode
indeed form a complex that functions in
DNA repair. The FA D2 protein (FANCD2)
functions as a downstream effector of this
complex, and the latest FA gene to be identi-
fied (FANCL) encodes a putative ubiquitin
ligase that might be responsible for the
mono-ubiquitylation of FANCD219,25. So,
the molecular genetics of a single syndrome
can define a previously unknown multipro-
tein complex, which in this example has an
important role in DNA repair.
The converse process is equally frequent
in human molecular genetics. If a molecular
pathway is already known, this knowledge
can be used to accelerate the gene-finding
process for a genetically heterogeneous dis-
ease. This candidate-gene approach was
used to show that recessive mutations in
each of the five subunits of translation initi-
ation factor eIF2B cause the same recessively
inherited leukoencephalopathic brain dis-
ease, which is characterized by vanishing
white matter26.
There are also several examples for which
the same phenotype is caused by the muta-
tion of either the receptor or the ligand gene
for a signalling step. A striking example of
this is the combined phenotype of pre-senile
dementia and bone cysts. Mutations in a
gene that encodes a membrane receptor on
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Myopia
Hearing loss
Nose
Hypertelorism
Ectodermal
dysplasia
Retinal detachment
Palate
Joints
Flat mala
Polydactyly
Anus
Hand
Syndactyly
Pallister–Hall syndrome
Stickler syndrome
Marshall syndrome
Figure 2 | Phenotype clustering. Each arrow represents a KEYWORD VECTOR. The components in a
keyword vector correspond to terms in the document (for example, ‘myopia’, ‘joints’, and so on).
Vectors that point in the same direction are more alike. Three documents that describe three
syndromes are shown (red: STICKLER SYNDROME; green: MARSHALL SYNDROME; and blue: PALLISTER–HALL
SYNDROME). Stickler and Marshall syndromes have similar phenotypes and share common terms
(‘myopia’, ‘palate’, ‘hearing loss’) in their keyword vectors. Pallister–Hall syndrome is clearly different,
and shares few terms with Stickler and Marshall, and therefore, the vector points in a different
direction. Some terms are more important than other terms. Terms are assigned different weights by
computing the INVERSE DOCUMENT FREQUENCY, which gives a weight factor to each term in the
collection. Terms in bold contribute the most to vector direction. Flat mala, low cheekbones;
hypertelorism, widely-spaced eyes.
Chapter 4 - Figure 2 Phenotype clustering. 
Each arrow represents a keyword vector. The components in a keyword vector correspond to terms 
in the document (for example, ‘myopia’, ‘joints’, and so on). Vector  that point in the same direction 
are more alike. Three documents that describe three syndromes are shown (red: Sti kler synd ome; 
green: Marshall syndrome; and blue: Pallister–Hall syndrome). Stickler and Marshall syndromes 
have similar phenotypes and share common terms (‘myopia’, ‘palate’, ‘hearing loss’) in their keyword 
vectors. Pallister–Hall syndrome (weblink) is clearly different, and shares few terms with Stickler 
and Marshall, and therefore, the vector points in a different direction. Some terms are more important 
than other terms. Terms are assigned different weights by computing the inverse document frequency, 
which gives a weight factor to each term in the collection. Terms in bold contribute the most to vector 
direction. Flat mala, low cheekbones; hypertelorism, widely-spaced eyes.
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Chapter 5 - Figure 5 - Histogram of normalized genotype relations as a function of phenotype-
phenotype similarity.All values are corrected for random information levels. Although the HPRD data 
set contains fewer relations than the other sets, the normalized signal is more than two times as strong, 
reﬂecting the quality of the HPRD dataset. The 0.8-0.9 and 0.9-1.0 phenotype similarity bins suffer 
from low counts.
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Ziektegen identiﬁcatie op basis van chromosomale lokalisatie is moeilijk en vaak tijdrovend. 
Het vereist het verzamelen van zoveel mogelijk informatie over de ziekte. Mogelijke hints voor 
het selecteren van kandidaat genen kunnen komen door het combineren van positie informatie 
en andere karakteristieken van de ziekte. We hebben gegevens van verschillende computer 
databases gecombineerd en bioinformatica strategieën ontwikkeld om zo systematisch 
ziektegenen te identiﬁceren.
Genetische aandoeningen worden veroorzaakt door veranderingen in ons erfelijk materiaal 
(DNA). In de westerse wereld zijn genetische ziekten de hoofdoorzaak van neonatale-, 
kinderziekten en kindersterfte. Mutaties die leiden tot ziekten spelen een belangrijke rol in het 
doorgronden van erfelijke ziekten bij mensen, en de moleculaire rol van de genen en eiwitten 
in de ontwikkeling. Deze kennis kan worden gebruikt in erfelijkheidsadvisering, het stellen 
van diagnoses en in onderzoek. Kennis over ziektegenen kan uiteindelijk mogelijkheden 
creëren voor behandeling.
Belangrijke indicaties voor het opsporen van de oorzaken en mechanismen van ziekten, komen 
van de klinische karakteristieken van de ziekte (het ziekte fenotype). Zowel voor klinische- 
als onderzoeksdoeleinden zijn ziektedeﬁnities en classiﬁcaties essentieel. Voor dit doel zijn 
diverse classiﬁcatiesystemen ontwikkeld en in gebruik. Geen van deze systemen is algemeen 
geaccepteerd met tot gevolg dat veel klinische informatie als vrije tekst ligt opgeslagen in 
literatuur databases.
We hebben twee bioinformaticastrategieën beschreven voor het identiﬁceren van kandidaat 
ziektegenen bij de mens (hoofdstukken 2 en 3) en voor het classiﬁceren van humane ziekten 
fenotypen (hoofdstukken 4 en 5). Onze hypothese was dat internet databases met genspeciﬁeke 
informatie en databases met fenotypische beschrijvingen, systematisch kunnen worden 
gebruikt voor het vinden en karakteriseren van ziektegenen en processen.
We hebben een systeem ontwikkeld (hoofdstukken 2 en 3; GeneSeeker) dat als doel heeft 
ondersteuning te bieden in het proces voor het vinden van kandidaat genen. Een vaak 
gebruikte strategie is het prioritiseren van genen in het chromosomale interval dat is verkregen 
via stamboom onderzoek. Deze prioritisering wordt gebaseerd op gen karakteristieken 
zoals expressie in de aangedane weefsels en fenotypen in modelorganismen. Dit proces 
wordt door GeneSeeker in silico nagebootst. Over het algemeen kan de chromosomale 
regio d.m.v. koppelingsonderzoek worden gereduceerd tot 20-200 genen. Het ontwikkelde 
systeem combineert positionele informatie met expressie en fenotype data van mens en 
muis. In hoofdstuk 2 worden tien syndromen geanalyseerd. Voor deze syndromen, inclusief 
twee syndromen die ten tijde van de analyse nieuw en nog niet in de databases beschreven 
waren, werden de kandidaat ziekten genen lijsten gereduceerd met een factor 7-25 terwijl de 
ziektegenen behouden bleven.
Hoofdstuk 3 beschrijft de technische achtergrond van de GeneSeeker in meer detail. Het 
programma vraagt informatie op van diverse databases direct via het world wide web (WWW). 
Negen databases leveren informatie en de modulaire opzet van het systeem maakt het indien 
nodig mogelijk databases toe te voegen. Door het direct raadplegen van de originele databases 
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via de web interfaces wordt het gebruik van de meest recente data gegarandeerd. Hierdoor 
kan data warehousing worden vermeden. GeneSeeker maakt kandidaatgen selecties zodat het 
aantal genen dat geanalyseerd moet worden kan worden beperkt.
GeneSeeker is over het algemeen het meest effectief in syndromen waarbij het ziektegen een 
veranderd expressie patroon heeft in de aangedane weefsels. In deze gevallen kan door de 
verkregen aanwijzingen tijd worden bespaard in de labexperimenten. Het veld voor kandidaatgen 
voorspelling en prioritisering is nieuw en slechts enkele methoden zijn gepubliceerd, ieder 
gebaseerd op verschillende databronnen. De prestaties van GeneSeeker zijn vergelijkbaar 
met deze methoden. Gebruik van GeneSeeker vereist klinische kennis vooraf. Echter, het is 
tot op heden de enige methode die lokalisatie, expressie, en fenotypische data van de muis 
exploreert.
In hoofdstuk 4 worden de relaties op fenotypisch niveau besproken.  In dit hoofdstuk verkennen 
we, gebruik makend van een aantal voorbeelden uit de literatuur, hoe vergelijkbare syndromen/
fenotypen aan elkaar zijn gerelateerd, en of zij een indicatie kunnen zijn voor de betrokken 
genen. We beargumenteren dat deze gelijkenissen een afspiegeling zijn van de biologische 
relaties in de cel. Bovendien bespreken we de toepasbaarheid van een fenotypische kaart voor 
het identiﬁceren van ziektegenen, ook bij multifactoriële/complexe aandoeningen.
In hoofdstuk 5 beschrijven we een methode voor het extraheren van  fenotypische 
beschrijvingen vanuit de vrije tekst in de OMIM database. De fenotypische kenmerken 
werden m.b.v. tekstanalyse technieken geëxtraheerd. In tegenstelling tot het gebruik van 
vooraf (handmatig) gedeﬁnieerde categorieën, hebben we een automatische methode gebruikt 
voor de fenotypische kenmerken identiﬁcatie en vergelijkingen. De fenotypische kaart werd 
geanalyseerd op biologisch relevante informatie. We vonden dat fenotypische gelijkenis 
positief gecorreleerd is met genfunctie op het niveau van eiwitsequentie, motieven, functionele 
annotatie, en eiwit-eiwit interacties afgeleid uit de literatuur. De analyse suggereert dat de 
automatisch gegenereerde fenotypische kaart inderdaad biologische relaties aan kan geven. 
Het doel van dit onderzoek was om enkele algemene principes van erfelijke ziekten bij de mens 
te vinden en bioinformatica strategieën te ontwikkelen voor het identiﬁceren van ziektegenen. 
Fenotype analyse is net zo relevant voor de identiﬁcatie van ziektegenen als het is voor de 
functionele annotatie van het menselijke genoom: Voor de komende jaren worden grote 
verbeteringen verwacht ten aanzien van genidentiﬁcatie-methoden voor monogenetische en 
multifactoriële ziekten, mutatie detectie, en methoden voor het vergelijken tussen organismen. 
Bioinformatica benaderingen zoals hier beschreven kunnen een aanvulling zijn voor analyses 
gebaseerd op sequentie en genen. Hoewel systematische fenotype-genotype analyses nog veel 
te ontdekken laten, is het essentieel om een gestandaardiseerde en internationaal aanvaarde 
nomenclatuur te ontwikkelen voor fenotype deﬁnitie, die zowel toepasbaar is op mensen als 
wel op de hedenten dage veel gebruikte modelorganismen. 
156
Curriculum vitae
Marc van Driel werd op 12 maart 1974 geboren te Arnhem. Zijn HAVO-opleiding volgde 
hij aan de scholengemeenschap Presikhaaf te Arnhem, waar hij in 1992 zijn eindexamen 
behaalde. Vervolgens startte hij de Hogere Laboratorium opleiding in Nijmegen in de richting 
Biochemie/Biotechnologie. Gedurende deze opleiding deed hij de extra vakken toxicologie en 
management. In het kader van een afstudeerstage in 1995 bij de afdeling Antropogenetica van 
het Radboud ziekenhuis te Nijmegen, werkte hij aan de positionele klonering van het gen voor 
een erfelijke vorm van geslachtsgebonden gespleten gehemelte onder leiding van Dr. Hans 
van Bokhoven. In 1996 rondde hij de HLO opleiding af, waarna hij begon als research analist 
op de afdeling Antropogenetica. In de groep van Prof. Dr. Frans Cremers werkte hij aan de 
genetische karakterisatie van diverse erfelijke oogziekten (ziekte van Stargardt, ouderdoms 
macula degeneratie, retinitis pigmentosa, kegel-staaf dystroﬁe, choroideremie en cystoïde 
macula dystroﬁe). Vanaf 1998 zette hij onder leiding van Prof. Dr. Frans Cremers dit  werk in 
de vorm van een promotie onderzoek voort in samenwerking met de afdeling Oogheelkunde 
(Prof. Dr. August Deutman en Dr. Carel Hoyng). In 2001 maakte hij de overstap van het 
laboratorium werk naar de bioinformatica en begon bij het Centrum voor Moleculaire en 
Biomoleculaire Informatica (CMBI). Onder leiding van Prof. Dr. Jack Leunissen (CMBI/
WUR), Prof. Dr. Gert Vriend (CMBI) en Prof. Dr. Han Brunner (Antropogenetica, UMCN St. 
Radboud) werkte hij aan het in dit proefschrift beschreven onderzoek. Sinds juni 2005 werkt 
hij als bioinformaticus in het lab van Prof. Dr. Henk Stunnenberg (Moleculaire  Biologie, 
Radboud Universiteit Nijmegen).
157
Dankwoord
Het proefschrift is klaar en dan is het ook tijd om terug te kijken. Veel mensen hebben een 
bijdrage geleverd en die wil ik graag hier bedanken. Als eerste mijn (co-)promotoren Gert, 
Han, en Jack. Jack, met de overstap van Antropogenetica begon ik bij jou op het CMBI met 
de GeneMachine, dat later tot ons beider ongenoegen helaas GeneSeeker moest gaan heten. 
Met je overstap naar Wageningen, om daar hoogleraar te worden, werd de afstand wel groter 
maar met het MimMiner project bleef het contact. Nu het proefschrift klaar is moeten we daar 
zeker een goede whisky op drinken. Gert, jouw betrokkenheid en inzet waren essentieel voor 
het tot stand komen van het proefschrift.  Er was geen dag dat je niet even tijd had. Ook was 
er altijd tijd voor een praatje over het werk of onze andere interesses. Bedankt voor wat je me 
hebt geleerd en voor het vertrouwen in een goede aﬂoop. Han, jouw bijdrage gaat terug tot de 
tijd dat ik nog bij Antropogenetica werkte. Daar is ons contact met het CMBI begonnen. Na 
mijn overstap was het dan ook logisch dat er contact bleef met jou. Dit contact groeide verder 
uit tot een intensieve samenwerking met dit boekje als resultaat. Bedankt voor alles wat je hebt 
gedaan. 
Mijn paranimfen Maarten en Jacopo. Maarten, we hebben veel gelachen en ik heb veel geleerd 
van je programmeerkunsten. Gelukkig heb ik ook nog wat bij kunnen dragen: data::dumper.. 
Jacopo, vanaf het moment dat je bij Antropo kwam werken hebben we veel gepraat en nog 
meer pasta gegeten. Bedankt voor jullie steun.
Martijn, Berend, de discussies met jullie waren meer dan welkom en ik heb er zowel direct als 
indirect veel aan gehad. Bedankt. Barbara, Esther, zonder jullie organisatorische ondersteuning 
zouden er veel zijn blijven liggen. Cursusplanning, materiaal, maar ook talloze andere zaken 
liepen gesmeerd dankzij jullie. Koen, menigmaal heb ik je aan de telefoon gehad voor de 
Antropogenetica bioinformatica vragen. Je besloot over te stappen naar Lion Bioscience en 
ik nam je project over. Bedankt voor je bijdrage en dat Belgische pintke pakken we straks. 
Patrick en de studenten Eric, Pieter en Geerten wil ik bedanken voor hun bijdrage aan de 
GeneSeeker. Binnen het MimMiner project ben ik bijzondere dank verschuldigd aan Jorn en 
later Martin. De meeste van jullie doen nu zelf promotie-onderzoek, veel succes daarmee. 
Op het CMBI stonden alle deuren open en ik kon vrijwel altijd binnenlopen met een vraag of 
voor een praatje. De afdeling is erg gegroeid de afgelopen jaren en er zijn mensen gekomen en 
gegaan. Er zijn meer dan 60 namen te noemen, maar dat durf ik niet aan. Ik wil jullie allemaal 
bedanken voor de bijdrage aan dit proefschrift, de leuke werksfeer en de gezellige kofﬁe/thee/
lunchpauzes. Een tijd die me nog lang zal heugen.
Hoewel ik dit werk heb gedaan bij het CMBI zijn er een aantal mensen van Antropogenetica 
die een belangrijke rol hebben gespeeld. Hans, in 1995 begon ik mijn stage bij jou en dat was 
een erg leuke tijd. Je zangkwaliteiten zijn geloof ik nog niet echt verbeterd, maar die van mij 
ook niet. Bedankt voor je inzet en tijd. Frans, toen je hoorde dat ik in Amsterdam kon beginnen 
heb je snel een leuke plek voor me op het lab geregeld. Eerst als analist, maar later gaf je me de 
kans om promotie-onderzoek te gaan doen. We hebben veel gelachen maar ook in andere tijden 
158
had je altijd een luisterend oor. Bedankt. Anneke, Dorien, Jacopo en Alessandra, jullie waren 
in werk en privé altijd daar. Bedankt. Ook alle andere mensen met wie ik bij Antropogenetica 
en ook Oogheelkunde heb gewerkt wil ik hier graag bedanken voor de leuke en leerzame tijd.
Vrienden buiten het werk zijn onmisbaar gebleken. Lieke, de squash-uurtjes waren altijd een 
welkome uitlaatklep of we nu speelden of niet. Maar ook voor een helpende hand was je altijd 
te bellen. Norbert, fotograﬁe was en is vaak het onderwerp. Daarnaast passeerde van alles de 
revue met natuurlijk een glas wijn. Nu is het tijd voor een nieuw, wellicht gezamenlijk, foto 
project. Nathalie, je motivatie en vriendschap zijn al die tijd een steun in de rug geweest. 
Cappuccino kaneel? Dennis, Remco en Hedy. Nacht, dag, druk, vakantie of thuis en altijd 
interesse. Jullie sleurden me nukkig of niet overal mee naar toe, soms op de meest onverwachte 
momenten. Bedankt dat jullie altijd klaar stonden. De familie Oudakker, jullie vroegen altijd 
hoe het ging en waren immer gastvrij. Bedankt voor jullie steun.
Astrid, zonder jou was dit boekje er niet geweest. Als geen ander bracht je een lach, rust, 
talloze andere dingen en was je een steun en toeverlaat. Duizendmaal dank!
Mijn broers Arno en Lars en mijn ouders. Betere had ik me niet kunnen wensen. Dit proefschrift 
is ook van jullie. Het is het resultaat van jullie steun, opvoeding, en onvoorwaardelijke liefde.
 Marc
159
List of publications
Allikmets, R., A. Hutchinson, R.A. Lewis, N.F. Shroyer, K. Dalakishvili, J.R. Lupski, K. 
Steiner, D. Pauleikhoff, F. Holz, B.H.F. Weber, P.S. Bernstein, N. Singh, N. Zabriskie, 
A. Peiffer, M. Leppert, J.M. Seddon, K. Zhang, J.S. Sunness, N.S. Udar, S. Yelchits, R. 
Silva-Garcia, K.W. Small, F. Simonelli, F. Testa, M. D’Urso, R. Brancato, E. Rinaldi, 
S. Ingvast, A. Taube, C. Wadelius, E. Souied, D. Ducroq, J. Kaplan, J.J.M. Assink, J.B. 
Brink, P.T.V.M. de Jong, A.A.B. Bergen, A. Maugeri, M.A. van Driel, C.B. Hoyng, 
F.P.M. Cremers, E. Paloma, R. Coco, S. Balcells, R. Gonzàlez-Duarte, S. Kermani, P. 
Stanga, A.C. Bird, S.S. Bhattacharya, and t.i.A.S. Consortium. 2000. Further evidence for 
an association of ABCR alleles with age-related macular degeneration. The International 
ABCR Screening Consortium. Am J Hum Genet 67: 487-491.
Brunner, H.G. and M.A. van Driel. 2004. From syndrome families to functional genomics. 
Nat Rev Genet 5: 545-551.
Cremers, F.P., D.J. van de Pol, M. van Driel, A.I. den Hollander, F.J. van Haren, N.V. Knoers, 
N. Tijmes, A.A. Bergen, K. Rohrschneider, A. Blankenagel, A.J. Pinckers, A.F. Deutman, 
and C.B. Hoyng. 1998. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy 
caused by splice site mutations in the Stargardt’s disease gene ABCR. Hum Mol Genet 
7: 355-362.
den Hollander, A.I., J.B. ten Brink, Y.J. de Kok, S. van Soest, L.I. van den Born, M.A. van 
Driel, D.J. van de Pol, A.M. Payne, S.S. Bhattacharya, U. Kellner, C.B. Hoyng, A. 
Westerveld, H.G. Brunner, E.M. Bleeker-Wagemakers, A.F. Deutman, J.R. Heckenlively, 
F.P. Cremers, and A.A. Bergen. 1999a. Mutations in a human homologue of Drosophila 
crumbs cause retinitis pigmentosa (RP12). Nat Genet 23: 217-221.
den Hollander, A.I., M.A. van Driel, Y.J. de Kok, D.J. van de Pol, C.B. Hoyng, H.G. Brunner, 
A.F. Deutman, and F.P. Cremers. 1999b. Isolation and mapping of novel candidate genes 
for retinal disorders using suppression subtractive hybridization. Genomics 58: 240-249.
Go, S.L., A. Maugeri, J.J. Mulder, M.A. van Driel, F.P. Cremers, and C.B. Hoyng. 2003. 
Autosomal dominant rhegmatogenous retinal detachment associated with an Arg453Ter 
mutation in the COL2A1 gene. Invest Ophthalmol Vis Sci 44: 4035-4043.
Klevering, B.J., M. van Driel, D.J. van de Pol, A.J. Pinckers, F.P. Cremers, and C.B. Hoyng. 
1999. Phenotypic variations in a family with retinal dystrophy as result of different 
mutations in the ABCR gene. Br J Ophthalmol 83: 914-918.
Klevering, B.J., M. van Driel, A.J. van Hogerwou, D.J. van De Pol, A.F. Deutman, A.J. 
Pinckers, F.P. Cremers, and C.B. Hoyng. 2002. Central areolar choroidal dystrophy 
associated with dominantly inherited drusen. Br J Ophthalmol 86: 91-96.
Maugeri, A., M.A. van Driel, D.J. van de Pol, B.J. Klevering, F.J. van Haren, N. Tijmes, A.A. 
Bergen, K. Rohrschneider, A. Blankenagel, A.J. Pinckers, N. Dahl, H.G. Brunner, A.F. 
Deutman, C.B. Hoyng, and F.P. Cremers. 1999. The 2588G-->C mutation in the ABCR 
gene is a mild frequent founder mutation in the Western European population and allows 
the classiﬁcation of ABCR mutations in patients with Stargardt disease. Am J Hum Genet 
64: 1024-1035.
Schulz, H.L., H. Stoehr, K. White, M.A. van Driel, C.B. Hoyng, F. Cremers, and B.H. Weber. 
2002. Genomic structure and assessment of the retinally expressed RFamide-related 
peptide gene in dominant cystoid macular dystrophy. Mol Vis 8: 67-71.
van den Hurk, J.A., D.J. van de Pol, B. Wissinger, M.A. van Driel, L.H. Hoefsloot, I.J. de 
Wijs, L.I. van den Born, J.R. Heckenlively, H.G. Brunner, E. Zrenner, H.H. Ropers, and 
160
F.P. Cremers. 2003. Novel types of mutation in the choroideremia ( CHM) gene: a full-
length L1 insertion and an intronic mutation activating a cryptic exon. Hum Genet 113: 
268-275.
van Driel, M.A., J. Bruggeman, G. Vriend, H.G. Brunner, and J.A. Leunissen. 2005a. A text-
mining analysis of the human phenome. submitted.
van Driel, M.A., K. Cuelenaere, P.P. Kemmeren, J.A. Leunissen, and H.G. Brunner. 2003. 
A new web-based data mining tool for the identiﬁcation of candidate genes for human 
genetic disorders. Eur J Hum Genet 11: 57-63.
van Driel, M.A., K. Cuelenaere, P.P. Kemmeren, J.A. Leunissen, H.G. Brunner, and G. Vriend. 
2005b. GeneSeeker: extraction and integration of human disease-related information from 
web-based genetic databases. Nucleic Acids Res 33: W758-761.
van Driel, M.A., A. Maugeri, B.J. Klevering, C.B. Hoyng, and F.P. Cremers. 1998. ABCR 
unites what ophthalmologists divide(s). Ophthalmic Genet 19: 117-122.
Van Lith-Verhoeven, J.J., M.A. van Driel, I.C. Meij, L. van Laer, A.J. Pinckers, H. Kremer, 
A.F. Deutman, H.G. Brunner, F.P. Cremers, and C.B. Hoyng. 2003. Clinical Classiﬁcation 
of Autosomal Dominant Cystoid Macular Edema and Genetic Fine Mapping of the 
Underlying Defect. Invest. Ophthalmol. Vis. Sci. 44: 1496-.
